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ABSTRACT
STRUCTURE-FUNCTION RELATIONSHIPS IN BACTERIAL REGULATORY PROTEINS AND AN
ENZYME INVOLVED IN ANTIBIOTIC BIOSYNTHESIS
by
Lanlan Han
The University of Wisconsin-Milwaukee, 2017
Under the Supervision of Professor Nicholas R. Silvaggi
The first part of my thesis is focused on a new family of two-component response
regulator proteins: Aspartate-Less Regulators (ALR). They lack the catalytic aspartate
residue required for the phosphorylation mechanism of typical two component response
regulators. We are using biophysical tools to characterize two proteins with redoxsensitive ALR domains: repressor of iron transport regulator (RitR) from Streptococcus
pneumonia R6 and diguanylate cyclase Q15Z91 from Pseudoalteromonas atalantica. The
structure of inactive RitRC128S monomer showed that the ALR domain and the DNA-binding
domain are linked by an α-helix that runs the length of the entire protein, with C128 near
the C-terminal end. Bioinformatic analysis of all streptococcal RitR homologs showed that
Cys128 is strictly conserved, suggesting that RitR may be a novel redox sensor. Hydrogen
peroxide was used to oxidize the cysteine thiol group to determine the structure of the
oxidized, dimeric form of RitR. Oxidation of C128 to the disulfide caused a conformational
change that caused the DBD to release from the ALR domain. Surprisingly, the freed DBD
was observed bound to the ALR domain of the other, disulfide-linked molecule of RitR,
recapitulating almost exactly the structure of the inactive, monomeric protein. An extended
dimeric conformation was found in the RitRL86A/V93A variant. It binds to the target DNA
according to gel filtration and differential scanning fluorimetry. The crystal structure of the
ii

RitRL86A/V93A ALR domain showed an unprecedented conformational change for a response
regulator protein, where helix α4 is disordered and the two protomers swap their α5
helices to form the dimer. Combined with the C128D mutant in vivo studies, it seems that
oxidation of C128 is part of the activation mechanism, but there must be an additional
factor that leads to dimerization of the ALR domains. The second ALR protein Q15Z91 has
R61 replacing the phosphorylatable aspartate residue in the ALR domain. According to the
structure of Q15Z91 with GTP and c-di-GMP, purified Q15Z91 is an activated but productinhibited dimer. C142 is conserved in the same position as C128 in RitR, and substitution
demonstrated that C142 residue is also a redox sensor that involved in Q15Z91 activity
regulation.
The second part is a mechanistic enzymology project aimed at understanding the
structure and mechanism of the novel pyridoxal-5’-phosphate (PLP)-dependent L-arginine
hydroxylase/deaminase, MppP, from Streptomyces wadayamensis (SwMppP). SwMppP is
predicted to be a type I/II aminotransferase based on primary sequence identity. However,
NMR and ESI-MS results showed that SwMppP is not an aminotransferase, but rather a
hydroxylase. The enzyme catalyzes the oxygen-dependent hydroxylation of L-arginine,
forming 4-hydroxy-2-ketoarginine and the abortive side-product 2-ketoargine in a ratio of
1.7:1. This is exciting because SwMppP is the first PLP-dependent enzyme to react with
oxygen in any context other than oxidative decarboxylation. The discovery of this new
activity is especially surprising given that the tertiary structure of SwMppP is very similar
to that of the prototypical aminotransferase, the E. coli aspartate aminotransferase (PDB
entry 1ARS; RMSD of aligned Cα atoms is 3.7 Å). The major differences between the two
enzymes are the disordered N terminus of SwMppP, and changes of a limited number of
iii

amino acids near the PLP cofactor. The N-terminal helix transitions from a disordered,
random-coil state to a helical conformation covering the active site only if/when the
substrate is bound. Specific roles of the un-conserved residues in the active site are being
studied by mutagenesis. So far, most of the SwMppP mutants have lost the hydroxylase
activity and only produce abortive side product 2-ketoarginine. Our mechanistic studies
have revealed that formation of the fully oxidized (hydroxylated) product requires 2
equivalents of dioxygen, while formation of 2-ketoarginine requires only one equivalent of
dioxygen. Interestingly, the hydroxyl group of 4-hydroxy-2-ketoarginine comes from H2O,
not dioxygen. Mutagenesis, structural and kinetic studies were used to understand how the
residues in the active site stabilize the quinonoid form of the L-arginine-PLP complex to
promote the reaction with dioxygen. Our structural and kinetic characterization of the
wild-type and variant forms of SwMppP have allowed us to propose a model where the
oxygen incorporated in the hydroxy-arginine product is derived from water rather than
from dioxygen. In addition, SwMppP exhibits very high substrate specificity. Either change
on the substrate length or guanidine group would result in no binding affinity or little
activity.

iv

© Copyright by Lanlan Han, 2017
All Rights Reserved

v

TABLE OF CONTENTS
ABSTRACT............................................................................................................................................ii
LIST OF FIGURES ............................................................................................................................... x
LIST OF TABLES ............................................................................................................................ xvii
ACKNOWLEDGMENTS................................................................................................................ xxiv
Chapter 1 Introduction to Bacterial Signal Transduction
1.1 Histindine Kinase ......................................................................................................................3
1.2 Response regulators (RRs) .....................................................................................................7
1.2.1 Activation mechanism of phosphorylation dependent RRs ................................................ 7
1.2.2 Conserved residues in phosphorylation-dependent RRs ................................................... 13
1.2.3 Atypical, phosphorylation-independent RRs containing the conserved Asp residue 16
1.2.4 Aspartate-Less Regulators (ALR) .............................................................................................. 18
1.2.4.1 Repressor of iron transport regulator (RitR)........................................................................................ 19
1.2.4.2 Diguanylate cyclase Q15Z91 .......................................................................................................................... 26

1.3 References ................................................................................................................................ 34
Chapter 2 The Atypical Response Regulator Protein Repressor of Iron Transport
Regulator (RitR) Exhibits an Alternative Mechanism of Activation
2.1 Background .............................................................................................................................. 41
2.2 Methods ..................................................................................................................................... 41
2.2.1 Cloning, expression, and purification of wild-type and mutant RitR .............................. 41
2.2.2 Preparation of purification of the oxidized RitR dimer (RitRox) ...................................... 43
2.2.3 Preparation of protein for structure determination ........................................................... 43
2.2.4 Differential scanning fluorimetry ............................................................................................. 44
2.2.5 Site-directed mutagenesis........................................................................................................... 46
2.2.6 Determination of C128 pKa by DTNB assay 6, 7 ....................................................................... 47
2.2.7 Crystallization, structure determination, and model refinement ................................... 48
2.2.8 Synthesis of binding site 3 (BS3) dsDNA oligonucleotides................................................. 52
2.2.9 Size exclusion chromatography (SEC) ..................................................................................... 53
2.2.10 Non-reducing SDS-PAGE and Native SDS-PAGE (NSDS) .................................................... 54

2.3 Results ....................................................................................................................................... 55
2.3.1 Determining the optimal RitR storage buffer for crystallization ..................................... 55
2.3.2 Monomeric structure of RitRC128S .............................................................................................. 57
2.3.3 The thiol group of the conserved C128 residue has a perturbed pKa ............................ 59
2.3.4 The structure of RitRox ................................................................................................................. 62
2.3.5 RitR incubated with different metals ....................................................................................... 66
2.3.6 Structural features important for RitR dimerization .......................................................... 69
2.3.7 Mutations to the gate residues L86 and V93 result in an “extended” dimer................. 81
2.3.8 Size exclusion chromatography of RitR : BS3 and RitRL86A/V93A : BS3 .............................. 83
2.3.9 Single mutants in helix α4 also bind to BS3-1........................................................................ 86
2.3.10 Crystallization of RitRL86A/V93A .................................................................................................. 87
2.3.11 Shorten BS3-1 length for crystallization............................................................................... 89

vi

2.3.12 The ratio of RitRL86A/V93A : BS3-3 and RitRL86A/V93A : BS3-6 ................................................ 90
2.3.13 Structure of the RitRL86A/V93A REC domain ............................................................................. 92
2.3.14 Structure of the RD2LV REC domain construct ................................................................... 97
2.3.15 RitR with GADDY motif (RitRGADDY) ......................................................................................... 99
2.3.16 The role of C128 in the RitRL86A/V93A variant ......................................................................101

2.4 Conclusions ............................................................................................................................ 104
2.5 References .............................................................................................................................. 110
Chapter 3 Uncharacterized Protein Q15Z91 from Pseudoalteromonas atlantica is an
ALR-Regulated Diguanylate Cyclase
3.1 Introduction ........................................................................................................................... 113
3.2 Methods ................................................................................................................................... 114
3.2.1 Expression and purification of Q15Z91.................................................................................114
3.2.2 Mutagenesis of Q15Z91 ..............................................................................................................116
3.2.3 Crystallization, structure determination, and model refinement .................................117
3.2.4 Quaternary structure characterization by size exclusion chromatography ...............119
3.2.5 Size exclusion chromatography with multi-angle light scattering (SEC-MALS) .........119
3.2.6 Biofilm assay on borosilicate tubes ........................................................................................120
3.2.7 Enzymatic assay ...........................................................................................................................121
3.2.7.1 RP-HPLC based end-point assay ............................................................................................................... 121
3.2.7.2 Biomol Green microplate assay................................................................................................................. 121
3.2.7.3 EnzCheck® Pyrophosphate Assay Kit (Sigma) ................................................................................. 122

3.3 Results ..................................................................................................................................... 122
3.3.1 Q15Z91 is an ALR-regulated diguanylate cyclase...............................................................122
3.3.2 Purification of Q15Z91 ...............................................................................................................124
3.3.3 The structure of Q15Z91 with c-di-GMP and citrate bound .............................................125
3.3.4 Probing the roles of conserved residues by site-directed mutagenesis.......................134
3.3.5 The oligomeric state of Q15Z91...............................................................................................136
3.3.6 Preliminary quantitation of biofilm phenotype..................................................................139
3.3.7 Preliminary enzymatic activity................................................................................................142

3.4 Discussion ............................................................................................................................... 144
3.5 References .............................................................................................................................. 146
Chapter 4 An Unusual PLP-Dependent Enzyme in Enduracididine Biosynthesis
4.1 Introduction ........................................................................................................................... 148
4.2 Biosynthesis of enduracididine ........................................................................................ 154
4.3 Pyridoxial 5’-phosphate is a versatile cofactor ............................................................ 159
4.4 Aminotransferases (ATase) ............................................................................................... 166
4.4.1 The AATase active site................................................................................................................167
4.4.2 Conformational changes associated with catalysis ............................................................168
4.4.3 Dual substrate recognition .......................................................................................................169

4.5 L-3,4-dihydroxyphenylalanine (L-DOPA) decarboxylase.......................................... 172
4.5.1 Mechanisms of decarboxylation and oxidative deamination..........................................172
4.5.2 Structure of human DOPA decarboxylase.............................................................................174

vii

4.6 References .............................................................................................................................. 177
Chapter 5 Streptomyces wadayamensis MppP is a PLP–Dependent L-Arginine
Oxidase in the L-Enduracididine Biosynthetic Pathway
5.1 Background ............................................................................................................................ 183
5.2 Methods ................................................................................................................................... 188
5.2.1 Cloning, expression, and purification of S. wadayamensis and Streptomyces
globisporus MppP...................................................................................................................................188
5.2.2 UV/Vis spectroscopy of SwMppP and its mutants reacting with L-Arginine and
dioxygen ...................................................................................................................................................191
5.2.3 Characterization of MppP reaction products by NMR .......................................................191
5.2.4 Characterization of MppP reaction products by mass spectrometry............................192
5.2.5 Ammonium detection by NADH based GDH assay3 ............................................................193
5.2.6 Defining the relationship between O2 usage and H2O2 formation .................................194
5.2.7 Reactions with 18O2, H218O .........................................................................................................194
5.2.8 Crystallization of wild-type and mutant forms of SwMppP, as well as SgMppP .........195
5.2.9 Preparation of 2-keto-arginine (3) .........................................................................................199
5.2.10 Steady State Enzyme Kinetics ................................................................................................199
5.2.11 The stoichiometry of L-Arg and O2 in the reaction...........................................................200
5.2.12 SwMppP substrate specificity ................................................................................................200
5.2.13 Testing for communication between the two binding sites of SwMppPD188A ............202
5.2.13.1 Isothermal Titration Calorimetry (ITC) ............................................................................................. 202
5.2.13.2 Determination of binding constants by fluorescence titration .............................................. 202
5.2.14 Pre-steady state enzyme kinetics .........................................................................................203

5.3 Results ..................................................................................................................................... 205
5.3.1 The products of SwMppP with L-Arg and O2 ........................................................................205
5.3.2 Ammonia is also a product of SwMppP with L-Arg and O2 ...............................................207
5.3.3 SwMppP is an oxidase and not an oxygenase ......................................................................208
5.3.4 The structures of SwMppP ........................................................................................................211
5.3.5 The structure of the SwMppP•L-Arg complex......................................................................217
5.3.6 Structures of SwMppP•product complexes ..........................................................................220
5.3.7 Characterization of N-terminus and active site residues .................................................223
5.3.8 Characterization of SwMppP and mutants ...........................................................................224
5.3.8.1 Stability of SwMppP and mutants by differential scanning fluorimetry.............................. 224
5.3.8.2 Determination of the reaction products of the mutants............................................................... 224
5.3.8.3 The steady state parameters monitored by O2 consumption .................................................... 227
5.3.9 Full oxidation of L-Arg requires two equivalents of O2 .....................................................239
5.3.10 Substrate specificity .................................................................................................................241
5.3.11 The structure of SwMppP with D-Arg ..................................................................................243
5.3.12 Proposed mechanism of SwMppP.........................................................................................247
5.3.13 Presteady state kinetics of SwMppP ....................................................................................248
5.3.14 Preliminary pre-steady state kinetics analysis of SwMppPH29A....................................254
5.3.15 Preliminary pre-steady state kinetics analysis of SwMppPΔ1-22 ...................................256
5.3.16 Independent binding between two binding sites of SwMppP.......................................257

5.4 Discussion ............................................................................................................................... 260
5.5 Reference ................................................................................................................................ 265
Appendices .................................................................................................................................... 268
viii

Appendix A: Crystallographic data collection and refinement statistics. ..............................268
Appendix B: Crystallographic data collection and refinement statistics. ..............................270
Appendix C: Crystallographic data collection and refinement statistics................................271
Appendix D: Proton NMR spectra for the products of SwMppP and its N-terminal mutants
with L-Arg.................................................................................................................................................275
Appendix E: Proton NMR spectra for SwMppP active site mutants with L-Arg. ...................277
Appendix F: Overlay the structure (A) and active site (B) of SwMppPL-Arg with
SwMppP2 ................................................................................................................................................279
Appendix G: Overlay the structure (A) and active site (B) of SwMppPL-Arg with
SwMppP3 ................................................................................................................................................279

ix

LIST OF FIGURES
Chapter 1
Figure 1-1

Schematic diagram of a typical two-component signal transduction
system of the OmpR/PhoB family

2

Figure 1-2

Prototypical histidine kinase with its cognate RR

4

Figure 1-3

Schematic showing of VicK domain organization

6

Figure 1-4

PhoB dimerization mechanism

9

Figure 1-5

Structural comparison of 3 classes of full-length OmpR/PhoB subfamily

11

Figure 1-6

Overlay of the inactive CheY with BeF3 activated CheY dimer

12

Figure 1-7

Conserved residues in phosphorylation-activated response regulators

15

Figure 1-8

The Structures of ChxR REC domain, full length ChxR dimer, and GlnR

Figure 1-9

REC domain

17

Sequence Alignment of RitR and PhoB

21

Figure 1-10 The structure of the RitR receiver domain

22

Figure 1-11 The α4 helix of response regulator REC domains appears to be
particularly malleable

23

Figure 1-12 Structure of the RitR “active site”

25

Figure 1-13 The structures of PleD monomer and dimer

28

Figure 1-14 The Wsp dimer, REC domain of WspR dimer and tetramer structure

32

Chapter 2
Figure 2-1

The structure of full-length RitRC128S and a close-up view on the interdomain interface

58
x

Figure 2-2

The pKa of conserved C128 in non-Group A/B subset of Streptococcal
species by DTNB assay

61

Figure 2-3

Different amounts of oxidized RitR dimer in different buffer conditions 63

Figure 2-4

The structure of RitRox

65

Figure 2-5

Oligomer state of RitR after incubated with different metals

67

Figure 2-6

Non-reducing-PAGE and native SDS-PAGE results of RitR treated
with different metals

Figure 2-7

68

Cα trace of full-length RitRC128S structure with the sites chosen for
mutagenesis marked as colored spheres

Figure 2-8

Oligomer states of wild-type RitR, K10D, N53D and N53A and the putative
active site of RitR

Figure 2-9

71

73

Comparison of gate regions of two ALR REC domains, RitR and ChxR, and
the canonical REC domains of PhoB and PhoP

Figure 2-10 Results of SEC experiments on the Y100A and D81A variants

75
76

Figure 2-11 Oligomer states of RitR mutants (F96G, Y102A, R113A, C128A and Y163F
with or without DTT treatment

77

Figure 2-12 The effects of gate residues on RitR dimerization

80

Figure 2-13 SEC retention times of wild-type RitR, RitRox, and RitRL86A/V93A

82

Figure 2-14 Size exclusion chromatography results for RitR and RitRL86A/V93A with
and without the BS3-1 dsDNA oligonucleotide

84

Figure 2-15 Tm value change of RitR, RitRox, and RitRL86A/V93A after incubated with
BS3-3 dsDNA

86

Figure 2-16 Gate residue variants bind to the dsDNA BS3-1

xi

87

Figure 2-17 Complex peak area comparison of 216 μM RitRL86A/V93A with 100 μM
of BS3-1, BS3-2, BS3-3, BS3-4 and BS3-5

89

Figure 2-18 Gel filtration results of different ratios of RitRL86A/V93A : BS3-3 and
RitRL86A/V93A : BS3-6

91

Figure 2-19 Ribbon representation of the RDLV structures

94

Figure 2-20 Comparison of the active site and switch residues in the wild-type
RitR REC domain and the RDLV variant

96

Figure 2-21 Ribbon representations of the RD2LV REC domain structure and the
RD2LV asymmetric unit

97

Figure 2-22 Sequence alignment of RitR homologs with other DNA binding proteins
in the OmpR family

99

Figure 2-23 Size exclusion chromatography results of the RitRGADDY mutant with
or without H2O2 or DTT treatments
Figure 2-24 The LVC triple mutant still binds to the BS3-3 target dsDNA

100
102

Figure 2-25 Size exclusion chromatography results of RitRC128D and overlay of
RitRC128D and RitRC128S structures

103

Figure 2-26 Proposed thiol group oxidation and reduction metabolism of RitR

106

Figure 2-27 The proposed RitR activation mechanism

109

Chapter 3
Figure 3-1

Sequence alignment of Q15Z91 with the RitR REC domain

123

Figure 3-2

The structure of Q15Z91 dimer with c-di-GMP and citrate bound

126

Figure 3-3

ALR domains of the Q15Z91 dimer and the overlay of the Q15Z91 and

xii

RitR ALR domains
Figure 3-4

128

Two molecules of c-di-GMP dimerize through stacking of their bases
and bind to the inhibitory sites on chain A and chain B

Figure 3-5

130

Citrate binds in slightly different orientations in the active sites of
chain A and chain B

131

Figure 3-6

The structure of Q15Z91 with c-di-GMP and GTP bound

Figure 3-7

The affects of H2O2 or DTT treatment on the oligomeric states of

133

Q15Z91 and Q15Z91free

136

Figure 3-8

SEC-MALS results for Q15Z91free

137

Figure 3-9

The oligomeric states of Q15Z91I99A, c-di-GMP free Q15Z91I99A,
Q15Z91G102A, c-di-GMP free Q15Z91G102A, Q15Z91C142S, and
Q15Z91R212N/D215A with or without H2O2 or DTT treatment

139

Figure 3-10 Biofilm formation after IPTG induction in Origami2 cells with Q15Z91
related plasmids

141

Figure 3-11 Time courses for the reaction of Q15Z91 and Q15Z91free with
0.2 mM GTP in the absence or presence of H2O2 or DTT

143

Chapter 4
Figure 4-1

The numbers of new antibiotic compounds approved have been declining
steadily since 1980

Figure 4-2

148

Comparison of the mannopeptimycin biosynthetic cluster with that of
enduracidin (partial) and the corresponding sequence similarity of L-End
biosynthetic genes

155
xiii

Figure 4-3

Ribbon diagrams of representative structures of the seven Fold Types of PLPdependent enzymes

Figure 4-4

164

The reaction catalyzed by aspartate aminotransferase and the structure and
active site of aspartate aminotransferase

Figure 4-5

166

Dual substrate recognition in lysine ε-aminotransferase from Mycobacterium
tuberculosis

171

Chapter 5
Figure 5-1

Absorbance spectra recorded on a Hewlett- Packard 8453 diode array
spectrophotometer for the reaction of 30 μM SwMppP with 2 mM L-Arg and
ambient (∼250 μM) O2

Figure 5-2

Figure 5-3
Figure 5-4

185

Proton NMR results of L-Arg and the reaction of 10 μM SwMppP with 2.0
mM L-Arg, both in 20 mM sodium phosphate pH 8.4 buffer

186

Compounds encountered in our studies of SwMppP

187

13C-NMR

spectrum of the reaction of 10 μM SwMppP with 2.0 mM L-Arg in

20 mM sodium phosphate pH 8.4 buffer
Figure 5-5

The ammonium formation in the reaction of SwMppP with L-Arg is
proportional to the L-Arg concentration according to the GDH assay

Figure 5-6

Figure 5-8

208

O2 regeneration after adding catalase into equilibrated SwMppP with varied
[L-Arg] solutions

Figure 5-7

206

209

Mass spectrometric analysis of SwMppP with L-Arg in the presence of 18O2
or H218O

210

The structure comparison between SwMppP and E. coli AATase

213

xiv

Figure 5-9

The active site of SwMppP

216

Figure 5-10 The structure and active site comparison between SwMppP and SwMppPLArg

218

Figure 5-11 The external aldimine structure in active site of SwMppPL-Arg

219

Figure 5-12 The active site of SwMppP•4HKA

221

Figure 5-13 The active site of SwMppP•2KA

222

Figure 5-14 Different residues in the active site of SwMppP•L-Arg

223

Figure 5-15 The active site of E15AL-Arg

227

Figure 5-16 The spectrum of SwMppP and its N terminus mutants with L-Arg

230

Figure 5-17 The spectrum of H29A with L-Arg and overlay the active site of SwMppP
and H29A

232

Figure 5-18 Overlaying the active site of H29A and H29AL-Arg, H29AL-Arg and
SwMppPL-Arg

234

Figure 5-19 The spectrum of F115Y with L-Arg and overlay the active site of SwMppP
and F115Y

235

Figure 5-20 The spectrum of F191Y with L-Arg

237

Figure 5-21 The spectrum of D218S with L-Arg

238

Figure 5-22 The spectrum of SwMppP with L-arginine, L-ornithine, L-citrulline, Lcanavanine, methyl-L-arginine and D-arginine

242

Figure 5-23 The active site of SwMppPD-Arg

244

Figure 5-24 The D-Arg dissociation constant determination

245

Figure 5-25 Dissociation constant determination of D-Arg into SwMppP by fluorescence
determination excited at 415 nm

xv

246

Figure 5-26 Global fitting of pre-steady state kinetics data in KinTek Explorer

250

Figure 5-27 The model used for global fitting by simulation in KinTek Explorer

252

Figure 5-28 Accumulation of the fully oxidized 4-hydroxy-2-ketoarginine and the
uncoupled 2-ketoarginine based on the global fitting by simulation

254

Figure 5-29 Comparison of fluorescence (λex=415 nm) and absorbance (510 nm) of
wild-type SwMppP and the H29A mutant reacting with L-Arg

255

Figure 5-30 Fluorescence excited at 415 nm of SwMppPΔ1-22 with L-Arg substrate under
anaerobic condition

256

Figure 5-31 Fluorescence change of SwMppPD188A with different concetrations of L-Arg
and the fitting data at 480 nm

259

xvi

LIST OF TABLES
Chapter 2
Table 2-1

Primers used for mutagenesis

46

Table 2-2

Sequences of the BS3 variants used in RitR binding assays

53

Table 2-3

Compounds from the Solubility & Stability Screen (Hampton Research)
giving the highest Tm values in the DSF assay

Table 2-4

56

Buffers from the Slice pH Screen (Hampton Research) giving the highest
Tm values in the Thermofluor assay

56

Table 2-5

Summary of the rationale of each mutation

71

Table 2-6

Buffers from the Solubility & Stability Screen (Hampton Research) giving
the highest Tm values in the Thermofluor assay

Table 2-7

82

Buffers from the lice pH Screen (Hampton Research) giving the highest
Tm values in the Thermofluor assay

83

Chapter 3
Table 3-1

Primers used for mutagenesis

Table 3-2

Buffers from the Solubility & Stability Screen giving the highest Tm values

Table 3-3

117

in the DSF assay

124

Buffers from the Slice pH Screen giving the highest Tm values in the

125

DSF assay
Table 3-4

Characteristics of wild-type and mutant forms of Q15Z91

xvii

135

Chapter 5
Table 5-1

Primers used for mutagenesis

189

Table 5-2

Tm values of SwMppP and mutants

224

Table 5-3

The products of SwMppP and its mutants with L-Arg and O2

225

Table 5-4

Steady state parameters monitored by O2 consumption

228

Table 5-5

The ratio of [O2 consumption]/[L-Arg added] of SwMppP and its mutants
reactions

240

xviii

LIST OF SCHEMES
Chapter 1
Scheme 1-1 Metabolism of cyclic-di-GMP

27

Scheme 1-2 Schematic representation of the diguanylate cyclase reaction where
two GTP molecules are condensed to form c-di-GMP

30

Chapter 2
Scheme 2-1 The mechanism of DTNB assay

47

Chapter 4
Scheme 4-1 Compounds mentioned in this chapter 4

150

Scheme 4-2 Enduracididine-containing natural products

152

Scheme 4-3 L-capreomycidine biosynthesis mechanism by VioD

157

Scheme 4-4 Some examples of reactions involving PLP

161

Scheme 4-5 Decarboxylation and oxidation deamination by DOPA decarboxylase

173

Chapter 5
Scheme 5-1 Ammonia assay reaction

193

Scheme 5-2 Proposed mechanism of SwMppP

248

xix

LIST OF ABBREVIATIONS
2KA

2-ketoarginine

2KE

2-ketoenduracididine

4HKA

4-hydroxy-ketoarginine

AATase

aspartate aminotransferase

ALR

aspartate-less receiver

APS

Advanced Photon Source

Atase

aminotransferase

c-di-GMP

bis-(3’-5’)-cyclic dimeric guanosine monophosphate

CA

catalytic ATP/Mg2+ binding site

D-βhEnd

D-β-hydroxyenduracididine

DBD

DNA-binding domain

DGC

diguanylate cyclase

DHp

dimerization interface and the phosphorylatable histidine residue

DSF

Differential scanning fluorimetry

DTNB

5,5’-dithiobis-(2-nitrobenzoic acid)

DTT

dithiothreitol

EcAAT

E. coli aspartate aminotransferase

EMSA

electrophoretic mobility shift assay

ESI-MS

mass spectrometry with electrospray ionization

FDASIA

Food and Drug Administration Safety and Innovation Act

GAIN

Generating Antibiotic Incentives Now

GDH

L-glutamate dehydrogenase

xx

GTP

guanosine triphosphate
histidine kinase, adenylyl cyclases, methyl-accepting chemotaxis proteins,

HAMP

and phosphatase

HK

histidine kinase

HPt

histidine-containing phosphoryl transmitter domain

HTH

helix-turn-helix

IPTG

isopropyl β-D-1-thiogalactopyranoside

ITC

Isothermol titration Calorimetry

L-Cap

L-capreomycidine

L-DOPA

L-3,4-dihydroxyphenylalanine

L-End

L-enduracididine

L-βhEnd

L-β-hydroxyenduracididine

LAAO

L-amino acid oxidase

LCMS

Liquid Chromatograph Mass Spectrometer

LS-CAT

Life Science Collaborative Access Team

MCPs

methyl-accepting chemotaxis proteins

MESG

2-amino-6-mercapto-7-methylpurine ribonucleoside

MRSA

methicillin-resistant Staphylococcus aureus

NADH

nicotinamide adenine dinucleotide

NMR

nuclear magnetic resonance

NSDS

native SDS-PAGE

OCST

one-component signal transduction

PAS

Per, ARNT and SIM

xxi

PEG

polyethylene glycol

pGpG

5’-phosphoguanosylyl-(3’-5’)-guanosine

PLP

pyridoxal-5’-phosphate

PMP

pyridoxamine phosphate

PNP

purine nucleoside phosphorylase

Q1

Quinonoid I

Q2

Quinonoid II

RD2LV

RitR(L86A/V93A) REC domain, residues 1-132

RDLV

RitR(L86A/V93A) REC domain, residues 1-124

REC domain

receiver domain

RitR

repressor of iron transport regulator

rmsd

root-mean-square deviation

RP-HPLC

reverse phase high performance liquid chromatography

RR

response regulator

SAD

single-wavelength anomalous diffraction

SAXS

small-angle X-ray scattering

SDS-PAGE

sodium dodecyl sulfate−polyacrylamide gel electrophoresis

SEC

size exclusion chromatography

SEC-MALS

size exclusion chromatography with multi-angle light scattering

SSM

secondary structure matching

TCST

two-component signal transduction

TLS

translation-libration-screw

TNB-

2-nitro-5-thiobenzoate

xxii

VRE

vancomycin-resistant enterococci

xxiii

ACKNOWLEDGMENTS
First and foremost, I would like to express my sincere gratitude to my advisor,
Professor Nicholas R. Silvaggi, for giving me the opportunity to work on such interesting
and exciting projects. He guided me through my PhD as a constructive, highly supportive
mentor. I greatly appreciate his patient mentoring, excellent advice and professional
training on crystallography. And also thank him for giving me chances to attend
crystallography workshops and teaching me scientific writing skills. All of these would lead
me become a real scientist. He always remains inspiring, active, and humorous, which
makes our lab in a pleasant and relaxed environment. It is my great pleasure to be a
member of the Silvaggi Lab.
I am very grateful to my committee, Professor Alexander A. Arnold, Professor Sonia
Bardy, Professor David N. Frick, Professor Graham R. Moran and Professor Xiaohua Peng
for their encouragement and insightful comments for my research and dissertation. I want
to sincerely thank Professor Alexander A. Arnold for his kind collaboration and
professional suggestions on my projects. Sincerely thank Professor David N. Frick for his
support and suggestions on the DNA foot printing and ITC experiments. Sincerely thank
Professor Xiaohua Peng for her support on the oligonucleotide synthesis. I also want to
especially thank Professor Graham R. Moran for his great help on my SwMppP project,
including the instruments training for enzyme kinetics, data analyzing, and answering my
questions.
I also want to especially thank Dr. Kenneth Johnson for all suggestions on the global
fitting of presteady state data. I want to thank Professor Andrew Ulijasz and Professor Alan
xxiv

Schwabacher, our great collaborators, for sharing knowledge and experience to solve
problems on my projects.
I want to greatly thank Spencer Anderson, Keith Brister, Joseph Brunzelle, Elena
Kondrashkina, David Smith, and Zdzislaw Wawrzak from Life Sciences Collaborative Access
Team, Advanced Photon Source in Argonne National Laboratory for their help in data
collection and processing. Additionally, I am also grateful for the people who taught me
new techniques: Dr. Frank Holger Foersterling (NMR), Revathi Kodali and Zhiqiang Wang
(MS), Amber Bakkum and Dr. Blake Hill at the Medical college of Wisconsin (SEC-MALS).
I would like to thank all previous and current members of the Silvaggi Lab including Dr.
Zahra Mashhadi, Dr. Lisa S. Mydy, Joshua Weiner, Alexander Gardner, Nemanja Vuksanovic
and Lamia T. Badhon for their kind assistance and support in my study. I also would like to
express my gratitude to the faculty members and staff of the Department of Chemistry and
Biochemistry at University Wisconsin-Milwaukee.
I want to especially thank my husband, Yongtao Zhu, for his love, sharing on all ups and
downs, indulgent to my every temper, unconditionally great support and encouragement
all the time. I could not have accomplished this without his restless inspiration.
Last but not the least, thank my parents, Naiguo Han and Haimei Chen, for their
understanding, support and love, which make it possible for me to reach this destination. I
also want to thank my lovely son Leo J. Zhu, who gives me endless energy and happiness. I
would also like to thank all my friends in Milwaukee, especially Guanguan Li, for all her
help in these years.

xxv

Chapter 1
Introduction to Bacterial Signal Transduction
All cells sense and respond to environmental stimuli using signal transduction systems.
In prokaryotes, these systems typically take the form of either one-component signal
transduction (OCST) systems or two-component signal transduction (TCST) systems. OCST
systems consist of one protein, which contains both input (sensory) and output (effector)
domains, but lacks phosphotransfer domains15. The quorum-sensing protein TraR

16

from

Agrobacterium tumefaciens is a one-component signaling system. When the autoinducer N(3-oxo-octanoyl)-L-homoserine lactone binds to the N-terminal domain, TraR dimerizes
and binds to DNA to activate expression of plasmid conjugal transfer genes

16, 17.

In

contrast, the more common TCST systems usually consist of five parts: (1) a sensory
protein to detect the stimulus, (2) an autophosphorylated histidine kinase (HK; often part
of the sensory protein), (3) a response regulator (RR) that accepts the phosphoryl group
from the HK, (4) a target that the response regulator acts on, and (5) a phosphatase to
restore the RR to its inactive state. The name “two-component” signal transduction system
refers to the histidine kinase/response regulator pair. A typical TCST system is illustrated
schematically in Figure 1-1. The sensor domain of the transmembrane histidine kinase
protein triggers autophosphorylation of a specific histidine side chain of the HK domain in
response to the stimulus, which can be the binding of some ligand
osmolality

20,

temperature

21

and nutrients

22.

18,

changes in pH

19,

The phosphoryl group on the HK is then

transferred onto the conserved aspartate residue on the receiver (REC) domain of a
cognate response regulator protein. This phosphotransfer reaction is catalyzed by the

1

response regulator itself and requires Mg2+.

Cytoplasmic membrane
ATP

ADP

Hi

His

Pi

s--

P

DBD

Asp REC

P Asp REC
P Asp REC

DBD

OR
DBD

DBD

REC Asp
Asp REC

DBD

DOWNSTREAM EFFECTS

Figure 1-1: Schematic diagram of a typical two-component signal transduction system of the
OmpR/PhoB family5. The stimulus (black solid circle) is represented as a small molecule that is
recognized by the sensor-kinase (blue); ligand binding triggers autophosphorylation of the histidine
kinase domain. The inactive response regulator (white) encounters the phosphorylation HK and
transfers the phosphate group to an aspartate residue in the receiver domain (REC) of the response
regulator. Inactive (unphosphorylated) response regulator proteins can exist as monomeric or inactive
dimeric conformations. Phosphorylation of the REC domain causes conformational changes that result
in formation of the active dimer conformation of the RR (green). The response regulator in this example
has a DNA-binding domain (DBD) as the output domain, and activation would result in either up- or
down-regulation of transcription from a specific gene locus.

2

Signal transduction systems in prokaryotes were recently found to be more
complicated than originally thought due to the discovery of auxiliary factors 23 and diverse
phosphotransmission pathways, such as the ArcB-ArcA anoxic redox control system in E.
coli

24,

the CheA-CheY/CheB chemotaxis system in E. coli 25, the KinA/KinB-Spo0F-Spo0B-

Spo0A sporulation control system in Bacillus subtilis

7,

and Ser/Thr and Tyr

phosphorylation systems mediated by bacterial eukaryotic-like serine/threonine and
tyrosine kinases and the cognate PP2C phosphatases26-28.

1.1 Histindine Kinase
According to the domain compositions, HKs can be generally divided into two types:
orthodox kinases and hybrid kinases. Orthodox histidine kinases typically contain a
transmembrane domain, a four-helix coiled coil HAMP (histidine kinase, adenylyl cyclases,
methyl-accepting chemotaxis proteins, and phosphatase) domain, a PAS (Per, ARNT and
SIM) 29 domain, and a C-terminal transmitter domain. The transmitter domain contains the
dimerization interface and the phosphorylatable histidine residue (DHp), and a catalytic
ATP/Mg2+ binding site (CA). EnvZ is an orthodox HK from E. coli that located in the inner
membrane and contains two transmembran regions and a large cytoplasmic domain. It
senses environmental osmolarity changes

1

and then phosphorylates the cognate RR

protein OmpR, which ultimately regulates the expression of the outer membrane porins
OmpF and OmpC 30 (Figure 1-2A). At high osmolality, OmpF is repressed and OmpC is the
major outmembrane porin. It was also found that higher osmolality induces intra-helical H
bonds, which enhances the H243 autophosphrylation and phosphoryl transfer to OmpR31.
3
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Figure 1-2: Prototypical histidine kinase with its cognate RR: Osmosis control (EnvZ 1-OmpR) (A), a
typical hybrid histidine kinase system, ArcB-ArcA 2 (B) and the KinA/KinB-Spo0F-Spo0B-Spo0A system 7
(C), which is involved in phosphor-relay control. HPt: Histidine-containing phosphoryl transmitter
domain.
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HKs usually have two or more transmembrane regions that separate the periplasmic
sensor region from the cytoplasmic transmitter domain. Some orthodox HKs do not have a
transmembrane region, like the chemotaxis kinase CheA32 and the nitrogen regulatory
kinase NtrB33. PAS domains are common in sensor proteins and can sense diverse
environmental or internal signals, including ligands, light, oxygen level and redox change34.
The architecture of proteins containing PAS domains is diverse, but the overall structures
of PAS domains are conserved35. Most PAS domains contain a central antiparallel β sheet
with several α helices packed against one face35, as exemplified by VicK36 from
Streptococcus mutans (Figure 1-3). The PAS domain contains a five-stranded central β sheet
surrounded by five α helices. The uppermost HAMP domain consists four parallel α helices
from two chains. Deletion of HAMP and PAS domains impaired the phosphatase activity of
VicK37. The dimerization domain is usually composed of two long α helices. The phosphoryl
receptor histidine locates in the helix (H217 in VicK). The loop connecting the two α helices
determines the specificity of the receptor for one or more specific RR proteins38. The main
body of kinases CA domains is conserved, consisting of an α/β-sandwich fold with a fivestranded mixed β sheet and three α helices, as observed in DesK39 and PhoQ40. This domain
is structurally homologous to the ATPase domains of DNA gyrase B41, MutL42, and Hsp9043.

5

Figure 1-3: Schematic showing of VicK domain organization (A) and ribbon representation of VicK structure
(PDB ID: 4I5S

36)

(the transmembrane domain is not included in the structure) (B). The colors of different

domains in chain A are matching the schematic from A. Chain B is colored in grey. The conserved H217
residues in the DHp domain are shown in stick with red carbon atoms.

6

Hybrid kinases are found in some prokaryotes and almost all eukaryotes

44.

Hybrid

kinases contain multiple phosphodonor and phosphoacceptor sites and undergo multi-step
phospho transfer, such as ArcB

2, 24

(Figure 1-2B). ArcB from E. coli that is involved in

anoxic redox control (Arc), is a typical HK of the hybrid kinase family. ArcB contains two Nterminal transmembrane regions, a kinase core, and a second His-containing
phosphotransfer domain. Once the N-terminal transmembrane domain senses the stimulus,
the signal is propagated into the transmitter domain by the HAMP domain, which triggers
dimerization via the dimerization domain. The resulting four-helix bundle of the dimer is
cross-phosphorylated on a conserved histidine residue of the dimerization domain using
ATP and Mg2+. The complexity of hybrid kinase structures allows different regulatory
pathways.

1.2 Response regulators (RRs)
1.2.1 Activation mechanism of phosphorylation dependent RRs
In prokaryotic TCST systems, the most common and well-studied RRs are
transcriptional regulators

15.

They have DNA-binding domains that bind specific DNA

sequences, and usually function as homodimers. The largest subgroup of DNA binding RRs
is OmpR/PhoB family. The RRs in OmpR/PhoB family are characterized with a REC domain
and a winged helix-turn-helix domain connected by a linker 45.
X-ray crystal structures have been determined for a number of full-length RR proteins
from the OmpR/PhoB family10, 46-48. In addition, the structures of some members of both

7

families have been determined in both the inactive, unphosphorylated and active,
phosphorylated states. The latter is commonly approximated by BeF3 adducts that mimic
the actual phosphorylated protein, owing to the difficulty of producing fully
phosphorylated (i.e. homogenous) protein for crystallization studies. The ability to
compare the structures of unphosphorylated and “phosphorylated” RRs has allowed some
insight into the phosphorylation-induced activation mechanisms in these proteins14, 48.
The REC domains of OmpR/PhoB subfamily adopt a sandwich (β/α)5 topology with a
central five-stranded parallel β sheet surrounded by 3 and 2 α helices on both sides (e.g.
PhoB in Figure 1-4). The phosphorylatable aspartate usually located in the loop between
β3 and α3, and the other two acidic residues usually located in the loop between β1 and α1.
These three acidic triad residues are involved in the Mg2+ coordination and phosphoryl
transfer

from

cognate

HK.

They

dimerize

through

α4-β5-α5

interface

upon

phosphorylation.
One well studied RR of OmpR/PhoB family is PhoB5, which controls the cellular
response to the phosphate-limitation in PhoR-PhoB5 (known as PhoP in some organisms)
TCST system in E. coli and Bacillus subtilis. PhoR is an autophosphorylated transmembrane
histindine kinase. It has a N-terminal transmembrane region and a cytoplasmic domain
consisting of PAS domain, DHp domain and CA domain49. PhoB (PhoP) is a transcriptional
regulator that modulates the expression of pho regulon genes by binding to the “pho box”
sequences of the promoters50. Both the inactive monomeric structure9 and the active
dimeric structure14 of PhoB were determined (Figure 1-4).

8

Figure 1-4: PhoB dimerization is triggered by beryllium trifluoride, a phosphoryl analog. The left side
shows the structure of the inactive PhoB monomer (PDB ID: 1B009), and the right side shows the BeF3activated dimer (PDB ID: 1ZES14). The acidic triad (E9, D10 and D53) and “switch” residues (T83 and
Y102) are shown as sticks. The yellow-green sphere represents the magnesium ion required for the
phosphotransfer reaction.

9

Once the aspartate residue accepts the phosphoryl group from histidine kinase, a subtle
structural rearrangement brings the α3 helix closer to the active site. The α4 helix and β5
strand undergo a more pronounced conformational change.

The side chain of T83

reorients and interacts with the phospho-Asp in the active site. In addition, the side chain
of Y100 rotates around to fill the void left by the reorientation of T83. This reorientation of
Y100 is thought to be an important factor in the formation of the α4-β5-α5 dimer
interface14. Thus, T83 and Y100 have come to be thought of as the “switch residues” that
are largely responsible for triggering dimerization by modulating the shape of the
interacting surface of the REC domain.
Comparisons of some full-length RRs structures in OmpR/PhoB family and the
autophosphorylation rate, it was found that the interdomain interactions between REC
domain and DBD of the inactive RRs affect the autophosphorylation rate51. According to the
extent of interdomain interactions, OmpR/PhoB subfamily RRs are indeed divided into
three subclasses (Figure 1-5)12. As shown in Figure 1-5A, the α4-β5-α5 dimer interface of
DrrB3 REC domain interacts extensively with the DBD, which represents the “closed”
subclass. DrrD10 (Figure 1-5B) has less interdomain interactions and the DNA recognition
helices are solvent accessible, which belongs to the “open” subclass. The representative of
third subclasses is HP104311 (Figure 1-5C), which has little interdomain interactions and
readily forms dimer through α4-β5-α5 dimer interface.

10

Figure 1-5: Structural comparison of various classes of full-length OmpR/PhoB subfamily structures. REC
domains are colored in yellow, DBD colored in green. (A) The structure of DrrB (PDB ID: 1P2F 3),
representing the “closed” subclass that has extensively interdomain interactions. (B) The structure of
DrrD (PDB ID: 1KGS

10),

representing the “open” subclass that has limited interdomain interactions (C)

The structure of HP1043 (PDB ID: 2HQR

11),

representing the “free” subclass that completely lacks the

interdomain interactions.

While DNA-binding effector domains are the most common, enzymatic domains
(diguanylate cyclase, phosphatase, kinase etc), RNA binding domain and protein binding
domain have also been observed in RRs52. Some RRs only have a REC domain and the
regulatory function resides in the REC domain. For example, CheY is a chemotaxis-related
regulator with a REC domain that directly regulates the direction of motor rotation of
bacterial flagella after phosphorylation by binding to the rotor protein FliM and FliN53, 54.

11

The chemotaxis system in E. coli mainly contains a transmembrane methyl-accepting
chemotaxis proteins (MCPs), an adaptor CheW and the TCST system CheA-CheY/CheB.
MCPs, including Tar, Tsr, Tap, Trg, Aer

55,

can bind various chemicals (e.g. sugars, amino

acids, O2) and control the autophosphorylation of CheA via the adaptor protein CheW. CheA
is a histindine kinase that lacks the periplasmic and transmembrane domains typically
found in HKs 56, 57. CheY, a response regulator with REC domain only and CheB, a glutamate
methylesterase, compete for the phosphoryl group on CheA. Once phosphorylated, CheY
binds to the switch protein on the flagella motor to change the rotation direction, while
CheB controls the adaptation of the MCPs by demethylation. Demethylated MCPs are poor
kinase activators58, which result in less activated CheA and less phosphorylated CheY.

Figure 1-6: Overlay of the inactive CheY (light pink) with BeF3 activated CheY dimer (green). Mn ions are
represented in purple sphere. Acidic triad residues and switch residues are shown in stick.

12

Comparison of the inactive and BeF3— activated mimic CheY structures59-61 shows that
CheY has a similar activation mechanism to that postulated for PhoB (Figure 1-4, Figure 16). Upon phosphorylation, the switch residue T87 of CheY rotates about to make a
hydrogen bonding interaction with one of the fluoride atoms in the D57-BeF3 adduct,
analogous to one of the phosphate oxygen atoms. The side chain of Y106 also undergoes a
conformational change, rotating inward to fill the void left by T87, where its phenolic
oxygen makes a hydrogen bonding interaction with the main chain carbonyl O atom of E89
and the ring itself is buried in a hydrophobic pocket formed by residues on β4 and α4.
CheB has an N-terminal regulatory domain and a C-terminal methylesterase domain
connected by a short linker. The regulatory domain of CheB is structurally homologous to
CheY, but CheB contains a phosphorylation site and also an active site for autodephosphorylation on the REC domain62. The N-terminal REC domain inhibits the
methylesterase activity in the inactive state, but after phosphorylation, the methylesterase
activity will be transiently activated62. In addition, the inhibited full-length CheB structure
is a “closed” conformation, because α4, α5 and β5 in the REC domain interact with the
methylesterase domain and block the catalytic site63. Phosphorylation of D56 changes the
conformations of α4 and α5, which disrupts the interdomain interactions and opens access
to the catalytic site.

1.2.2 Conserved residues in phosphorylation-dependent RRs
Comparison of response regulator sequences (Figure 1-7) demonstrates that the
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residues mentioned above, Ser/Thr and Tyr/Phe switch residues, the acidic triad residues
including phosphorylatable aspartic acid are all highly conserved in phosphorylationactivated RRs. The acidic triad residues comprise a motif (Asp-Asp/Glu-Asp) that is
essential for binding of the Mg2+ (or other divalent metal ions) required for phosphoryl
group transfer. The conserved phosphorylatable aspartate residue plays a key role in
activation. Substitution of this aspartate residue by glutamate, which has been used as a
phospho-Asp mimic to examine activation in CheY

64,

RcsB

65

and NtrC

66,

resulted in

constitutive activation. In contrast, substitution by asparagine or alanine in RcsB65 and
NtrC

66

eliminated activation in these proteins. The switch residues Thr/Ser and Tyr/Phe

are essential for forming the active dimer conformation in many RRs. Substitutions of these
two switch residues (e.g. T87 into isoleucine or Y106 into trptophan) impairs activation in
CheY and affects chemotaxis

67.

Likewise, mutation of T87 to isoleucine prevents the side

chain of Y106 from adopting the “inward-facing” conformation even when CheY is
phosphorylated 67.
In the REC domain of CheB 63, there is another important acidic residue E58. E58 is near
the acidic triad and orients toward the metal-binding site. The E58K mutant of CheB
exhibited a much slower rate of phosphoryl transfer from phospho-CheA and autodephosphorylation of CheB, which suggests that E58 contributes to the phosphoryl group
transfer from CheA and autophosphotase activity of CheB. Phosphorylation-activated
response regulators often have another conserved basic residue, a lysine, located near the
phosphorylation site and interact with phospho-Asp.

14

Figure 1-7: Conserved residues in phosphorylation-activated response regulators.

However, these highly conserved residues may have different roles in the transition to
the activated state. In CheY, D57 is the conserved phosphorylatable residue68. In vivo, the
CheY mutant D57N was phosphorylated at an alternative residue, S56, and still regulated
the rotation of flagella69. However, a CheY D57E mutant, which in other systems has been
thought to mimic phospho-Asp, exhibited no activity in vivo, although it was still
phosphorylated by CheA. In NtrC (nitrogen regulatory protein C), the variant D54E mimics
the phospho-Asp and has an NtrC+ phenotype70. In vitro phosphorylation studies verify
that the NtrC D54E protein can still be phosphorylated even though not stable71. Like CheY,
NtrC also has a serine residue (S53) adjacent to the conserved phospho-acceptor residue
D54. However, the NtrC D54N mutant does not have any active phenotype70,

71.

The

conserved basic residue K109 in CheY interacts with the phospho-Asp and contributes to
the phosphorylation by providing a simple electrostatic on-off switch72-74. While mutating

15

the analogous residue, K107 in CheB, to Arg does not affect the phosphorylation of D56, but
it does slow down the dephosphorylation step75. The analogous residue in NtrC, K103, is
also not required for phosphorylation 71.

1.2.3 Atypical, phosphorylation-independent RRs containing the conserved Asp
residue
We talked about the phosphorylated RRs activation mechanism and the conserved
residues above. For the remainder of this discussion, the phosphorylation-dependent
response regulators will be referred to as “typical” or “canonical” RRs. Recently, a large
group of RRs with atypical REC domains has been identified whose members respond to
signals other than phosphorylation. For example, the regulators in MarR family can be
activated by binding small molecules or oxidation of specific cysteine residues76,96-98.
The orphan regulator NblR from Synechococcus that lacks the cognate histidine kinase,
has the conserved phosphorylatable Asp residue, but it is not required for NblR function77,
78.

Experiments with yeast and bacterial two-hybrid systems demonstrated that NblR does

not interact with NblS (a conserved histidine kinase in Cyanobacteria), but rather with
NarB (nitrate reductase).

16

Figure 1-8: (A) The structure of ChxR REC domain (PDB ID: 3Q7R 8). Chain A colored in green, chain B
colored in cyan. In comparison with typical OmpR/PhoB RRs, ChxR lacks α2, α3 and the second and third
helices are labeled as “α4” and “α5”, respectively. (B) The model of full length ChxR dimer according to the
best fit SAXS data 12 reflects a “free” conformation due to no interdomain interaction. The REC domains are
linked with DBD by dash line. (C) The structure of GlnR REC domain (PDB ID: 4O1H 13). Chain A colored in
green, chain B colored in cyan. The putative acidic triad (except D50) and switch residues are all missing
in GlnR.

ChxR from Chlamydia trachomatis exists as a constitutively active homodimer without
phosphorylation79. First, the structure of the ChxR REC differs from those of typical
(phosphorylation-dependent) RRs in that ChxR lacks two helices (α2 and α3) found in the

17

typical OmpR/PhoB-type regulators (Figure 1-8A)8. Second, ChxR does not have both of the
Thr/Ser and Tyr/Phe switch residues. The tyrosine residue on β5 is present, but the
Ser/Thr on β4 is missing. Furthermore, the two residues in ChxR equivalent to the switch
residues (L72 and Y90) are oriented similarly to those of inactive OmpR/PhoB family
regulators, which indicate ChxR has a different activation/dimerization mechanism. Based
on small-angle X-ray scattering (SAXS) analysis of full-length ChxR (Figure 1-8B), ChxR
belongs to the “free” subclass that lacks interdomain interaction between the REC domain
and DBD

12,

indicating that ChxR can bind to DNA in a phosphorylation-independent

manner.
Another atypical regulator, GlnR from Amycolatopsis mediterranei, represses the
expression of the glutamine synthetase gene and is thus involved in regulating nitrogen
metabolism. GlnR is an orphan RR, because the cognate HK is not identified 80. Like ChxR,
GlnR also possesses the conserved phosphorylatable aspartate residue (D50), but functions
as a homodimer without phosphorylation (Figure 1-8C). Interestingly, the other two acidic
triad residues (E, D/E), the conserved Lys residue, and the switch residues (Ser/Thr,
Tyr/Phe) are all not conserved in GlnR. In addition, Arg52 located on the loop between β3
and α3 (Lβ3α3) is essential for maintaining dimerization by occupying the
“phosphorylation pocket” and interacting with the conserved D50 13.

1.2.4 Aspartate-Less Regulators (ALR)
Among atypical RRs, there are many proteins lacking the phosphorylatable Asp residue,

18

such as the atypical response regulator HP1043 from Helicobacter pylori. HP1043 regulates
the transcription of tlpB gene that encoding a methyl-accepting chemotaxis protein and is
essential for cell growth

81.

In HP1043, a serine residue is substituted for the

phosphorylatable Asp residue. The protein binds to DNA in a phosphorylation-independent
way 11. This raises the question of whether the loss of the phosphorylatable Asp residue is a
common evolutionary theme in bacterial signal transduction. We recently defined a new
subfamily of RR proteins with aspartate-less receiver (ALR) domains 6. The ALR domains
are common, accounting for ~4% of REC domain sequences in the Pfam database, and they
are well distributed among bacteria, archaea, and eukaryotes. A large number (~28%) of
ALR regulators have DNA-binding output domains. When compared to the entire class of
RRs, the ALR domain-containing response regulators are enriched for enzymatic output
domains, such as diguanylate cyclase (GGDEF) domains, Ser-Thr kinase, and phosphatase
domains. Although these atypical receiver domains have been known to exist for some
time, the molecular details of their regulatory mechanisms have remained unclear. In the
next two chapters, the structure-function relationships of two ALR proteins will be
explored: RitR (Repressor of iron transport regulator, Chapter 2) and Q15Z91 (diguanylate
cyclase, Chapter 3).

1.2.4.1 Repressor of iron transport regulator (RitR)
RitR is an orphan two-component signal transduction response regulator in
Streptococcus pneumoniae R6. Analysis of the S. pneumoniae genome indicates that there
are 13 pairs of TCST proteins (HK and RR) in this organism and a single orphan regulator,
19

RitR

82-84.

Searching the genome sequence, there is no kinase gene close to the ritR locus.

Instead, the adjacent gene gnd encodes a 6-phosphogluconate dehydrogenase and is cotranscribed with ritR, as evidenced by Northern Blot analysis85. RitR represses iron uptake,
activates some resistance proteins to oxidative stress, and is required for pathogenicity in a
mouse lung model85.
Analysis of REC domain sequences shows that RitR belongs to the OmpR/PhoB
subfamily of RRs, and suggests that RitR likely has a similar tertiary structure to other
OmpR/PhoB family members. A representative sequence alignment with the typical
response regulator PhoB (Figure 1-9) shows that the conserved, phosphorylatable Asp
residue in RitR is replaced by asparagine (N53; highlighted in yellow in Figure 1-9).
Furthermore, RitR does not have any other residue near this position that would be
capable of accepting a phosphate group, such as Ser56 in CheY. The absence of any obvious
candidates for phosphorylation in the sequence suggests that RitR does not have a
phosphorylatable site in the “active site”. Further underscoring the likely functional
differences between RitR and other PhoB-type RRs is the substitution of an aspartate
residue in RitR for the Ser/Thr switch residue.
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Figure 1-9: Sequence Alignment of RitR and PhoB. An “*” (asterisk) indicates positions which have same
residue. A “:” (colon) indicates conservation between groups of strongly similar properties. A . (period)
indicates conservation between residues of weakly similar properties. The acidic triad residues are
colored magenta (Mg2+-binding) and red (phosphorylation site). The conserved Asp residue is replaced by
Asn in RitR. The two switch residues are colored blue. The yellow boxes mark the differences in conserved
residues between RitR and PhoB.

The three-dimensional structure of the RitR receiver domain (PDB ID: 4LZL 6) was
obtained by molecular replacement (Figure 1-10). The RitR REC domain is monomeric,
which means that this structure represents an inactive (no DNA binding) conformation. It
has the same (β/α)5 topology observed in other OmpR/PhoB family members, with only
subtle differences (see below).
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Figure 1-10: The structure of the RitR receiver domain (this figure is downloaded from PLOS Pathogens
11(4): e1004795 6). (A) Ribbon representation of the RitR REC domain with helices α1- α3 and α5 colored
orange, the unusual α4 helix colored green, and the β-strands colored blue. N53 is shown in sticks. (B)
Schematic view showing “hydrophobic interactions“ (yellow dotted lines) and the hydrogen-bonding
network (green dotted lines) in the “hydrophobic gate” region of the structure.

The most obvious difference is the broken α4 helix (colored green in Figure 1-10A), the
pieces of which are labeled α4a and α4b, respectively. The hydrophobic residues on the α4
helix interact with residues on β3, β4 and β5, forming a hydrophobic core (as shown in
Figure 1-10B). There are other RRs with unusual α4 helices, though none are “broken” like
helix α4 of RitR. For example, DosR from Mycobacterium tuberculosis adopts an unusual
(β/α)4 fold, where the canonical α4 helix and β5 strand have been lost

86

(Figure 1-11).

Helix α4 in DosR is positioned where the canonical helix α5 is located in other NarL
subfamily RR proteins. The conserved Y101 and K104 residues that are normally located
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on strand β5 and the loop Lβ5α5, are instead located in linker helix α5 and far away from
the phosphorylation site. In DrrD from Thermotoga maritima, helix α4 is roughly
perpendicular rather than parallel to the other helices 3, as shown in Figure 1-11.

Figure 1-11: The α4 helix of response regulator REC domains appears to be particularly malleable. The
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conserved residues equivalents are shown in stick. The typical topology where α4 is parallel to β5 and
unbroken is exemplified by PhoB (PDB ID 1B00 9), Other RR proteins have unusual α4 helices. For example,
helix α4 is broken into two pieces in RitR (PDB ID: 4LZL 6), while that of DrrD (PDB ID: 1KGS 10) is roughly
perpendicular to strand β5. Finally, DosR (PDB ID: 3C3W 86) has a completely different topology where α4 is
missing entirely, as is strand β5.

In the so-called “active site” of RitR, the phosphorylatable aspartate is replaced with an
asparagine residue and there is no bound metal (Figure 1-12A). In what would be the
metal-binding site, E9 interacts with N53 and the conserved residue K103. The basic
residue K10, which is normally one of the residues of the acidic triad, sits near the top of
the putative phosphorylation site and disrupts the acidic environment that promotes metal
binding. As shown in Figure 1-12B, not only is the acidic environment is disrupted, but also
the cleft for Mg2+ binding is eliminated in RitR. As mentioned above, RitR lacks a cognate
histidine kinase. The lack of a cognate HK protein, together with the lack of key residues
found in phosphorylation-dependent RRs makes it clear that RitR must be activated by a
different mechanism from the typical, phosphorylation-dependent proteins.
Another noteable feature of RitR is the single cysteine, located in the linker region
between REC domain and DBD. Bioinformatic results demonstrate that this cysteine128 is
highly conserved in Streptococcus family. The specific role of this cysteine will be discussed
in chapter 2.
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Figure 1-12: Structure of the RitR “active site” (this figure is downloaded from PLOS Pathogens 11(4):
e10047956). The stereoview of the 2|Fo|-|Fc| electron density in the RitR putative phosphorylation site
(magenta mesh) contoured at 1.5 σ (A) shows the network of interactions and the lack of a large electron
density peak that would indicate bound metal. Water molecules are shown as blue spheres. A comparison of
the vacuum electrostatic surface potentials of the RitR and PhoB REC domains (B) highlights the differences
in the surface properties of RitR that account for the loss of metal binding. The Mg2+ in PhoB is shown as a
magenta sphere and highlighted with a white arrow. Both the electronegative environment and the physical
cleft for Mg2+ binding are lost in the RitR putative phosphorylation site.
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1.2.4.2 Diguanylate cyclase Q15Z91
A search of response regulator sequences for ALR proteins that also possess a cysteine
residue at the C-terminal end of the linker helix (α5) and an enzymatic output domain led
to the identification of a protein known only by its Uniprot accession code, Q15Z91. This
putative regulatory protein from Pseudoalteromonas atlantica Tc6 contains an ALR domain
linked to a diguanylate cyclase effector domain. This protein was chosen for study in order
to explore the mechanism of ALR activation in the context of enzymatic activity rather than
DNA binding. An enzymatic activity was preferred due to the facts that (1) it is simpler to
conceptualize the active and inactive states of an enzyme and (2) it is significantly easier to
quantify enzymatic activity than DNA-binding. A boon of the diguanylate cyclase domains
in general is that the product, cyclic-di-guanosine monophosphate, is an important second
messenger in biofilm formation. Thus, the biofilm phenotype is easily observed during
heterologous expression in E . coli Origami™ 2 (DE3) cells, which will be discussed in detail
in chapter 3.
The diguanylate cyclase (DGC) domain of Q15Z91 catalyzes the condensation of two
molecules of GTP to yield bis-(3’-5’)-cyclic dimeric guanosine monophosphate (c-di-GMP)
(Scheme 1-1). A separate phosphodiesterase enzyme cleaves c-di-GMP to give 5’phosphoguanosylyl-(3’-5’)-guanosine (pGpG). Cyclic di-GMP is an important second
messenger that regulates biofilm formation, cell adhesion, and induction of virulence
factors in some bacteria 87-89.
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Scheme 1-1: Metabolism of cyclic-di-GMP. DGC: diguanylate cyclase; PDE-A: type A phosphodiesterase
with EAL motif; PDE-B: type B phosphodiesterase with HD-GYP motif; pGpG: 5’-phosphoguanylyl-(3’-5’)guanosine.

The diguanylate cyclases usually contain a conserved GG(D/E)EF motif for catalysis and
an RxxD motif for regulation of the DGC activity by product inhibition. A well-studied
diguanylate cyclase, PleD from Caulobacter crescentus, is activated by phosphorylation90. As
shown in Figure 1-13, PleD contains two CheY-like REC domains (a true receiver domain
[D1] and an inactive “adapter” domain [D2]) and a DGC domain91. The receiver and adapter
domains of PleD share the (β/α)5 topology common to typical OmpR/PhoB RRs. Upon
phosphorylation of D53 in the acidic pocket of the REC domain (D1), the conserved switch
residues T83 and F102 undergo a conformational change that triggers a rearrangement of
the D1 and D2 domains relative to one another. This rearrangement optimizes one face of
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the D1/D2 pair for dimerization between two PleD molecules90,

92

(Figure 1-13A).

Interestingly, the two REC domains (D1/D2) form an α4-β5-α5 dimer interface very similar
to those seen in other OmpR/PhoB subfamily regulators, while the interactions between
the PleD protomers includes residues from D1 domain (α1, β2, β3, α5) and D2 domain (α8
and α10).
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Figure 1-13: The receiver (D1) and adapter (D2) domains of PleD rearrange after BeF3- treatment (A). BeF3was used to mimic phosphorylation of D53. The DGC domains were omitted for clarity. The acidic triad
residues are shown as sticks. The Mg2+ ions are shown as green spheres. The inactive form of PleD is shown
on the left, and the BeF3 activated mimic structure is shown on the right. The D1 domain is colored cyan, and
the D2 adapter domain is colored blue. In the activated PleD structure, the D1 and D2 domains of the second
protomer in the dimer are colored grey. After D53 accepts the phosphoryl group, REC1 and REC2 form a
tighter dimer interface. PleD dimerization (B) is promoted by phosphorylation and c-di-GMP binding
immobilizes the DGC domain against the D1 and D2 domains. As above, the inactive PleD structure is shown
on the left and the activated mimic on the right. The c-diGMP molecules are shown as sticks. In the inactive
structure, c-di-GMP is bound to both the inhibitory (I) and active (A) sites. In the BeF3 phospho-mimic
structure of the PleD dimer, c-di-GMP is still bound in the inhibitory site, which restricts DGC domains from
catalysis. Two GTP molecules (shown in stick) bind in each active site respectively.

The conserved DGC domain (GGEEF motif) consists of a five-stranded central β sheet
surrounded by α helices, which is similar to the structure of adenylate cyclase and type I
DNA polymerase. A single DGC domain binds only one GTP molecule, which means that a
single domain contains only half of an active site. As shown in Scheme 1-2, for reactions to
happen, two GTP molecules from two DGC domains need to get closer and well aligned.
Thus, activity requires the antiparallel association of two DGC domains, each with GTP
bound. The regulatory logic is clear: antiparallel association of two DGC domains is much
more likely in the dimeric form of PleD, where it is a unimolecular process, than it is in the
case of free PleD monomers. In the active site of PleD, the conserved residues G368, G269
and E371 make key interactions for binding GTP, while E370 is essential for catalysis91. In
PleD, inhibitory sites on the DGC domains, marked by an RxxD motif, bind intercalated c-diGMP dimers that “pin” the DGC domains to the regulatory domains in the case of
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unactivated PleD, or to each other in an unproductive back-to-back orientation in the case
of activated (phosphorylated) PleD. This c-di-GMP dimer binding is the basis of the
observed product inhibition that modulates DGC activity. Disruption of the inhibitory sites,
for example by mutating the Arg or Gly residues of the RxxG motif, abrogates the product
inhibition93. This allosteric feedback inhibition is not affected by phosphorylation status
(Fig1-15B).

Scheme 1-2: Schematic representation of the diguanylate cyclase reaction where two GTP molecules are
condensed to form c-di-GMP. The c-di-GMP contains two GMP moieties linked by O3’-P phosphodiester
bonds. Four Mg2+ ions are shown as green spheres. The two GTP molecules are held in close proximity and
with the proper alignment by four Mg2+ ions that are coordinated with the phosphate groups of GTP and
the carboxyl groups of the conserved residues E370, E371, and D327. D327 is thought to promote
deprotonation of the 3’-OH group of GTP to initiate the reaction. The deprotonated 3’-hydroxyl group
would then attack the Pα-O bond, and release pyrophosphate (PPi). This is repeated in the other half of
the active site so that a total of two molecules of PPi are released during each catalytic cycle.
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The diguanylate cyclase WspR from Pseudomonas aeruginosa is very similar to PleD in
that it is also regulated by feedback inhibition, though the exact mechanism differs4. WspR
contains a single CheY-like REC domain and a DGC domain (Figure 1-14A). These two
domains are linked by a long helix α5 4. The REC domain has a similar structure to those of
activated OmpR/PhoB RRs. The switch residue Y117 adopts an inward conformation,
promoting association through the commonly observed α4-β5-α5 dimer interface (Figure
1-14B). However, no post-translational modification of WspR, such as phosphorylation, has
been observed in the structure. In vitro activity study of Wsp and phosphorylated WspR
showed that unphosphorylated WspR can catalyze c-di-GMP formation but phosphorylated
WspR exhibited faster DGC activity94. WspR from P. aeruginosa functions as a compact, c-diGMP-free dimer. However, other WspR homologs, such as that from P. syringae, require
phosphorylation-induced tetramerization for high cyclase activity95. This activated cyclase
activity was only obtained by phosphodiesterase treatment of WspR to remove c-di-GMP,
followed by phosphorylation-induced tetramerization95. Both WspR homologs exhibit
product immobilization inhibition. WspR from P. aeruginosa is purified as a mixture of
dimer and tetramer4, 95. In the crystal lattice, WspR formed a distinct 222-symmetric
tetramer, and the long helix α5 facilitates the antiparallel tetramer formation4, 95, as shown
in Figure 1-14A. Molecules of c-di-GMP dimers bind to the specific I sites (RxxD motif) that
composed by two protomers from different dimers (e.g. chain A and chain C) in the
tetramer. The cross-linked DGC domains forced the active sites apart and prevent the
cyclization of two GTP molecules.
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Figure 1-14: The Wsp dimer (A), REC domain of WspR dimer (B) and tetramer (C) structure from
Pseudomonas aeruginosa (PDB ID: 3BRE 4). Chain A is colored cyan, chain B is colored green, chain C is colored
magenta, and chain D is colored yellow. Residues in phosphorylation site and switch residues are shown as
sticks. The Mg2+ ions are represented with green spheres. The GTP binding active site are shown in red sphere
in (A). Four c-di-GMP dimers in (C) are shown as sticks. In the crystal, two WspR dimers packed in an
antiparallel way to form the inactive tetramer with c-di-GMP bound.
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Both of these diguanylate cyclases, PleD and WspR, have the structural features
required for phosphorylation-dependent activation. In the case of PleD, phosphorylation
has been shown to be the primary regulatory factor, whereas with WspR, phosphorylation
accelerates the DGC activity. In contrast, Q15Z91 has lost these structural features, such as
the conserved, phosphorylatable aspartate residue and the Mg2+-binding site. This
prompted us to ask, “what is the mechanism of activation of Q15Z91?” Is it also controlled
by the non-competitive allosteric product inhibition? These questions will be addressed in
Chapter 3.
In summary, ALRs exists in most classes of bacteria (averaging ~2 per genome), and are
also prevalent in archaea, fungi, plants and possibly even insects and primitive animals.
The key “invariant” catalytic and signaling residues required in canonical REC domains are
found to be changed in many ALR sequences. Although these atypical REC domains has
been known to exist for some time, it remain unknown that how they are regulated in the
absence of the conserved Asp. Combining structural data with biochemical and genetic
examination of two founding members of the ALR family, RitR and Q15Z91, we
demonstrate that ALRs might have evolved to accommodate more diverse environmental
signals, while largely retaining their time-tested ancestral post-input signaling
mechanisms. This work also provides a foundation for future experimentation to decipher
the largely unknown functional roles of these proteins.
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Chapter 2
The Atypical Response Regulator Protein Repressor of Iron Transport
Regulator (RitR) Exhibits an Alternative Mechanism of Activation
2.1 Background
RitR is an orphan response regulator in S. pneumonia R6 that has been shown to downregulate the expression of iron-transport proteins to avoid oxidative damage during
aerobic growth

1, 2.

RitR differs from typical two-component systems in that 1) it lacks a

cognate HK protein, 2) the conserved phosphorylatable aspartate residue (D53) is
substituted with asparagine, and 3) the binding site for Mg2+, which is required for the
phosphorylation reaction, is apparently disrupted in RitR. Together, these differences
suggest that RitR cannot be phosphorylated and, thus, must use a different mechanism of
activation. So my work is using biophysical tools to determine the regulatory mechanisms
of proteins with ALR domains.

2.2 Methods
2.2.1 Cloning, expression, and purification of wild-type and mutant RitR
The gene encoding wild-type RitR from Streptococcus pneumoniae strain R800 was
amplified and cloned into the pE-SUMOkan expression vector (LifeSensors Inc, Malvern, PA)
using primers containing BsaI and XbaI restriction sites. The His6-tagged SUMO-RitR fusion
protein was expressed from E. coli BL21 Star (DE3) cells (Invitrogen Inc, Carlsbad, CA)
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carrying the pE-SUMO-RitR plasmid. Cultures were grown in Luria-Bertani medium with
50 µg/mL kanamycin at 37 °C with agitation at 250 rpm. When the cultures reached an
OD600 of ~1.0, protein expression was induced with 0.4 mM IPTG. The temperature was
then reduced to 16 °C and the cultures were grown overnight. Cells were harvested by
centrifugation, resuspended in 5 mL/g of buffer A (25 mM TRIS pH 8.0, 300 mM NaCl, 10
mM imidazole) supplemented with 0.1 mg/mL DNAse I (Worthington Biochemical Corp.,
Lakewood, NJ). Cells were lysed using a Branson Sonifier S-450 cell disruptor (Branson
Ultrasonics Corp., Danbury, CT) for a total of 5 min of sonication at 60% amplitude with 30
s pulses separated by 50 s rest periods. The temperature was maintained at or below 4 °C
by suspending the steel beaker in an ice bath directly over a spinning stir bar. The lysate
was clarified by centrifugation at 39,000 x g for 45 minutes and then applied to a 5 mL
HisTrap column (GE Lifesciences, Piscataway, NJ) at a flow rate of 5 mL/min to isolate the
His6-SUMO-RitR fusion protein. The protein was eluted by a 4-step gradient of buffer B (25
mM TRIS pH 8.0, 300 mM NaCl, and 250 mM imidazole; 5, 15, 50, and 100% B). The His6SUMO-RitR fusion protein eluted in the third and fourth steps and was ~90% pure, as
judged on coomassie-stained SDS-PAGE gels. Peak fractions were pooled and dialyzed
overnight against 4 L of 25 mM TRIS pH 8.0, 150 mM NaCl, and ~3 µM SUMO protease
(LifeSensors Inc). The dialysate was passed through the HisTrap column a second time to
remove the cleaved His6-SUMO tag as well as the protease. The resulting RitR preparation
was >95% pure according to SDS-PAGE results. The protein was desalted using a HiTrap
Desalting column (GE Lifesciences) into storage buffer (pH 6.5, 25 mM TRIS, 150 mM NaCl,
100 mM Malic acid) and stored at -80 °C. All mutants mentioned in the chapter 2 were
expressed and purified using the same protocol as the wild type RitR.
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2.2.2 Preparation of purification of the oxidized RitR dimer (RitRox)
RitRox was prepared by treating purified, wild-type RitR with 1 mM hydrogen peroxide
for 3 h, followed by size exclusion chromatography to obtain the oxidized dimer. A HiPrep
26/60 Sephacryl S100 HR column was equilibrated with 2 column volumes of buffer C (pH
6.5, 20 mM TRIS, 150 mM NaCl, 100 mM malic acid, 1 mM H2O2). The first peak to elute
from the column, which was consistent in size with the dimer (~60 kDa), contained the
dimeric RitRox protein.

2.2.3 Preparation of protein for structure determination
The mutant SeMet labeled RitRC128S from T7 Express Crystal cells (New England
BioLabs, Ipswich, MA) carrying the pE-SUMO-C128S plasmid. Cells were grown in
SelenoMethionine Medium Complete (Molecular Dimensions, Newmarket, Suffolk, UK) with
50 µg/mL kanamycin. This selenomethionine-labelled RitRC128S mutant was purified using
the same protocol described for RitR. But it was stored in 25 mM TRIS pH 8.0, 5 mM DTT
for crystallization. The mutant RitRC128D was purified using the same protocol described for
RitR. But it was stored in 10 mM ADA pH 7.0 buffer.
Two forms of a RitRL86A/V93A ALR domain were devised to probe the structural
consequences of this double mutation: one corresponding to the original RitR ALR domain
structure, which ends well before the putative redox-active C128 residue (RitRL86A/V93A
residues 1-124; RDLV) and a longer version that included the entire α5 helix (residues 1132; RD2LV). Selenomethionine-labelled protein was prepared for both double mutants
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from T7 Express Crystal cells (New England BioLabs, Ipswich, MA) carrying the pE-SUMORDLV or pE-SUMO-RD2LV plasmid. Cells were grown in SelenoMethionine Medium
Complete (Molecular Dimensions, Newmarket, Suffolk, UK) with 50 µg/mL kanamycin.
Both selenomethionine-labelled double mutant RitRL86A/V93A REC domains were purified
using the same protocol described for RitR.

2.2.4 Differential scanning fluorimetry
Differential scanning fluorimetry (DSF) was used to search for buffer conditions where
the relatively unstable WT RitR might be stable enough to crystallize. Wild-type RitR was
diluted to 20 μM with water (1.1ml final volume) and 2µl of SYPRO Orange dye was added.
This protein solution (10 µl) was mixed 1:1 with the Slice pH buffer screen (Hampton
Research) in a 96-well PCR plate. The plate was heated from 20 °C to 95 °C in 1 oC steps in
an Eppendorf RealPlex real-time PCR machine. At each temperature step, the fluorescence
signal from the SYPRO Orange dye (ThermoFisher Scientific) in each well of the plate was
monitored. Plotting the second derivative of the fluorescence intensity vs temperature plot
gives a peak corresponding to the Tm of the protein in that buffer. Buffers showing at least a
2-3 °C upward shift in the Tm were investigated as storage buffers for RitR.
DSF was also used to assess the ability of RitR and various mutants to bind to DNA by
monitoring the ability of DNA to stabilize the proteins. To test the buffer and pH effects on
the Tm, RitR and RitRL86A/V93A were incubated with a dsDNA oligo corresponding to the
putative

primary

RitR

binding

site
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in

S.

pneumoniae

R6

(BS3-3:

5'-

ATGAAACTTTCTCATTATTTAATTGGCTTACTTCT-3') in different buffers at different pH.
Firstly, 1500 μl solution containing 200 μM protein and 100 μM BS3-3 was incubated at
room temperature for 2 hours. Then 2 μl of the protein/BS3-3 mixture was mixed with 18
μl of different buffers at different pH containing the SYPRO Orange dye. Protein-only
negative controls were prepared by mixing 200 μM RitR or RitRL86A/V93A protein with
different buffers only containing SYPRO Orange dye.
Finally, DSF was used to double check the gel shift results by looking at the shifts in Tm
when different forms of RitR were incubated with BS3-3 in the binding buffer1 (20 mM
HEPES pH 7.2, 5 mM MgCl2, 1 mM CaCl2, 0.1 mM EDTA) and with the optimal protein:DNA
ratio for binding (protein:DNA = 4:1). The protein variants investigated included RitRox,
RitRL86A/V93Aox and RitRL86A/V93A/C128Sox. Oxidized proteins were prepared by incubating with
1mM H2O2 at 4 oC overnight. Each RitR variant (RitR, RitRox, RitRL86A/V93A, RitRL86A/V93Aox,
RitRL86A/V93A/C128S, and RitRL86A/V93A/C128Sox) was mixed with BS3-3 at final concentrations of
400 µM protein and 100 µM DNA in 25 mM TRIS pH 8.0, 150 mM NaCl buffer for 2 hours at
room temperature. Then 2 μl of each protein/BS3-3 mixture was mixed with 18 μl of
different buffers (buffer 1: 20 mM TRIS pH 6.5, 150 mM NaCl, 100 mM Malic acid; buffer 2:
binding buffer; or buffer 3: binding buffer supplemented with 150 mM NaCl) containing
SYPRO Orange dye. The protein-only controls were prepared by mixing 400 μM protein
with buffer with SYPRO™ orange fluorescent dye.
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2.2.5 Site-directed mutagenesis
The K10A, N53A, N53D, D81A, L86A, L90A, V93A, L86A/V93A, F96G, Y100A, Y102A,
R113A, C128A, C128S, C128Dand Y163F mutants were prepared by the Ulijasz lab. Other
mutants, L86A/V93A/C128S, RDLV and RD2LV, were constructed as part of this work. The
full-length mutants were obtained by the Quick-ChangeTM mutagenesis method using the
primers listed in Table 2-1. The Quick-ChangeTM protocol used the Pfusion DNA polymerase
and the high fidelity (HF) master mix (New England Biolabs, Ipswich, MA). The PCR
program included an initial denaturing step at 98 oC for 30 s, followed by the cyclic portion
of the program (denature at 98 oC for 10 s, anneal at (Tm of primer pair – 2) oC for 25 s,
extend for 210 s at 72 oC; 17 cycles), and a final extension step at 72 oC for 10 min. After
PCR, DpnI (20 U) was added to the 50 μl PCR reaction to digest the methylated template
DNA at 37 oC for 1 h. The DpnI-treated PCR reaction (5 μl) was used to transform NEB5α
competent E. coli (New England Biolabs, Ipswich, MA). Transformants were sequenced to
confirm the presence of the mutation. The genes of two ALR domains of RitRL86A/V93A were
amplified from pSUMO-RitRL86A/V93A plasmid. After BsaI and XbaI digestion, the genes were
ligated into XbaI digested pSUMO kan plasmid. The success of ligation was checked by
sequencing.
Table 2-1: Primers used for mutagenesis
Names

Primer sequence

sumo-RitRL86A_RD_Fwd

GCGGTCTCAAGGTATGGGGAAACGGATTTTAT

sumo-RitRL86A_RD_Rev

GCTCTAGATTAAATGAAGTCCCGACCTCGG
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sumo-RitRC128S_Fwd

GACTTCATTGATCAACACAGCAGTCTGATGAAAGTTC

sumo-RitRC128S_Rev

GAACTTTCATCAGACTGCTGTGTTGATCAATGAAGTC

sumo-RDLV_Rev

GCTCTAGATTAAATGAAGTCCCGACCTCGG

sumo-RD2LV_Rev

GCTCTAGATTATTTCATCAGACTGCAGTGTTGATC

sumo-RitRC128D_Fwd

GACTTCATTGATCAACACGACAGTCTGATGAAAGTTC

sumo-RitRC128D_Rev

GAACTTTCATCAGACTGTCGTGTTGATCAATGAAGTC

2.2.6 Determination of C128 pKa by DTNB assay 6, 7
The thiol-reactive reporter compound 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) can be
used to determine the number of free, solvent-exposed thiol groups in a protein or to
estimate the pKa in cases where a single thiol group is present. The assay is based on the
formation of 2-nitro-5 thiobenzoate (TNB-) upon reaction of DTNB with thiol groups. The
ionized reporter group, TNB2- absorbs UV light at 412 nm (Scheme 2-1).

Scheme 2-1: The mechanism of DTNB assay

Reactions contained 5 μM RitR and 20 μM DTNB in 50 mM CHB buffer (50 mM citric
acid, 50 mM HEPES, 50 mM Bicine, 150 mM NaCl, with pH adjusted by titration with NaOH
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or HCl as appropriate) at pH values ranging from 4 to 9. The reactions were conducted at
room temperature (~21 °C) in an EvolutionTM 300 UV-Vis spectrophotometer (Thermo
Scientific). The absorption at 412 nm was recorded until it plateaued. Then the pHdependent rate of each reaction k(pH) was determined by fitting the time course to the
following equation:
!"#$ (&) = !"#$,* + ∆!"#$ (1 − / 01(23)4 )

Equation 1

Since k(pH) is directly dependent on the proportion of the cysteine thiolate group, the pKa of
the C128 thiol was obtained by fitting the plot of k(pH) vs pH to the following equation:
5(23) =

1
78
?7@
#6#* 9,:;<=>

Equation 2

where k(pH) is the observed rate constant at a particular pH value, and k is the maximal rate
of TNB2- formation at high pH.

2.2.7 Crystallization, structure determination, and model refinement
Crystals of selenomethionine (SeMet)-substituted RitRC128S were grown by the vapor
diffusion method with hanging drop geometry. Drops were comprised of equal parts
protein solution (20 mg/ml RitRC128S in 25 mM TRIS, pH 8.0) and crystallization solution
(25% (w/v) polyethylene glycol (PEG) 3350, 0.1 M ammonium acetate). Partially-hollow
rods appeared after several days at 16oC. Crystals were prepared for flash-cooling by
sequential soaks in solutions containing 25% PEG (w/v) 3350, 0.2 M ammonium acetate,
and 5, 10, or 20% glycerol (v/v).
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Crystals of RitRC128D were grown by the same method, except with hanging drops
composed of 1 μl of protein solution (15.3 mg/mL RitRC128D in 10 mM ADA pH 7.0) and 1 μl
of crystallization solution (0.1 M HEPES pH 7.5, 22.5% Jeffamine ED-2001 pH 7.0). Long
rod-shaped crystals grew after 3 days at 16 oC. Crystals were prepared for flash-cooling by
sequential soaks in solutions containing 0.1 M HEPES pH 7.5, 22.5% Jeffamine ED-2001 pH
7.0, and 5, 10, or 20% glycerol (v/v).
Crystals of RitRox were grown by the hanging-drop, vapor diffusion method with drops
consisting of 2 μl of protein solution (6 mg/ml RitRox in pH 6.5, 20 mM TRIS, 150 mM NaCl,
100 mM malic acid, 1 mM H2O2) and 1 μl of crystallization solution (10% (w/v) PEG 3350,
0.3 M magnesium sulfate). Prism-shaped crystals appeared after several days at 16 oC.
Crystals were prepared for flash-cooling by soaking in a solution containing 10% (w/v)
PEG 3350, 0.3 M magnesium sulfate, and 20% glycerol (v/v).
Crystals of RitR oxidized by treatment with CuCl2 rather than H2O2 were grown from
drops containing 1 μl of protein solution (5 mg/mL RitRCuOX in pH 6.5, 25 mM TRIS, 150
mM NaCl, 100 mM Malic acid, 1 mM CuCl2) and 1 μl of microseeding solution (4%
Tacsimate pH 6.0, 7.5% PEG 3350 containing microseeds derived from its own crystals).
Single prism-shaped crystals grew after several days at 16 °C. Crystals were prepared for
flash-cooling by sequential soaking in solutions containing 4% Tacsimate pH 6.0, 7.5% PEG
3350, and 5, 10, or 20% glycerol (v/v).
Crystals of selenomethionine-substituted RitRL86A/V93A REC domain, residues 1-124
(RDLV), were grown in drops consisting of equal parts of protein solution (4.4 mg/ml RDLV
in 10 mM TRIS pH 8.5, 50 mM Succinic acid) and crystallization solution (20% (w/v) PEG
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3350, 0.2 M magnesium sulfate, 0.1 M TRIS pH 8.5, 1 mM DTT). Small rods appeared after
several days at 16 oC. Crystals were prepared for flash-cooling by sequential soaks in
solutions containing 20% PEG (w/v) 3350, 0.2 M magnesium sulfate, 0.1 M TRIS pH 8.5,
and 5, 10, or 20% glycerol (v/v).
Crystals of SeMet-substituted RitRL86A/V93A REC domain, residues 1-132 (RD2LV), were
grown by the hanging-drop, vapor diffusion method in drops comprised of equal parts of
protein solution (19 mg/ml RD2LV in 10 mM glycine pH 8.8, 25 mM L-Arg) and
crystallization solution (22.5% (w/v) polyethylene glycol (PEG) 3350, 12% Tacsimate pH
8.2). Small plate-shaped crystals appeared after several days at 16 oC. Crystals were
prepared for flash-cooling by sequential soaks in solutions containing 22.5% (w/v) PEG
3350, 12% Tacsimate pH 8.2, and 5, 10, or 20% glycerol (v/v).
X-ray diffraction data for SeMet RitRC128S were collected at beamline 21-ID-F of the Life
Science Collaborative Access Team (LS-CAT) at the Advanced Photon Source (APS),
Argonne National Laboratory. The RitRC128D data set was collected at LS-CAT beamline 21ID-G. The RitRox data set was collected at LS-CAT beamline 21-ID-F. The SeMet RDLV data
was collected at LS-CAT beamline 21-ID-G. The SeMet RD2LV data were collected at LS-CAT
beamline 21-ID-D. All data sets were processed with HKL20008.
The structure of RitRC128S was determined by the single-wavelength anomalous
diffraction (SAD) method using 1.5 Å-resolution data collected from a single crystal of
SeMet-substituted RitRC128S at 0.97889 Å, 61.0 eV below the tabulated K-edge wavelength
for Se (0.97950Å). The program autoSHARP9 was used to solve the Se substructure, which
contained 16 of the 18 Se atoms in the asymmetric unit, and to calculate density-modified
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electron density maps. An initial model comprising ~90 % of the asymmetric unit contents
was built using BUCCANEER10.
The structure of RDLV was determined by the single-wavelength anomalous diffraction
(SAD) method using 1.9 Å-resolution data collected from a single crystal of SeMetsubstituted proteins at 0.97857 Å, 61.0 eV below the tabulated K-edge wavelength for Se
(0.97950Å). The program autoSHARP9 was used to solve the Se substructure, which
contained 16 of the 18 Se atoms in the asymmetric unit, and to calculate density-modified
electron density maps. An initial model comprising ~90 % of the asymmetric unit contents
was built using BUCCANEER10. The structure of RD2LV was determined by the singlewavelength anomalous diffraction (SAD) method using 2.6 Å-resolution data collected from
a single crystal of SeMet-substituted proteins at 0.97872 Å, 61.0 eV below the tabulated Kedge wavelength for Se (0.97950Å). The program autoSHARP9 was used to solve the Se
substructure, which contained 16 of the 18 Se atoms in the asymmetric unit, and to
calculate density-modified electron density maps. An initial model comprising ~90 % of the
asymmetric unit contents was built using BUCCANEER10.
Chain A of this model was used as the search model for molecular replacement in
PHASER11 to phase the RitRox structure. Both models were subjected to iterative cycles of
manual model building in COOT12 and maximum likelihood-based refinement using the
PHENIX package (phenix.refine13). Ordered solvent molecules were added automatically in
phenix.refine and culled manually in COOT. Hydrogen atoms were added to the model
using phenix.reduce14 and were included in the later stages of refinement to improve the
stereochemistry of the model. Positions of H atoms were refined using the riding model
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with a global B-factor. Regions of the model for translation-libration-screw (TLS)
refinement were identified using phenix.find_tls_groups (P.V. Afonine, unpublished work)
and the TLS parameters were refined in phenix.refine. Once the refinement converged, the
model was validated using the tools implemented in COOT and PHENIX 15, 16. Sections of the
backbone with missing or uninterpretable electron density were not included in the final
model. Data collection and model refinement statistics are listed in Appendix A.
Coordinates and structure factors for both RitRC128S and RitRox models have been deposited
in the Protein Data Bank (www.rcsb.org) with accession codes 5U8K and 5U8M.

2.2.8 Synthesis of binding site 3 (BS3) dsDNA oligonucleotides
Early footprinting experiments detected 3 binding sites for RitR(BS1-BS3)1. Since RitR was
deemed to have the highest affinity for BS3, this sequence was used to investigate the DNAbinding activity of RitR and its variants. To facilitate co-crystallization of RitR bound to
DNA, different lengths of BS3 were designed (Table 2-2), since the length of the
oligonucleotide is a key parameter in the crystallization of protein:DNA complexes. Both
strands of BS3-1, BS3-2, BS3-3, BS3-4, and BS3-5 were synthesized by Integrated DNA
Technologies (Coralville, IA). Both strands of BS3-6 were synthesized via standard
automated DNA synthesis techniques in a 1.0 μM scale using commercial 1000 Å CPGsuccinyl-nucleoside supports. Deprotection of the nucleobases and phosphate moieties as
well as cleavage of the linker were carried out under mild deprotection conditions using a
mixture of 40% aq. MeNH2 and 28% aq. NH3 (1:1) at room temperature for 2 h.
Oligonucleotides were purified by 20% denaturing polyacrylamide gel electrophoresis.
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Quantification of oligonucleotides was carried out using a Phosphorimager equipped with
ImageQuant Version 5.2 software. Double-stranded DNA was obtained by mixing the two
single-stranded oligonucleotides in 250 mM TRIS pH 6.5, 150 mM NaCl buffer and heating
to 90 oC for 5 min, followed by slow cooling to room temperature.

Table 2-2: Sequences of the BS3 variants used in RitR binding assays.
Name
BS3-1
BS3-2
BS3-3
BS3-4
BS3-5
BS3-6

Sequence
5'-GGTATGAAACTTTCTCATTATTTAATTGGCTTACTTCT-3'
3’-CCATACTTTGAAAGAGTAATAAATTAACCGAATGAAGA-5’
5'-GGTATGAAACTTTCTCATTATTTAATTGGCTTAC-3'
3’-CCATACTTTGAAAGAGTAATAAATTAACCGAATG-5’
5'-ATGAAACTTTCTCATTATTTAATTGGCTTACTTCT-3'
3’-TACTTTGAAAGAGTAATAAATTAACCGAATGAAGA-5’
5'-AAACTTTCTCATTATTTAATTGGCTTACTTCT-3'
3’-TTTGAAAGAGTAATAAATTAACCGAATGAAGA-5’
5'-CTTTCTCATTATTTAATTGGCTTACTTCT-3'
5’-GAAAGAGTAATAAATTAACCGAATGAAGA-3’
5'-CTTTCTCATTATTTAATTGGCTTA-3'
3’-GAAAGAGTAATAAATTAACCGAAT-5’

Length (bp)
38
34
35
32
29
24

2.2.9 Size exclusion chromatography (SEC)
The oligomeric states of wild-type and mutant forms of RitR were assessed by size
exclusion chromatography (SEC). All separations were carried out using an Agilent 1220
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Compact HPLC equipped with a 250 x 4.6 mm BioBasic SEC-300 column equilibrated with
pH 6.5, 10 mM TRIS, 150 mM NaCl, and 100 mM malic acid. The column was calibrated with
the Gel Filtration Molecular Weight Marker kit from Sigma-Aldrich (Cytochrome C (12.4
kDa), Carbonic Anhydrase (29 kDa), Bovine Serum Albumin (66 kDa), and Sweet Potato
Amylase (200 kDa)). The H2O2- or CuCl2- treated RitR proteins were injected (5 μl of 4
mg/mL proteins) onto the column and separated at a flow rate of 0.5 ml/min at ambient
temperature. Wild-type and mutant forms of RitR was assayed for DNA-binding activity by
mixing 260 μM protein (RitR, RitRL86A/V93A, RitRL86A/V93A/C128S and other mutants) with 100
μM each of the BS3 variant oligonucleotides (BS3-1, BS3-2, BS3-3, BS3-4, BS3-5, BS3-6).
SEC experiments were carried out under the same conditions used for the RitR proteins in
the absence of DNA.

2.2.10 Non-reducing SDS-PAGE and Native SDS-PAGE (NSDS)
Proteins were incubated with different metals for 2 hours at room temperature. These
samples were then mixed with SDS loading dye lacking reducing agent, boiled for 5 min,
and loaded on 12% SDS polyacrylamide gel. Proteins were revealed by staining with
GelCode™ Blue Safe Protein Stain (Thermo SCIENTIFIC, Rockford, IL) for 1 h and destained
in MilliQ H2O. The slightly modified protocol for running native SDS-PAGE is followed as
previously described by Nowakowski AB17.
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2.3 Results
2.3.1 Determining the optimal RitR storage buffer for crystallization
Like many DNA-binding proteins, such as the γδ resolvase18, MarA19, and MarR20, the
full-length RitR protein is not stable in low ionic strength buffers. In low ionic strength
buffers like 25 mM TRIS pH 8.0, RitR precipitated out as a flocculent white solid, and this
precipitate could be redissolved by addition of NaCl. Since it is generally preferred to
search for crystallization conditions with the protein in a dilute, low ionic strength buffer,
we performed experiments to find the lowest NaCl concentration where RitR would be
stable. To begin, purified RitR was desalted into 25 mM TRIS pH 8.0, with concentrations of
NaCl ranging from 50 to 200 mM in 50 mM steps. Samples were incubated overnight at 4 °C
and the amount precipitate was assessed qualitatively. The lowest NaCl concentration
tested that did not give visible precipitate was 150 mM. With the ionic strength optimized,
we set about exploring the effect of buffer identity and pH on RitR stability. This was done
using differential scanning fluorimetry together with the Solubility & Stability and Slice pH
screens (Hampton research). The Solubility and Stability Screen, which is a collection of 96
small-molecule additives, was run in the 25 mM TRIS pH 8.0, 150 mM NaCl buffer. The top
10 conditions from the Solubility & Stability and the Slice pH screens, as judged by the
degree of increase in the Tm above the average Tm, are shown in Table 2-3 and Table 2-4,
respectively.
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Table 2-3: Compounds from the Solubility & Stability Screen (Hampton Research)
giving the highest Tm values in the DSF assay
Tm - Tm,averaged (oC)
6.2

Additive
Spermine tetrahydrochloride

4.8

GSH, GSSG

4.7

Choline acetate

4.7

Ammonium sulfate

4.6

Succinic acid pH 7.0

4.4

Sodium malonate pH 7.0

4.4

Sodium sulfate decahydrate

4.3

L-Arginine, L-Glutamic acid

4.1

1-Ethyl-3-methylimidazolium acetate

4.0

Sodium chloride

Table 2-4: Buffers from the Slice pH Screen (Hampton Research) giving the highest Tm
values in the Thermofluor assay
Tm - Tm,averaged (oC)

Additive

4.6

DL-malic acid pH 5.6

4.4

Succinic acid pH 6.0

4.2

DL-malic acid pH 5.3

4.0

Succinic acid pH 5.7

3.5

BIS-TRIS propane pH 7.3

3.4

BIS-TRIS pH 6.6

3.3

ADA pH 7.0

3.3

HEPES sodium pH 6.6

3.2

MES monohydrate pH 6.5

3.1

Sodium cacodylate trihydrate pH 6.1
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Since malonate is used as a cryo-protecting agent for protein crystals, 100mM malonate
was added to the protein storage buffer. The agents with similar structures, such as DLmalic acid (ACROS Organics) and citric acid (ACROS Organics), were also used for wild-type
RitR protein storage and crystallization.
According to the Slice pH screen results, the optimal pH is ~6 to 6.5. We chose pH 6.5,
25 mM Tris, 150 mM NaCl, 100 mM malonic acid/DL-malic acid/citric acid buffers to store
wild-type RitR. RitR in these three buffers were crystallized. Crystals were obtained at all
these buffers. But better crystals were obtained in DL-malic buffer, so the final RitR storage
buffer I used is pH 6.5, 25 mM Tris, 150 mM NaCl, 100 mM DL-malic acid buffer.

2.3.2 Monomeric structure of RitRC128S
Gel filtration chromatography suggests that inactive RitR is predominantly monomeric,
but a second species, consistent in size with a dimer, is also present and accounts for ~1020% of the sample. Likely because of this heterogeneity, the full-length, wild-type RitR
proved impossible to crystallize. To facilitate crystallization, the only cysteine residue
(C128) was mutated to serine (RitRC128S). This variant proved to be 100% monomeric as
judged by gel filtration chromatography and native-PAGE.
The structure of RitRC128S was determined to 1.7 Å resolution by using phases derived
from SeMet single-wavelength anomalous diffraction (Se-SAD)(Figure 2-1). It is a
monomer, which is in agreement with biochemical data mentioned above. There are two
monomers in the asymmetric unit. But these two monomers do not form a dimer, nor with
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their symmetry mates. RitRC128S contains regulatory ALR domain and DNA binding domain
(DBD). The only cysteine residue in RitR, C128, is located at the C-terminal end of the long
α5 linker helix, which connects the ALR domain with the DBD. The ALR domain structure is
same with the earlier solved RitR ALR domain only structure (PDB ID: 4LZL3, Figure 1-10).
DBD has the helix-turn-helix (HTH) motif, which is the simplest and most common motif in
prokaryotes and eukaryotes21. This HTH motif contains two fixed angled helices connected
by a small loop. The more C-terminal helix (colored in red in Figure 2-1) is the recognition
helix that used for contacting with specific DNA major groove.

Figure 2-1: Ribbon representation of the structure of full-length RitRC128S (A) and a close-up on the interdomain interface (B). Important amino acid side chains are shown as sticks. The regulatory domain is
shown in blue, except for the putative α4-β5-α5 dimer interface, which is colored green. The DNA-binding
domain is colored yellow, except for the DNA-contacting helix and trans-activation loop, which are colored
red and magenta, respectively.
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There is an extensive network of salt bridges and hydrogen bonds between the
regulatory ALR domain and DBD, with each domain contributing a surface area of
approximately ~850 Å2 (Figure 2-1B). E91 makes salt bridges with R202 (3.1 Å). E91 and
Q94 make hydrogen bonds to Tyr203 with distances of 2.0 Å and 2.2 Å, respectively). R95
interacts with S206 (2.5 Å), residues that are found on the DNA-contacting helix of the DBD,
helix α4b, and helix α5 of the ALR domain. Both α4 and α5 are contributed to the
dimerization interface in other OmpR/PhoB type response regulator proteins. The DNAcontacting helix interacts with helix α4b and is thus not free to interact with DNA.
Additionally, the trans-activation loop is involved in the interdomain interface and would
thus be unavailable to interact with RNA polymerase. All of these facts demonstrate that
this monomeric conformation is not the active, DNA-binding conformation of RitR.

2.3.3 The thiol group of the conserved C128 residue has a perturbed pKa
We assumed that, like most DNA-binding RR proteins, the active DNA-binding form of
RitR is a homodimer. Comparing the sequences of all RitR homologs in the Streptococci
(Figure 2-2A) shows that this Cys residue is strictly conserved. This raises the possibility
that RitR could be a redox-responsive response regulator protein. In other cysteine-based
redox sensor proteins, the side chain thiol groups of the key cysteine residues have been
found to have significantly depressed pKa values22, 23. In order to ascertain whether or not
the C128 thiol group also has a perturbed pKa, and could thus be expected to be redox
active under physiological conditions, the pKa of C128 was determined using the DTNB
assay. The rate of reaction of DTNB with thiol groups depends directly on the proportion of
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thiols that are present as the thiolate anion. The reaction (Scheme 2-1) releases TNB-,
which readily deprotonates to give TNB2-, a species that absorbs at 412 nm. By monitoring
the rate of the DTNB reaction at different pH values, it is possible to derive an estimate of
the pKa of the thiol group. Reactions containing 20 µM DTNB in a buffer system consisting
of citric acid, HEPES, and bincine (50mM each) were initiated by the addition of 5 µM RitR,
and the absorbance at 412 nm was monitored (Figure 2-2 B). Nonlinear fitting of these
progress curves to Equation 1 gave estimates of the pH-dependent rate constant of the
reaction, k(pH). These values were plotted as a function of pH, and then fit to Equation 2
(Figure 2-2C) to gives an estimate of the pKa of C128 of 7.2 ± 0.2. This is slightly decreased
from the thiol pKa of cysteine in solution, which is generally quoted above 8.3. Different
buffer systems were tested for this assay, giving a pKa range for C128 of 6.9-7.5. The
perturbed pKa of C128 suggests that this residue is more reactive than a typical surfaceexposed cysteine residue and thus may be part of a redox-sensing switch mechanism in
RitR.
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Figure 2-2: (A) Sequence alignment of RitR homolog in a non Group A/B subset of Streptococcal species
demonstrated a conservation of redox sensor C128. (B) The absorbance at 412 nm (dots) and fitting lines
at pH 5.1 (red), 5.5 (blue), 6.0 (green), 6.6 (black), 6.9 (magenta), 7.6 (cyan), 7.9 (purple) and 8.4 (orange).
(C) The pH dependence of the rate constants of C128 with DTNB.The plot of rate constants (k(pH)) vs pH
gives the C128 pKa of 7.2 ± 0.2.
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2.3.4 The structure of RitRox
RitR is a transcriptional regulator with a DNA-binding effector domain, which suggests
that RitR probably functions as a homodimer, since oligomerization is an extremely
common feature of DNA-binding proteins, and of response-regulators in particular. The
depressed pKa of C128 suggested the possibility of a redox-based activation mechanism in
RitR. Accordingly, the consequences of H2O2-mediated oxidation of RitR with respect to the
oligomeric state and structure were investigated by size exclusion chromatography and Xray crystallography.
Initial experiments showed that brief incubations of H2O2 with RitR failed to produce
any change in the oligomeric state of the protein (Figure 2-3A). Using different buffers for
the oxidation, such as citric acid, malic acid, or malonic acid, all at 50mM and pH 6.5,
likewise did not alter the oligomeric state when RitR was treated with 1 mM H2O2 (Figure
2-3B). Extending the oxidation time to 19h did increase the proportion of dimer present,
the maximum proportion of dimer (~90%) was only obtained when the SEC running buffer
contained 1 mM H2O2. Once the optimal oxidation conditions were established, a
preparative scale Sephacryl S-200 10/300 column was used to prepare samples of RitR
dimer (i.e. RitRox) for crystallization. The dimer peak from the S-200 column was collected
and stored in pH 6.5, 25 mM TRIS, 150 mM NaCl, 100 mM malic acid, and 1 mM H2O2. This
material was concentrated to 10 mg/ml and subjected to screening for crystallization
conditions.
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Figure 2-3: Different amounts of oxidized RitR dimer in different buffer conditions were determined by
gel filtration on a Sephacryl S-200 10/300 column. (A) The gel filtration results of RitR in pH8, 25 mM Tris,
150 mM NaCl buffer. Black line represents no H2O2 treatment, while red line represents 1 mM H2O2
treatment. (B) The gel filtration results of RitR in pH 8, 25 mM Tris, 150 mM NaCl, 100 mM malonic acid
buffer with different H2O2 treatment conditions. Black line represents no H2O2 treatment. Red line
represents RitR was treated with 1 mM H2O2 for 3 h. Blue line represents RitR was treated with 1 mM
H2O2 for 19 h. Green represents RitR was treated with 1 mM H2O2 for 3 h and containing 1mM H2O2 in the
running buffer. Orange represents RitR was treated with 10 mM H2O2 for 3 h and containing 1mM H2O2 in
the running buffer. The maximum amounts of RitRox were obtained with 1 mM H2O2 in the running buffer.

Diffraction-quality crystals of RitRox were obtained from a hanging drop containing 2 μl
of protein solution (6 mg/ml RitRox in pH 6.5, 20 mM TRIS, 150 mM NaCl, 100 mM malic
acid, 1 mM H2O2) and 1 μl of crystallization solution (10% (w/v) PEG 3350, 0.3 M
magnesium sulfate. The structure was determined to 1.7 Å resolution by using RitRC128S as
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the model. The structure of RitRox shows that the tertiary structures of the individual
domains do not change significantly. However, the two chains present in the asymmetric
unit form a domain-swapped dimer (Figure 2-4A). Upon oxidation, the DNA-binding
domain must be released from the REC domain. The structural change that triggers release
of the DNA-binding domain may be a rearrangement of the C-terminal end of the long α5
linker helix, which appears to unwind upon oxidation of C128 (Figure 2-4B) to form an
inter-chain disulfide bond. Since there is no DNA to bind, and the restricted conformation
imposed by the inter-chain disulfide bond, the DNA-binding domain of one protomer
interacts with the REC domain from the other protomer to almost perfectly recapitulate the
inactive, monomeric structure (Figure 2-4D). Overlaying the REC domain of chain A
together with the DBD of chain B onto the RitRC128S monomer gives a root-mean-square
deviation for aligned Cα atoms of 0.7 Å. This inactive “cross-dimer” conformation may be
an intermediate that forms before the oxidized dimer encounters its cognate DNA
sequence, or it may indicate that oxidation of C128 is not the entire signal.
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Figure 2-4: The structure of RitRox. (A) Ribbon representation of the RitRox structure, Rec domain colored in
blue (dark blue in chain A and light blue in chain B); α5 helix colored in orange (dark orange in chain A and
light yellow in chain B); DNA binding domain colored in green (dark green in chain A and light green in
chain B). (B) Close up view of disulfide bond. The 2|Fo|-|Fc| electron density map contoured at 1.0σ is shown
as magenta mesh, and the 2|Fo|–|Fc| composite omit map, also contoured at 1.0σ is shown as green mesh. (C)
RitRox structure with transparent blue surface in chain B. (D) Superimpose RitRox with inactive monomeric
RitRC128S (purple). RMSD = 0.7 Å
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2.3.5 RitR incubated with different metals
Because RitR is the repressor of iron transport, we hypothesized that iron or another
divalent metal might be involved in the activation mechanism of RitR. To study the effect of
metals on RitR dimerization, RitR was treated with FeIIICl3, FeIISO4, MgCl2, MnCl2, CaCl2,
CuCl2, or ZnCl2, all in pH 6.5, 20 mM TRIS, 150 mM NaCl, 100 mM malic acid buffer. Size
exclusion chromatography was used to check the oligomeric state, and the results are
shown in Figure 2-5.

Figure 2-5: Oligomer state of RitR after incubated with different metals. Blue line represents RitR only.
Cyan line represents RitRL86A/V93A only. This mutant represented an extended dimer, which will be
discussed below. Magenta line represents RitR with 1 mM metals. (A) RitR were incubated with CuCl2. (B)
RitR were incubated with FeIIICl3 with DTT. (C) RitR were incubated with FeIIICl3 (D) RitR were incubated
with FeIISO4 with 0.1 N HCl. (E) RitR were incubated with MgCl2. (F) RitR were incubated with ZnCl2. (G)
RitR were incubated with CaCl2. (H) RitR were incubated with MnCl2.
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SDS-PAGE, non-reducing-PAGE, and native SDS-PAGE were also used to check the
oligomeric state after treatment with the various metals. The results of these experiments
are shown in Figure 2-6.

Figure 2-6: (A) Non-reducing-PAGE results of RitR treated with different metals. 1, wild-type RitR; 2,
RitRL86A/V93A; 3, RitR with 1 mM FeIIICl3; 4, RitR with 10 mM MgCl2; 5, RitR with 10 mM MnCl2; 6, RitR with 1
mM CuCl2; 7, RitR with 10 mM CuCl2; 8, RitR with 1 mM ZnCl2; 9, Marker; 10, RitR with 10 mM ZnCl2. (B)
Native SDS-PAGE results of RitR treated with different metals. 1, Marker; 2, wild-type RitR; 3, RitRL86A/V93A; 4,
RitR with 1 mM FeIIICl3; 5, RitR with 10 mM MgCl2; 6, RitR with 10 mM MnCl2; 7, RitR with 1 mM CaCl2; 8, RitR
with 10 mM ZnCl2; 9, RitR with 10 μM CuCl2; 10, RitR with 100 μM CuCl2; 11, RitR with 1 mM CuCl2; 12, RitR
with 10 μM FeIIICl3 with 0.1 mM DTT; 13, RitR with 100 μM FeIIICl3 with 0.1 mM DTT; 14, RitR with 1 mM
FeIIICl3 with 0.1 mM DTT. Top bands located around the 50 kD marker, corresponding to dimer, while the
bottom bands located around the 25 kD marker, corresponding to monomer.

When the metal-treated samples of RitR were run on a non-reducing gel (Figure 2-6A)
to preserve any disulfide bonds, wild-type RitR runs mainly as a monomer, while the
double mutant RitRL86A/V93A runs mainly as a dimer. This constitutively dimeric double
mutant will be discussed in detail below. Treatment of the wild-type RitR with Fe3+, Fe2+,
Mg2+, Mn2+, Zn2+, did not alter the dimer/monomer ratio. However, treatment with Cu2+
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promoted dimerization of RitR as judged from the non-denaturing SDS-PAGE gel. This
result was confirmed by native SDS-PAGE (nSDS-PAGE). Increasing the CuCl2 concentration
increased the proportion of dimer obtained (lane 10 and lane 11 in Figure 2-6B). These
results indicated that Cu2+ induced the dimerization of RitR.
The structure of RitR dimer by CuCl2 treatment (data not shown) is same with RitRox by
H2O2 treatment, because copper also can oxidize the cysteine residue to form disulfide
bond 24-26. So the structure of RitRox,CuCl2 is also an inactive conformation.

2.3.6 Structural features important for RitR dimerization
The active, DNA-binding form of RitR is hypothesized to be a homodimer, which binds
to specific sequences in the piu promotor and represses the expression of genes associated
with iron uptake and up-regulates the expression of genes involved in the response to
oxidative stress. We saw above that the DBD of the RitR dimer obtained by oxidation alone
(i.e. in the absence of DNA) is characterized by a conformational change at the C-terminal
end of α5 and a domain-swapping arrangement that matches almost perfectly with the
inactive monomeric structure. There is virtually no contact between the ALR domains in
this so-called “cross dimer.” By analogy to other RR proteins whose active structures are
known, we hypothesize that the ALR domains will dimerize in the active, DNA-binding
state, likely through the same α4-β5-α5 interface that interacts with the DBD in the inactive
structure. Again, by analogy to other RRs, there is likely to be a conformational change that
makes formation of this ALR dimer more favorable in the activated state. To investigate
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what residues are involved in the disruption of the ALR-DBD interface, and thus facilitate
dimerization of the ALR domains, site-directed mutagenesis was employed. Specific point
mutants were chosen based on the RitRC128S and RitRox structures and are concentrated in
regions of the structure known to be important in other RRs, or in regions that are
particularly unusual in RitR. For example, residues in the active site that differentiate RitR
from typical REC domains were investigated (K10D, N53D and N53A, D81A). Likewise,
residues on the unusual α4 helix that were hypothesized to be part of a “hydrophobic gate”
that could influence dimerization were also mutated (L86A, L90A, V93A, L86A/V93A,
F96G). Residues on β5 that are involved in dimerization in other RRs were targeted (Y100
and Y102), since these residues make extensive interactions with the DBD in both
structures. Finally, we tested the effects of mutating residues in the α5 linker helix that
make key interactions in the ALR-DBD interface (R133A). C128 was targeted due to its
central hypothesized role in redox-based sensing (C128A, C128S, C128D) and Y163 was
mutated to Phe to break the water-mediated interaction with C128. The locations of the
mutagenesis sites are shown in Figure 2-7, and the rationale for each is given in Table 2-5.
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Figure 2-7: Cα trace of full-length RitRC128S structure with the sites chosen for mutagenesis marked as
colored spheres. The ALR domain is colored blue, except for the α4-β5-α5 face, which is colored green.
The DBD is colored pale yellow, except for the DND-contacting helix (red) and the trans-activation loop
(magenta).

Table 2-5: Summary of the rationale of each mutation
Mutation Site
K10
N53
D81
Y100
F96
Y102
R113
C128
Y163
L86
L90
V93

Reason for mutation
Basic residue in the putative phosphorylation site, usually acidic residue
in typical RRs.
Phosphorylatable site
Switch residue
Switch residue
Hydrophobic core and impede the Y100 reorientation for dimerization
Point outward and affect the dimer interface formation
Interact with Y100 and impede the Y100 reorientation for dimerization
Redox sensing
Interact with S128(C) through a water
Hydrophobic core and impede the Y100 reorientation for dimerization
Hydrophobic core and impede the Y100 reorientation for dimerization
Hydrophobic core and impede the Y100 reorientation for dimerization
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The oligomeric state of each of the mutants was assessed by size exclusion
chromatography in the hope of finding at least one variant that was dimeric even in the
fully reduced state. Accordingly, each mutant was analyzed on the BioBasic SEC-300
column in the presence or absence of dithiothreitol (DTT). Wild-type RitR mainly exists as
monomer, with a small portion of dimer (green trace in Figure 2-8A), which disappears
when DTT is added (red trace). According to the sequence alignment in Figure 1-3, one of
the acidic triad residues of typical response regulators is replaced with a basic residue,
lysine, in RitR (K10; Figure 2-8B). The side chain of K10 disrupts both the acidic
environment and the cleft for Mg2+ binding. The mutant K10D, which partially reconstitutes
the Mg2+-binding site, like the wild-type protein, exists mainly as monomer (Figure 2-8C).
Interestingly, changing N53, which in typical RRs is the phosphorylatable aspartic acid
residue, leads to a shift in the oligomeric state in the N53A variant (Figure 2-8D). This
protein has a greater proportion of dimer than the wild-type, but monomer is still the
major species. Changing N53 back to Asp (N53D) leads to an unstable and likely mostly
unfolded protein (Figure 2-8E).
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Figure 2-8: Oligomer states of wild-type RitR (A), RitRK10D (C), RitRN53D (D) and RitRN53A (E) without any
treatment (green) or with 10 mM DTT treatment (red). (B) The putative active site of RitR. K10 and N53
are shown in stick.
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In RitR, the residue that is equivalent to the threonine of the Y/T switch found in typical
RRs is D81. This residue is oriented toward N53 and is held there by interactions with a
number of active site residues (Figure 2-9). Compared with the corresponding residue in
atypical regulator ChxR (L72) and typical regulator PhoP (T79), D81 in RitR represents the
active conformer (Figure 2-9). This conformation of D81 is reminiscent of the interaction
between T83 and the phospho-Asp side chain in activated PhoB27 (Figure 1-4). In the
inactive state, L72 in ChxR and T79 in PhoP forms part of gate residues, but in RitR, D81
points toward the putative active site and leaves L86 replacing the corresponding position.
Some other atypical RRs that have been studied, such as ChxR, have a leucine residue at this
position. It also shifts away from the active site.
The hydroxyl group of tyrosine of inactive ChxR and PhoB point outward from the
domain, which interrupts the dimer interface formation. In the structure of nonphosphorylated PhoP (Figure 2-9), even it forms a similar “active” dimer with the switch
residue Y98 pointing outward, but this dimer was obtain at high crystallization
concentration and the helix α4 exhibits very high flexibility, which suggests this high
concentration induced dimer is not a stable dimer. The phosphorylation-induced
dimerization of PhoP (PDB ID: 2PL15) is stable with Y98 side chain pointing inward. So in
RitR structure, Y/T switch is effectively “uncoupled”, where Asp81 is in the active form but
Tyr100 is in the inactive form.
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Figure 2-9: Comparison of gate regions of two ALR REC domains, RitR (PDB ID 4LZL3) and ChxR (PDB ID
3Q7T4), and the canonical REC domain of PhoB (PDB ID 1B00) and PhoP (PDB ID 2PKX5). These structures
are all in an inactive state according to the positions of their Y/T switch residues. Even PhoP forms a
dimer (Chain A colored in grey, chain B colored in yellow), but the dimer is a high protein concentration
induced, unstable dimer. The activated dimer of PhoP is a more stable dimer with the switch residues shift
inward. Gate residues are represented in green spheres, Y/T switch residues are shown as sticks with
orange carbon atoms, and important catalytic residues are shown as sticks with cyan carbon atoms. Note
that the Y/T switch residues L72 in ChxR, T83 in PhoB and T79 in PhoP form part of the gate, whereas
D81 in RitR does not and is turned toward N53, resembling the active conformation of PhoB. In RitR, the
switch residue side chain position is substituted by gate residue L86, which is strategically placed in front
of tyrosine 100, allowed by the unusual formation of the kinked α4 helix in RitR.
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In order to determine whether or not D81 and Y100 act similarly to the switch residues
in other RR proteins, both residues were mutated (singly) to alanine and the effects on the
oligomeric state assessed by SEC. Substitution of Y100 with Ala does not significantly
increase the proportion of RitR in the dimeric conformation (Figure 2-10A). After
treatment with DTT, there was no evidence of the dimer form of the Y100A variant. In
contrast, the D81A variant exists as 65% dimer and 35% monomer (Figure 2-10B). After
treatment with DTT, the proportion of dimer is less (~50%), but still represents a
significant portion of the sample.

Figure 2-10: Results of SEC experiments on the Y100A (A) and D81A (B) variants. The green traces
show the results in the absence of DTT treatment, and the red traces show the data after treatment with
10 mM DTT.

As shown in Figure 2-11, F96, which is located at the C-terminal end of helix α4b, is
involved in the hydrophobic interactions within the hydrophobic core (β3, α3, β4).
Substituting Gly for Phe at position 96 does increase the proportion of dimer compared to
the wild type, but after DTT treatment, there was no dimer detectable. Also, the F96G
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variant was not stable in solution.

Figure 2-11: (A) F96 residue is involved in the hydrophobic interactions within hydrophobic core. (B)
Oligomer states of RitRF96G (B), RitRY102A (D), RitRR113A (E), RitRC128A (G) and RitRY163F (H) with or without
DTT treatment. Green represents no DTT treatment; brown red represents proteins were treated with 10
mM DTT. (C) Y102 and R113 both interact with the switch residue Y100 through water molecules. (F)
Y163 interacts with serine in redox sensor C128 position through a water molecule.
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Like Y100 discussed above, Y102 also points outward, away from the core of the ALR
domain and projects out from the α4-β5-α5 face of the protein (Figure 2-11C), which may
interfere with formation of the dimer interface. In addition, Y102 forms hydrogen bonds
with Q87 and Y100 (through a water molecule), which likely impedes the reorientation of
the Y100 side chain. When Y102 is mutated to Ala, there is little effect on the monomerdimer equilibrium. The slight increase in the proportion of dimer becomes undetectable
after treatment with 10 mM DTT by analytical SEC (Figure 2-11D). R113, which is located
on the α5 linker helix, is also involved in interactions with Y100 and also makes a key
interaction with the DBD in the inactive structures. Substitution of R113 with Ala results in
a protein that is purely monomeric, whether or not it is treated with DTT (Figure 2-11E).
As expected, the C128 mutants (C128A) are purely monomeric (Figure 2-11G). The
hydroxyl group of Y163 forms a water-mediated hydrogen bonding interaction with the
hydroxyl group of S128 in the C128S variant (Figure 2-11F). This interaction could
potentially be involved in the pKa perturbation of C128. To test this idea, Y163 was mutated
to Phe to remove the hydroxyl group. This change has very little effect on the monomerdimer equilibrium. There is a slight increase in the proportion of dimer compared to the
wild-type (Figure 2-11H), and treatment with DTT pushes the protein fully toward the
monomeric form.
One feature of the RitR ALR domain that distinguishes it from typical OmpR/PhoB-type
RRs is the kinked α4 helix. Helix α4 is broken in two, with an approximately 100o angle
between the helical axes of the two pieces (α4a and α4b). No REC domain has been shown
to have a similar conformation of helix α4. Three hydrophobic residues located in α4a
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(L86), the short stretch of helix between α4a and α4b (L90), and in α4b (V93), pack against
the central β sheet and make van der Waals interactions with V54 (Lβ3α3), I79 (β4), A97
(Lα4β5), Y100 (β5) and Y102 (β5) to form the hydrophobic core of this part of the protein
(Figure 2-12A). This solidly packed core would seem to be a mechanical barrier impeding
the reorientation of Tyr100 as seen in the structures of activated REC domains: a sort of
“hydrophobic gate.” If reorientation of Y100 is required for RitR dimerization as seen in
other RRs, and if the hydrophobic gate residues do influence the conformation of Y100,
then mutating these residues should have an impact on dimerization.
To test this idea, a series of mutants was constructed, including L86A, L90A, and V93A.
The oligomeric state of each mutant was analyzed by size exclusion chromatography. The
mutant L90A exists as a roughly equal mixture of monomer and dimer, and treatment with
DTT shifts the equilibrium toward the monomeric form (~30% dimer; Figure 2-12B).
Interestingly, RitRL86A and RitRV93A both exist as predominantly dimer in solution, and the
response of each of these mutants to DTT is quite different (Figure 2-121C, D). The RitRL86A
variant is nearly insensitive to DTT, with only slightly more monomer present after
treatment with 10mM of the reductant. On the other hand, the V93A variant shifted
dramatically, becoming predominantly monomeric after DTT treatment. Since they had the
greatest amount of dimer of any mutants tested, the RitRL86A and RitRV93A mutants were
combined (RitRL86A/V93A; Figure 2-12E). The double mutant was slightly more stable to DTT
treatment than the RitRL86A variant. In all, Ala substitution on any of the three hydrophobic
gate residues dramatically increases the proportion of RitR dimers. The RitRL86A/V93A
double mutant was purified in large quantities for crystallographic structure
determination.
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Figure 2-12: The effects of gate residues on RitR dimerization. (A) Schematic view of RitR gate residues van
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der Waals interactions (yellow dotted lines) and hydrogen-bonding network (green dotted lines) in the
dimer/gate region. Oligomer states of wild-type RitRL90A (B), RitRL86A (C), RitRV93A (D) and RitRL86A/V93A (E)
without any treatment (green) or with 10 mM DTT treatment (red).

2.3.7 Mutations to the gate residues L86 and V93 result in an “extended” dimer
We were surprised to learn that the retention time of the RitRL86A/V93A dimer was
significantly earlier (5.4 min) than that of the “cross dimer” conformation (5.6 min)
observed for the wild-type protein oxidized with H2O2 (Figure 2-13). In addition, the tiny
monomer peak of the RitRL86A/V93A variant eluted earlier than that of the wild-type RitR
monomer. Both of these observations suggest that the conformation of RitRL86A/V93A is more
extended, making it behave like a larger protein on the SEC column. This led us to believe
that the inter-domain interactions between the RitRL86A/V93A ALR domain and the DNAbinding domain are disrupted. This is supported by the small difference in thermal stability
between the double mutant and the wild-type protein measured by differential scanning
fluorimetry. The average Tm value (46.6oC) measured for RitRL86A/V93A is lower than that of
wild-type RitR (52.2 oC), which suggests that RitRL86A/V93A is less stable than RitR. The D,Lmalic acid buffer used for storage of the wild-type protein is still a good buffer to store
RitRL86A/V93A (Table 2-6 and Table 2-7).
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Figure 2-13: SEC retention times of wild-type RitR (as purified, colored in blue), wild-type treated with
H2O2 (RitRox, colored in brown), and the RitRL86A/V93A variant (colored in cyan).

Table 2-6: Buffers from the Solubility & Stability Screen (Hampton Research) giving the
highest Tm values in the Thermofluor assay.
N.O.

Tm - Tm,averaged (oC)

Buffer

1

4.3

Sodium phosphate monobasic, Potassium phosphate dibasic

2

3.5

Methyl α-D-glucopyranoside

3

3.3

Lithium citrate tribasic tetrahydrate

4

3.2

Sodium sulfate decahydrate

5

3.1

Sucrose

6

2.9

Succinic acid pH 7.0

7

2.7

Spermine tetrahydrochloride

8

2.6

Sodium malonate pH 7.0

9

2.5

DL-Malic acid pH 7.0

82

Table 2-7: Buffers from the lice pH Screen (Hampton Research) giving the highest Tm
values in the Thermofluor assay.
N.O.

Tm (oC)

Buffer

1

3.0

DL-malic acid pH 5.3

2

2.7

DL-malic acid pH 5.9

3

2.7

Succinic acid pH 6.0

4

2.5

Succinic acid pH 5.7

2.3.8 Size exclusion chromatography of RitR : BS3 and RitRL86A/V93A : BS3
Since the two domains in the double mutant appeared to be dissociated from one
another, while still allowing the protein to dimerize, it is possible that the RitRL86A/V93A
mutant dimer conformation is the active conformation. To ascertain whether or not this
variant is active, the DNA-binding ability of RitRL86A/V93A to bind to DNA was assessed by
SEC. RitR is known to directly bind and repress piu transcription, and three binding sites
(BS1-3) were identified by electrophoretic mobility shift assay (EMSA)1. Due to the much
higher affinity of RitR for BS3, we concentrated on this target sequence. In this thesis, I
tested the affinity of six lengths of BS3 for crystallization (Table 2-1). And BS3 is called BS31 in this thesis.
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Figure 2-14: Size exclusion chromatography results for RitR with and without the BS3-1 dsDNA
oligonucleotide (A) and RitRL86A/V93A with and without BS3-1 (B). In both panels, the traces for the wildtype RitR protein alone are blue, the RitRL86A/V93A protein alone cyan, BS3-1 alone black, RitR or
RitRL86A/V93A with BS3-1 without H2O2 green, and with 1 mM H2O2 red. For the mixture of RitR or RitRox
with BS3-1, dsDNA BS3-1 and proteins were eluted separately. For the mixture of RitRL86A/V93A with BS3-1,
the RitRL86A/V93A:BS3-1 complex was eluted, as indicated by the earlier elution time when compared to the
BS3-1-only and protein-only peaks.

As shown above, and in Figure 2-14A above, RitR exists mainly as a monomer in the
absence of any oxidant. Incubating the wild-type protein with the BS3-1 olignucleotide did
not result in formation of a stable RitR:BS3-1 complex. Oxidation of RitR with 1 mM H2O2
for several hours prior to the addition of BS3-1 DNA, resulted in about 60% RitR forming
the “cross dimer” RitRox conformation. There is no peak corresponding to the RitRox:BS3-1
complex. The RitRL86A/V93A variant, on the other hand, is present almost exclusively as the
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extended dimer, and when DNA was added, the majority of the protein elutes as a complex
with the BS3-1 oligonucletide (retention time ~5.1 min). Oxidation of RitRL86A/V93A with
H2O2 did not significantly alter the oligomeric state of the double mutant or its ability to
bind to the BS3-1 DNA. To verify the binding of RitRL86A/V93A to BS3-3 while the wildtype
RitR protein does not, differential scanning fluorimetry was used. When the protein bound
to BS3-3, the protein would get stabilized and resulted in a higher Tm value. But if the
protein cannot bind to the DNA, Tm value would not be affected. In all three buffers I tried,
Tm of RitR value does not change significantly, while the Tm value of mutant RitRL86A/V93A
significantly increases (Figure 2-15). These results show that wild-type RitR in both its
reduced and oxidized forms is not able to bind to the dsDNA oligonucleotide BS3-1.
However, there is a complex peak formed for the sample RitRL86A/V93A with dsDNA BS3-1,
while RitRL86A/V93A with its presumed altered conformation, is able to do so, whether or not
it is treated with H2O2. This suggests that the L86A/V93A substitutions bypass the intiatory
C128-mediated redox-sensing trigger, resulting in a constitutively active form of RitR.
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Figure 2-15: Tm value change of (A) RitR, RitRox and (B) RitRL86A/V93A after incubated with BS3-3 dsDNA. 1:
pH 6.5, 25 mM TRIS, 150 mM NaCl, 100 mM DL-malic acid; 2: 20 mM HEPES pH 7.2, 5 mM MgCl2, 1 mM
CaCl2, 0.1 mM EDTA; 3: 20 mM HEPES pH 7.2, 5 mM MgCl2, 1 mM CaCl2, 0.1 mM EDTA, 150 mM NaCl. After
incubated with BS3-3, RitR Tm did not change significantly in three different buffers. Similar results were
obtained for RitRox. But the mutant RitRL86A/V93A Tm value increased significantly in all three buffers.

2.3.9 Single mutants in helix α4 also bind to BS3-1
The studies above verified that mutagenesis on both L86 and V93 that located in the
kinked α4 helix bind to the target DNA BS3-1. To investigate the binding ability of three
single mutants (L86A, L90A, V93A) in α4 helix, the oligomer states of these mutants with
BS3-1 were determined by SEC. The results were shown in Figure 2-16. These three single
mutants on α4 helix all bind to BS3-1, because a complex peak eluted earlier than BS3-1
only peak.
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Figure 2-16: Gate residue variants bind to the dsDNA BS3-1 due to a complex peak eluted. In the
panel, the traces for the wild-type RitR protein alone are green, the RitRL86A/V93A protein alone cyan,
BS3-1 alone brown, RitRL86A with BS3-1 green, RitRL90A with BS3-1 blue and RitRV93A with BS3-1 red.

2.3.10 Crystallization of RitRL86A/V93A
RitRL86A/V93A is almost entirely dimeric as observed by SEC, but there are detectable
amounts of monomer. Since this heterogeneity would make the protein difficult to
crystallize, the dimer form was purified by preparative SEC with the same protocol used to
purify the RitRox dimer (with the exception of the H2O2 treatment). The fractions containing
the RitRL86A/V93A dimer were concentrated to 7.2, 10.1, or 34.0 mg/ml and used to set up
sparse matrix screens for the identification of crystallization conditions (Index, PEG/Ion,
SaltRx, and PEGRx from Hampton Research). These screens resulted in only clear drops,
phase separation, or amorphous precipitate; no conditions resulted in crystalline protein.
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Examination of the conditions that gave phase separation (super-concentrated protein)
showed that the protein favors neutral pH (HEPES or BIS-TRIS at pH 6.5-7.5), PEG3350,
and a variety of salts having monovalent cations (ammonium sulfate, lithium sulfate,
sodium formate, sodium malonate). These conditions were optimized with different
RitRL86A/V93A concentrations on both sitting drop and hanging drop methods at different
temperatures (room temperature, 16 oC, 22 oC). Considering the protein crystallization
diagram, increase the protein concentration (supersaturation) was necessary for
nucleation. So the highest protein concentration I tried was 88 mg/mL. However, there was
no crystal formed and only stronger phase separation was obtained. To get nucleation or
crystals on those phase separation conditions, additive screen (Hampton) was also tried.
There was no crystal formed either. I also tried to use some other protein crystals as
microseeds (SbADC, RitRox, RitRC128D) to crystallize the RitRL86A/V93A protein, but none
succeeded.
Some proteins only crystallize with the cognate DNA, for example, AmrZ in
Pseudomonas aeruginosa28. Based on the shorter retention time on size exclusion column,
RitRL86A/V93A is assumed to be an extended dimer. Because it’s so hard to crystallize
RitRL86A/V93A protein, RitRL86A/V93A probably is the protein that only crystallizes with
cognate DNA. Then I tried to co-crystallize RitRL86A/V93A with dsDNA.
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2.3.11 Shorten BS3-1 length for crystallization
One variable of protein-DNA complex crystallization is the length of DNA. The general
principle is “smallest functional”. So different lengths of oligonucleotides were designed to
provide blunt-ended dsDNA fragments. In addition, the ratio of protein to DNA is also
important for successful crystallization. This ratio relates directly to the shape of the
protein component, rather than the oligonucleotide, because the overall shape of the BDNA is regular and cylindrical.

Figure 2-17: Complex peak area comparison of 216 μM RitRL86A/V93A with 100 μM of BS3-1 (38 bp, red),
BS3-2 (34 bp, orange), BS3-3 (35 bp, green), BS3-4 (32 bp, blue) and BS3-5 (29 bp, purple).

To find out which blunt-ended dsDNA at what ratio to RitRL86A/V93A protein gives the
most quantity of protein-DNA complex for crystallization, the complex peak area of
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different ratios of RitRL86A/V93A to dsDNA (BS3-1 to BS3-5) was determined by SEC.
RitRL86A/V93A protein (216 μM) was mixed with 100 μM of dsDNA (BS3-1 to BS3-5). The
results were shown in Figure 2-17. Comparing the complex absorbance at 280 nm of
RitRL86A/V93A with different lengths of DNA, BS3-3 with 35 bp nucleotides gives the most
quantity of protein-DNA complex.

2.3.12 The ratio of RitRL86A/V93A : BS3-3 and RitRL86A/V93A : BS3-6
Based on the above results, BS3-3 gives the most quantity of protein-DNA complex, so BS33 was chosen to cocrystallize with RitRL86A/V93A. Another shorter dsDNA (BS3-6, 24 bp) was
also used in cocrystallization with RitRL86A/V93A protein. Because the dsDNA is limiting, to
get the maximum protein-DNA complex, the “best” ratio of RitRL86A/V93A over BS3-3/BS3-6
was determined by comparing the absorbance of complex peak at different protein : DNA
conditions. According to the gel filtration results shown in Figure 2-18, the absorbance of
protein-DNA complex increases as the protein to DNA ratio increases. For RitRL86A/V93A with
BS3-3 (Figure 2-18A), the maximum complex was obtained at the ratio of 4 : 1 with the
excess protein. Increasing the ratio to 10:1 does not increase the protein-DNA complex
peak absorbance. For RitRL86A/V93A with BS3-6 (Figure 2-18B), the BS3-6 DNA peak
overlaps with the RitRL86A/V93A protein only peak. The binding affinity is lower than that of
BS3-3, because even treated with 10 fold more protein, the complex absorbance still not
get maximum. So the maximum ratio of 10 : 1 with the excess protein was used. The two
conditions were used for incubating protein with DNA, and then the complex was
separated on a HiPrepTM 26/60 Sephacryl® S100 HR column. Before making the
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crystallization tray, extra BS3-3/BS3-6 DNA was added into the complex solution. But there
is no crystal was obtained but salt crystals.

Figure 2-18: Gel filtration results of different ratios of RitRL86A/V93A : BS3-3 (A) and RitRL86A/V93A : BS3-6
(B). In both panels, the traces for the RitRL86A/V93A protein alone are dark green, the RitRL86A/V93A protein
alone cyan, BS3-3 or BS3-6 alone brown, 100 μM BS3-3 or BS3-6 were incubated with 50 μM (orange),
200 μM (red) and 500 μM (blue) of RitRL86A/V93A.
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2.3.13 Structure of the RitRL86A/V93A REC domain
Likely owing to the higher degree of flexibility in the “extended dimer” of the
RitRL86A/V93A, we were not successful in obtaining diffraction-quality crystals of the fulllength protein. Attempts to “lock down” the DNA-binding domains by co-crystallizing a
number of BS3 variants with the double mutant. This was also unsuccessful. In order to
determine whether or not the ALR domains of RitRL86A/V93A formed a stable dimer, an
expression construct was prepared that included only residues 1-124 (RDLV; the same
residues used in the original wild-type ALR domain structure). Diffraction-quality crystals
were obtained from hanging drops containing 1 μl protein solution (4.4 mg/ml RDLV in 10
mM TRIS pH 8.5, 50 mM Succinic acid) and 1 μl crystallization solution (20% (w/v) PEG
3350, 0.2 M magnesium sulfate, 0.1 M TRIS pH 8.5), which diffracted to 1.8 Å resolution.
The crystals belonged to space group P2221 (a = 50.1 Å, b = 62.9 Å, and c = 80.3 Å) and
contained 2 chains per asymmetric unit. We expected that the structure would be solved
easily by molecular replacement, since the structure of the wild-type ALR domain was
known. However, the molecular replacement calculation consistently failed, no matter
which REC domain structure was used as the search model. SeMet-substituted RDLV was
prepared, and it crystallized in the same condition used for the native protein, except 1 mM
DTT was added to prevent heterogeneity due to oxidation of the SeMet residues. The data
extended to 1.9 Å resolution and the anomalous signal from the 14 Se atoms provided
excellent initial phase estimates that allowed Autobuild29 to build an approximately 74%
complete model. The two chains in the asymmetric unit form a dimer, which is consistent
with the size exclusion chromatography results (data not shown). There are numerous
hydrogen bonds between two chains, with an interface area of approximately 2,261 Å2.
92

Shockingly, the topology of the RitRL86A/V93A ALR dimer is drastically altered from the
(β/α)5 topology seen in all previous REC domain structures (Figure 2-19, Figure 2-10).
There are two primary differences between the RDLV and all other REC domain structures.
First, the kinked α4 helix rearranges to form an extension of strand β4 and a long loop
leading into β5. Owing to the loss of α4, β5 is no longer parallel to β4. Thus the central
sheet in the RDLV ALR domain is mixed rather than parallel as it is in the wild-type ALR.
Second, “α5,” which is technically the 4th α-helix in the structure, is no longer docked with
β5 and the rest of the domain, but rather participates in a domain-swapping interaction
with the other protomer of the dimer. The two protomers literally swap their “α5” helices,
and other than coming from the opposite dimer, there is little difference in the positions of
“α5” of the RDLV and α5 of the monomeric ALR with respect to the rest of the tertiary
structure.

Figure 2-19: Ribbon representation of the RDLV structure (A) showing the arrangement of the secondary
structure elements. Chain A of the RDLV dimer is colored dark blue and dark orange (the rearranged β4,
β5 and α5); chain B is colored light blue.and yellow (the rearranged β4, β5 and α5). The Y100 residues of
each chain (shown as sticks) stack with each other in the dimer interface. Note the loss of the α4 helix,
which becomes part of β4 and a long loop leading into β5. This reverses the direction of strand β5 and
results in a mixed β sheet structure, rather than the parallel sheet typical of REC domains. The “α5” helices
are swapped between the two chains, but occupy a position in the structure very similar to that of α5 in
the monomeric RitR REC domain. (B) The overlay of the RDLV structure (chain A, colored in dark blue)
onto the wild-type RitR REC domain structure (colored in grey) highlights the extent of the structural
rearrangements leading to this dimeric form of the ALR domain.
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Of course, the pronounced changes in the topology of the RDLV REC domain lead to
serious changes in the active site and switch residues (D81 and Y100; Figure 2-20). With
the rearrangement of the hydrophobic core in the β4-α4 region of the protein, the side
chains of N53 and N55, which point away from each other in the wild-type structure, both
rotate ~180° to participate in a hydrogen bonding network that includes the amide
nitrogen of V54. The side chain of the switch residue D81, which makes a hydrogen
bonding interaction with the V54 amide nitrogen atom in the wild-type REC domain moves
slightly in the RDLV REC domain so that it no longer interacts with V54. The other switch
residue, Y100, also has an ~180° change in the orientation of its side chain, though in this
case it is due to the “flipping” of the β5 strand rather than a simple rotation about the Cα-Cβ
bond. In this orientation, the rings of Y100 from each protomer stack against one another
at the heart of the dimer interface.

Figure 2-20: Comparison of the active site and switch residues in the wild-type RitR REC domain (A) and
the RDLV variant (B). The wild-type REC domain is colored grey; RDLV dimer is colored in dark blue
(chain A) and light blue (chain B). Because the kinked α4 helix forms the loop between β4 and β5 and
changes the orientation of β5, the loop between β3 and α3 then moves due to the changed interactions.
The N55 side chain flips and occupies the space occupied by K10 in the wild-type RitR REC domain.
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2.3.14 Structure of the RD2LV REC domain construct
Because of the radical nature of the structural changes observed in the RDLV variant,
we thought it important to confirm that the structure is not affected or induced by
crystallization. To this end, we constructed a slightly longer form of the RDLV REC domain
that includes the putative redox-sensing C128. This longer construct was dubbed RD2LV.
SeMet-substituted protein was produced and diffraction-quality crystals were obtained
from Hanging drops containing 1 μl of protein solution (19 mg/ml RD2LV in 10 mM glycine
pH 8.8, 25 mM L-Arg) and 1 μl of crystallization solution (22.5% (w/v) polyethylene glycol
(PEG) 3350, 12% Tacsimate pH 8.2).. These crystals diffracted to 2.6 Å resolution. They
belonged to space group P21212 with a = 115.3 Å, b = 125.4 Å, and c = 40.2 Å. The
asymmetric unit contained four molecules arranged as two homodimers (Figure 2-21B).
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Figure 2-21: Ribbon representations of the RD2LV REC domain structure (A) and the RD2LV asymmetric
unit (two dimers). The presence of C128 does not alter the domain swapped dimer, which is nearly identical
in both structures. There are inter-dimer disulfide bonds that technically turn this into a tetramer. This
appears to be an artifact of crystallization, as no tetramer is detectable in SEC traces of RD2LV (data not
shown).

The structure of RD2LV is nearly identical to that of the shorter RDLV protein, both in
terms of the tertiary structure of the protomer as well as the quaternary structure of the
dimer (Figure 2-21A). The largest difference between the two structures is the fact that the
“α5” helix is longer in RD2LV, which is not unexpected. This leads both to a modest
increase in the number of hydrogen bonds and salt bridges between two chains, while the
buried surface area of the interface is nearly unchanged (2,272 Å2 vs 2,261 Å2). More
importantly, there are two disulfide bonds between the C128 residues of the two dimers
(Figure 2-21B). The inter-dimer disulfide bonds are likely an artifact of the high
concentrations required for crystallization, since there is not clear evidence of
tetramerization in the analytical SEC data for the RD2LV variant (data not shown).
Presumably, the α5 helices of the two protomers in a single dimer could also become
disulfide linked, and this would hold the two DBDs in the proper orientation for DNA
binding. The arrangement of the α5 helices in the RD2LV dimer suggests that the highly
unusual REC domain structure observed here may be biologically relevant.
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2.3.15 RitR with GADDY motif (RitRGADDY)
A comprehensive investigation of OmpR family proteins30 shows that RitR homologs
have lost not only the phosphorylatable Asp residue, but also several highly conserved
acidic residues that comprise the REC “GADDY motif” (see residues highlighted with red in
Fig. 2-22), which is begins in the loop between α4 and β5 (Lα4β5) and ends near the
middle of strand β5. The GADDY motif contributes to hydrogen bonding in the dimer
interface of canonical REC domains 3, 31. The terminal Tyr residue of the GADDY motif is the
Y/T couple residue. We hypothesized that the loss of the GADDY motif in RitR (the motif
becomes (F/Y)AVSY in RitR homologs) may explain why it only forms dimers in response
to Cys128 oxidation.

Figure 2-22: Sequence alignment of RitR homologs with other DNA binding proteins in the OmpR family.
The major differences in the Streptococcal RitR homologs and the typical REC domain proteins are labeled
in red. Asn/Ser substitutes for the phosphorylatable Asp residue, and the conserved GADDY motif is
replaced with (F/Y)AVSY in RitR proteins.
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To explore the hypothesis, we constructed a triple mutant of RitR where the equivalent
“FAVSY” sequence is changed to GADDY (RitRGADDY). The oligomeric state of RitRGADDY was
investigated by SEC and the results are shown in Figure 2-23. The RitRGADDY variant has
significantly more dimer than wild-type RitR protein in the absence of added oxidant. The
retention time of the RitRGADDY dimer is the same as that of RDLV, but earlier than the RitRox
cross dimer. The retention time of the RitRGADDY monomer is also earlier than that of the
wild-type RitR monomer. These observations suggest that both the dimeric and monomeric
forms of RitRGADDY are more “extended” than the wild-type, likely due to dissociation of the
ALR and DBD domains. The dimer/monomer ratio in RitRGADDY is still dependent on the
redox state of C128. After treatment with 1 mM H2O2, RitRGADDY forms pure extended dimer,
while it forms pure extended monomer after treatment with DTT (Figure 2-23).

Figure 2-23: Size exclusion chromatography results of the RitRGADDY mutant with or without H2O2 or DTT
treatments. The mutant RitRGADDY protein (magenta) exists as a mixture of extended dimer and extended
monomer. After treatment with H2O2 (red), it forms almost pure dimer. And after DTT treatment (dark blue),
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it forms almost pure monomer. The RitRox “cross dimer” is dark red, the RitRL86A/V93A (“extended dimer”) is
cyan, wild-type RitR is green.

2.3.16 The role of C128 in the RitRL86A/V93A variant
C128 in RitR is highly conserved among a non-Group A/B subset of streptococcal
species. To check if C128 has a role in the DNA-binding activity of RitR, we mutated C128 to
Ser in the RitRL86A/V93A variant. The RitRL86A/V93A variant was used for these experiments,
since it is the only form of RitR that we are reliably able to bind to DNA. The affinity of this
RitRL86A/V93A/C128S triple mutant (LVC) for the BS3 target sequence was qualitatively
assessed by SEC and differential scanning fluorimetry. As is evident in Figure 2-24, the LVC
mutant binds to the BS3 forming protein-DNA complex. There is a peak corresponding to
the complex with a retention time of 5.1 min, and stability of the protein significantly
increased in the presence of DNA. As expected from the results above, it seems that
oxidation of C128 is only the beginning of the signal, and some other factor is required to
trigger the structural rearrangement of the α4-β5-α5 face of the REC domain that leads to
dimerization, and it would seem, to DNA binding.
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Figure 2-24: The LVC triple mutant still binds to the BS3-3 target dsDNA. Size exclusion chromatography
results of LVC in the presence of BS3-3 (A) show that a peak eluted at 5.1 min that is not present in traces
of either the protein or DNA alone and likely corresponds to the complex between the two. The presence
of BS3-3 also significantly increased the stability of LVC as judged by differential scanning fluorimetry (B).
1: pH 6.5, 25 mM TRIS, 150 mM NaCl, 100 mM DL-malic acid; 2: 20 mM HEPES pH 7.2, 5 mM MgCl2, 1 mM
CaCl2, 0.1 mM EDTA; 3: 20 mM HEPES pH 7.2, 5 mM MgCl2, 1 mM CaCl2, 0.1 mM EDTA, 150 mM NaCl.

Our collaborators in the Ulijasz laboratory at Loyola University Chicago constructed
three C128 mutants in the natural chromosomal position in Streptococcus pneumoniae
strain R800 and D39: C128A (sensory dead), C128S (reduced mimetic) and C128D
(oxidized mimetic). They found that the C128A mutant strain exhibited significantly
impaired growth under aerobic conditions, whereas the C128S exhibited an intermediate
growth defect. Conversely, the C128D mutant grew faster than the wild type. The results of
the streptonigrin killing assay, which is an indirect indicator of cellular iron concentrations,
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suggest that these effects are due to RitR-mediated repression of iron transport (to be
published).

Figure 2-25: (A) Size exclusion chromatography results of RitRC128D with 1 mM H2O2 or 1mM DTT. The
traces of RitRC128D only colored in blue, H2O2 treatment colored in red and DTT treatment colored in green.
(B) Overlay of RitRC128D and RitRC128S structures. RitRC128D is colored green, while the RitRC128S structure is
colored cyan. The rmsd for the matched Cα atoms in the two structures is 0.30 Å.

To investigate the structure and function relationship of the RitRC128D mutant, the
oligomeric state and the protein structure were determined. The results are shown in
Figure 2-25. The RitRC128D mutant exists as monomer, even after treatment with 1 mM H2O2
for several days. The structure of RitRC128D is very similar to that of the RitRC128S structure.
Superposition of the RitRC128S and RitRC128D structures using secondary structure matching
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(SSM)32 gives a root-mean-square deviation (rmsd) of 0.3 Å for 220 of the 229 Cα atoms in
the RitRC128S chain A. This indicates that the two structures are essentially identical. The
long α5 linker helix still connects the REC and DBD domains of the protein and runs almost
the entire length of the protein. However, the C-terminal end of this helix is disordered in
the RitRC128D variant. This suggests that the Cys > Asp substitution mimics the oxidized
form of RitR at least enough to trigger the disordering of the C-terminal end of α5 that was
observed in the RitRox structure, even though it was apparently not enough to trigger
dissociation of the domains.

2.4 Conclusions
To propagate a signaling response, the typical TCST system employs a sensory histidine
kinase that phosphorylates a receiver domain on a conserved aspartate residue. However,
RitR is an orphan TCST response regulator in Streptococcus pneumonia R6 that lacks a
cognate histidine kinase. In addition, there are some other characteristics suggesting that
RitR has a different activation mechanism: the phosphorylatable aspartate is replaced by
asparagine in RitR; D10 in the acidic triad is substituted by basic lysine; one switch residue
T83 is substituted with D81; and there is a conserved cysteine residue near the DBD, C128,
that is not present in other response regulators. This cysteine residue appears to be redox
active and to influence the quaternary structure of RitR.
Analogy to other DNA-binding response regulators suggests that the active form of RitR
binds to DNA as a dimer. As purified, RitR exists as a monomer in equilibrium with a very
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small amount of homodimer. To get homogenous protein for crystallization, C128 was
mutated to serine; the resulting C128S variant is purely monomeric. The structure of
RitR(C128S) showed that the ALR domain and the DNA-binding domain are linked by an
unusually long α-helix that runs the length of the entire protein, with C128 near the Cterminal end. Bioinformatic analysis of all streptococcal RitR homologs showed that C128
is strictly conserved, suggesting that RitR may be a novel redox sensor. The environment of
the cysteine thiol group, as inferred from the position of S128 Oγ is quite polar (Figure 211F). Thus there is no clear indication why the C128 thiol group has a pKa of 7.2 (Figure 22), which is significantly lower than the pKa of free cysteine in aqueous solution. It is
possible that other hydrogen bonding interactions, e.g. the water-mediated hydrogen bond
to Y163, as well as the concentration of basic amino acids toward the C-terminus of α5
(H127, H147, and R160, as well as R135, which is located on the loop after α5) might
mitigate the unfavorable interaction between a cysteine thiolate and the helix dipole.
However, what is evident is that the C-terminus of helix α5, despite an extensive hydrogen
bonding network around C128 that includes H147, D115, R160 and D164, is one of the
more dynamic regions of the structure. The last few turns of helix α5 become disordered in
the H2O2-oxidized protein, as well as the oxidized (sulfenate/sulfinate)-mimetic mutant
RitR(C128D) (Figure 2-4 and Figure 2-25). Cysteine sulfenic acid (Cys-SOH) is a notuncommon feature in redox-active proteins. For example, sulfenic acid was found to be an
intermediate for disulfide bond formation in vitro33. The dramatically faster growth
phenotype of the C128D mutant strain of S. pneumoniae verifies that the disordering of the
C-terminal end of α5 is one step of RitR activation.
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Iron is an important micronutrient in bacteria, which influences cell growth, virulence
and metabolism. To stop the repressor signal, the gnd gene that co-transcribed with RitR,
may be involved in the shutdown of oxidization-induced RitR activation. The gnd encodes a
6-phosphogluconate dehydrogenase that catalyzes NADPH formation. NADPH is, in turn,
the cosubstrate of glutathione reductase, which may be involved in repressing RitR
activation by reducing the sulfenic acid or disulfide bond into the reduced thiol group
(Figure 2-26).

Figure 2-26: Proposed thiol group oxidation and reduction metabolism of RitR.
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The structure of an oxidized, dimeric form of RitR was determined by X-ray
crystallography. Oxidation of C128 to the disulfide caused a conformational change that
caused the DBD to release from the ALR domain. Surprisingly, the freed DBD was observed
bound to the ALR domain of the other, disulfide-linked molecule of RitR, recapitulating
almost exactly the structure of the inactive, monomeric protein.
A second dimeric conformation was found in the RitR(L86A/V93A) variant. L86 and
V93 were both mutated to Ala. These residues are found in the kinked α4 helix that
interacts with the DBD and form part of the hydrophobic core of this region of the protein.
RitR(L86A/V93A) elutes significantly earlier than the “cross-dimer” conformation of the
oxidized, inactive wild-type RitR, suggesting that it has a different, likely more extended,
overall shape. This “extended-dimer” binds to the target DNA according to gel filtration and
differential scanning fluorimetry.
Attempts to crystallize the full-length RitR(L86A/V93A) protein alone, or in complex
with oligonucleotides of various lengths were unsuccessful. Only blunt-ended dsDNA was
tested in these experiments; it is possible that sticky-end dsDNA might promote
crystallization of the protein:DNA complex by forming long, repeating assemblies of
oligonucleotides34. Because the protein component is usually globular, packing of the
bound protein within the lattice formed by neighboring DNA oligonucleotide assemblies
can be important for growth of a three-dimensional crystal.
Since the full-length protein did not crystallize readily, we targeted the isolated
RitR(L86A/V93A) REC domain for crystallization. The crystal structures of two constructs
were determined: a 1-124 version that matches the original wild-type REC domain
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construct (RDLV) and a longer 1-132 version that includes the putative redox-active C128
(RD2LV). Both RDLV and RD2LV exhibited the same unprecedented conformational change
for a response regulator protein, where helix α4 is disordered and the two protomers swap
their “α5” helices to form the dimer. The α5 helices point in opposite directions, which
would place the DNA-binding domains far apart and give the extended shape suggested by
gel filtration.
The fact that strains harboring a reduced mimetic RitR mutants (e.g. C128S) have a
growth defect phenotype, it seems that oxidation of C128 is part of the activation
mechanism. The RitRox structure demonstrates that the dissociation of the REC domain
from the DBD upon oxidation, but the dissociated DBD re-binds to the REC domain of the
other protomer. So there must be an additional factor that leads to dimerization of the ALR
domains, the active form of which likely has a similar structure to the RitR(L86A/V93A)
REC domain.
Based on these studies, we propose a model for RitR activation, as shown in Figure 227. Under reducing conditions, RitR mainly exists as inactive monomer. Upon oxidation, as
might happen during the oxidative burst phase of the pneumococcus growth where
millimolar amounts of H2O2 are produced

35,

RitR favors the dissociated and extended

conformation. In the absence of target DNA, RitR would eventually form the inactive crossdimer. In the presence of DNA, it may bind to DNA at low affinity. Under the influence of
some still-unknown factor, the ALR domain of RitR would undergo a conformational
rearrangement of the α4-β5-α5 region to promote dimerization and place the two DBDs far
from the ALR domains. In that way, RitR can keep the extended, active conformation to
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bind to DNA with high affinity. Alternatively, the ALR domains might be triggered to
dimerize before binding to DNA, and only bind to target DNA when the active conformation
has been obtained.

Figure 2-27: The proposed RitR activation mechanism.

Comparative transcriptome analysis demonstrated that, in addition to repressing
expression of the piu iron transport genes, RitR also activates expression of bacterial
ferritin, several genes involved in sugar uptake and other genes involved in DNA repair 1.
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To check whether up-regulated sugars might contribute to RitR activation (dimerization),
co-incubation of RitR with several carbohydrates (sucrose, sorbitol, mannitol, glucose,
isoleucine) was conducted at room temperature for several hours. Size exclusion
chromatography results showed that no oligomer state change was observed. So future
studies on finding the trigger for RitR ALR domain dimerization are still needed to explore.
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Chapter 3
Uncharacterized Protein Q15Z91 from Pseudoalteromonas atlantica is
an ALR-Regulated Diguanylate Cyclase

3.1 Introduction
Aspartate-less receiver (ALR) proteins are a subclass of response regulator proteins in
bacterial signal transduction systems. In typical two-component signaling systems, the
receiver domain of the regulator would be phosphorylated in the conserved aspartate
residue by the cognate histidine kinase. In ALR-containing response regulators, there is no
conserved Asp residue for phosphorylation, which means that ALRs must necessarily
respond to different regulatory stimuli. Chapter 2 described my work aimed at elucidating
the activation mechanism of an ALR protein, RitR. I showed that it functions as an
“extended dimer” where the DNA-binding domains are released from the ALR domain,
partly in response to oxidation of C128. Owing to its activity as a DNA-binding protein, it
was difficult to make quantitative studies of RitR activation. The assays used to detect DNA
binding often gave contradictory results and could be highly dependent on the
experimental system (e.g. choice of buffer, salt concentration, and temperature). For this
reason, we chose to study an ALR-containing response regulator whose effector domain
has an enzymatic activity, which would allow a much more nuanced and quantitative
assessment of activation. We identified just such a protein through BLAST2, 3 searches using
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residues 1-132 of RitR, which comprise the ALR domain and the extended α5 helix that
contains the redox-active cysteine (C128). By manually filtering the results of the BLAST
search for sequences that contained the same “HCS” motif found in RitR, we found an
uncharacterized protein from Pseudoalteromonas atlantica TC6, which is known only by its
UNIPROT accession code, Q15Z91, which catalyzes the formation of the bacterial second
messenger molecule bis-(3’-5’)-cyclic dimeric guanosine monophosphate (c-di-GMP) from
two molecules of GTP. In this chapter I describe my structural and enzyme kinetics studies
of Q15Z91.

3.2 Methods
3.2.1 Expression and purification of Q15Z91
The coding sequence of Q15Z91 (Genbank locus ID Patl_0265) was optimized for
expression in E. coli and synthesized by GenScript Inc (Piscataway, NJ). The synthetic gene
was sub-cloned into the pE-SUMO kan expression vector (LifeSensors Inc, Malvern, PA)
using primers containing BsaI and XbaI restriction sites (Q15Z91 forward: 5’GGTCTCAAGGTATGCAAAATCCGGAAAGTGC-3’,

Q15Z91

reverse:

GCTCTAGATCATTATGACACCAGACGGTTACGA-3’). The His6-tagged SUMO-Q15Z91 fusion
protein was expressed from Origami2 E. coli cells (Invitrogen Inc, Carlsbad, CA) carrying
the pE-SUMO-Q15Z91 plasmid. Cultures were grown in Luria-Bertani medium with 50
µg/mL kanamycin at 37 °C. When the cultures reached an OD600nm of ~0.7, protein
expression was induced with 0.4 mM IPTG. The temperature was reduced to 16 °C and the
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cultures were grown overnight with shaking at 250 rpm. Cells were harvested by
centrifugation, resuspended in 5 mL of buffer A (25 mM TRIS pH 8.0, 300 mM NaCl, 10 mM
imidazole) supplemented with 1 mg/mL hen egg lysozyme (Hampton Research) and 0.1
mg/mL DNAse I (Worthington Biochemical Corp., Lakewood, NJ) per gram wet weight of
cells. Cells were lysed using a Branson Sonifier S-450 cell disruptor (Branson Ultrasonics
Corp., Danbury, CT) for a total of 10 min of sonication at 60% amplitude with 30 s pulses
separated by 50 s rest periods. The temperature was maintained at or below 4 °C by
suspending the steel beaker in an ice bath directly over a spinning stir bar. The lysate was
clarified by centrifugation at 39,000 x g for 45 minutes and then applied to a 5 mL HisTrap
column (GE Lifesciences, Piscataway, NJ) at a flow rate of 5 mL/min to isolate the His6SUMO-Q15Z91 fusion protein. The protein was eluted by a 4-step gradient of buffer B (25
mM TRIS pH 8.0, 300 mM NaCl, and 250 mM imidazole; 5, 15, 50, and 100%). The His6SUMO-Q15Z91 fusion protein eluted in the third step and was ~90 % pure, as judged on
coomassie-stained SDS-PAGE gels.

Fractions corresponding to A280nm peaks on the

chromatogram were pooled ~3 µM SUMO protease (LifeSensors Inc) were added. The
sample was loaded into SnakeSkin dialysis tubing and dialyzed overnight against 4 L of
SUMO protease digestion buffer (25 mM TRIS pH 8.0, 150 mM NaCl). The dialysate was
passed through the HisTrap column a second time to remove the cleaved His6-SUMO tag as
well as the protease. The resulting Q15Z91 preparation was > 95% pure. The protein was
desalted using a 2x5 mL HiTrap Desalting column (GE Lifesciences) equilibrated with 25
mM TRIS pH 7.5, 150 mM NaCl and stored at -80 °C. The mutants described below were
purified using the same protocol as the wild type protein.
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Q15Z91 co-purified with c-di-GMP as determined by spectroscopy and crystallography.
To get c-di-GMP-free Q15Z91 protein, SadR, a phosphodiesterase from Pseudomonas
aeruginosa, was used to linearize the c-di-GMP. The SadR expression construct was a kind
gift of professor Holger Sondermann in the Department of Molecular Medicine, College of
Veterinary Medicine, Cornell University. The His6-tagged SadR protein was purified as
described by De, et al4, omitting the precision protease cleavage step. SadR treatment
results in the degradation of c-di-GMP to free pGpG, which is easily removed by gel
filtration. The His6-tagged SadR protein was added to the purified Q15Z91 and dialyzed in 4
L of 50 mM TRIS pH 8.0, 150 mM NaCl, 2 mM MgCl2 buffer at 4 oC overnight. The dialysate
was passed through the HisTrap column a third time to separate c-di-GMP free Q15Z91
(Q15Z91free) from the His6-tagged SadR. The resulting Q15Z91 protein was desalted using a
HiTrap Desalting column equilibrated with 25 mM TRIS pH 7.5, 150 mM NaCl and stored at
-80 °C. In the desalt step, the free pGpG would be separated from protein. The c-di-GMP
free mutants described below were purified using the same protocol as Q15Z91free.

3.2.2 Mutagenesis of Q15Z91
The full-length mutants were obtained using the Q5 site-directed mutagenesis kit (New
England Biolabs, Ipswich, MA) as described for RitR in Chapter 2. The sequences of the
mutagenic PCR primers are listed in Table 3-1.
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Table 3-1: Primers used for mutagenesis
Name

Primer sequence

sumo-Q15Z91_C142S_Fwd

CCTGATTTCTTCCACCGATGGCC

sumo-Q15Z91_C142S_Rev

GCCAGGGTGCGCAGTTTC

sumo-Q15Z91_R212N/D215A_Fwd

TCTGCTGCGATGGGCCGCTACGGC

sumo-Q15Z91_R212N/D215A _Rev

TTCATTCTGCAGGCTAGCTTCAATCGTGGTTG

sumo-Q15Z91_I99A _Fwd

GAAATCACTGGCTCTGTCGGGCC

sumo-Q15Z91_I99A _Rev

GGGGTGTCTTTGCCATAC

sumo-Q15Z91_G102A _Fwd

GATTCTGTCGGCCCTGGAAGCGG

sumo-Q15Z91_G102A _Rev

AGTGATTTCGGGGTGTCTTTG

3.2.3 Crystallization, structure determination, and model refinement
Crystals of Q15Z91 alone were grown by the vapor diffusion method with sitting-drop
geometry. Crystals formed in many different conditions. The highest quality crystals
formed in drops comprised of equal parts protein solution (8 mg/ml Q15Z91 in 10 mM
TRIS/100mM citric acid pH 4.5, 150 mM NaCl, and crystallization solution (20% (w/v) PEG
3350, and 0.2 M sodium citrate tribasic dehydrate). Cube-shaped crystals appeared after
several months at 4oC and were prepared for flash-cooling by soaks in solutions containing
2 μl of well solution and 0.7 μl of glycerol (~26%). Crystals of Q15Z91 without GTP bound
were grown by mixing 1 μl of 8 mg/mL Q15Z91 that pre-incubated with 5mM MgCl2, 200
μM ZnCl2, 3 mM GTP with crystallization solution (8% v/v Tacsimate pH 7.0, 20% w/v
Polyethylene glycol (PEG) 3,350). Cube-shaped crystals appeared after several months at 4
oC.

Crystals were prepared for flash-cooling in the same way as Q15Z91 alone crystals.
117

X-ray diffraction data were collected from crystals of Q15Z91 at beamline 21-ID-D of
the Life Science Collaborative Access Team (LS-CAT) at the Advanced Photon Source (APS).
Data were collected from crystals of the protein with GTP at LS-CAT beamline 21-ID-G.
Data were processed with HKL2000 5. The structure of Q15Z91 was determined by
molecular replacement using 3BRE REC domain and effector domain as two ensembles in
Phaser5. The initial model comprising 88% of the asymmetric unit contents was built by
Autobuild6. Chain A of this model was used as the search model for molecular replacement
in PHASER7 to phase the Q15Z91 with GTP bound structure. Both models were subjected to
iterative cycles of manual model building in COOT8 and maximum likelihood-based
refinement using the PHENIX package (phenix.refine9). Ordered solvent molecules were
added automatically in phenix.refine and culled manually in COOT. Hydrogen atoms were
added to the model using phenix.reduce10 and were included in the later stages of
refinement to improve the stereochemistry of the model. Positions of H atoms were refined
using the riding model with a global B-factor. Regions of the model for translationlibration-screw (TLS) refinement were identified using phenix.find_tls_groups (P.V.
Afonine, unpublished work) and the TLS parameters were refined in phenix.refine. Once
the refinement converged, the model was validated using the tools implemented in COOT
and PHENIX9, 11. Sections of the backbone with missing or uninterpretable electron density
were not included in the final model. Data collection and model refinement statistics are
listed in Table 3-2. Coordinates and structure factors for both Q15Z91 and Q15Z91 with
GTP models will be deposited in the Protein Data Bank (www.rcsb.org).

118

3.2.4 Quaternary structure characterization by size exclusion chromatography
SEC experiments were carried out using an Agilent 1220 Compact HPLC equipped with
a 250 x 4.6 mm BioBasic SEC-300A column equilibrated with 25 mM TRIS pH 7.5, 150 mM
NaCl. The column was calibrated with the Gel Filtration Molecular Weight Marker kit from
Sigma-Aldrich (Cytochrome C (12.4 kDa), Carbonic Anhydrase (29 kDa), Bovine Serum
Albumin (66 kDa), and Sweet Potato Amylase (200 kDa)). Q15Z91 was pre-incubated with
1 mM H2O2 or 1mM DTT and 5 µl of the treated proteins were injected onto the column and
separated at a flow rate of 0.5 ml/min at ambient temperature. The separation was
monitored using a variable wavelength UV-visible detector set to 280 nm.

3.2.5 Size exclusion chromatography with multi-angle light scattering (SEC-MALS)
To confirm the molecular weights estimated from the calibrated SEC runs of Q15Z91 on
the BioBasic SEC-300A column, the separations were repeated on the SEC-MALS system in
the laboratory of Dr. Blake Hill at the Medical college of Wisconsin. The multiple-angle light
scattering detector provides a direct estimate of the molecular weights of particles eluting
from the column that is independent of the retention time. The same 250 x 4.6 mm
BioBasic SEC-300A column was used with 24-hour equilibration in 25 mM TRIS pH 7.5, 150
mM NaCl at 0.5 ml/min. The running buffer is same as used above, except that it was
filtered through a 0.022 μm filter, rather than a 0.22 µm filter. Due to the relatively low
sensitivity of the MALS detector the separation was done with 100-200µg of Q15Z91,
rather than the ~15 µg used for the UV/vis-monitored separations. The concentrated

119

proteins were centrifuged at 16,900 x g for 20 min at 4oC before loading.

3.2.6 Biofilm assay on borosilicate tubes
Assays to quantify the degree of biofilm formation in E. coli expressing wild-type or
mutant forms of Q15Z91 were performed as a way to assess the in vivo activity of the
proteins. Overnight cultures of Origami2 E. coli carrying the pSUMO-Q15Z91 (or mutant)
plasmids were adjusted to the same inoculum amounts in 3 ml of fresh LB broth with 50
µg/ml kanamycin in 14 ml borosilicate glass tubes. After growth with rotating at 37 °C for
~5 hours, the cultures were equalized by adding extra fresh LBkan medium and then protein
expression was induced by the addition of 0.4 mM IPTG. The cultures were allowed to
rotate overnight at 25oC. The next day, the cultures were removed from their respective
test tubes, which were washed three times with tap water. After washing, crystal violet was
used to stain any biofilm that had been deposited on the walls of the tubes. After staining,
the culture tubes were washed with tap water five times. The culture tubes were then dried
and the residual stain – that bound in the biofilm – was dissolved in 2 mL of 80% (v/v)
ethanol/20% (v/v) acetone. The absorbance at 540 nm was measured on a spectrometer
and taken to be a qualitative indicator of the degree of biofilm formation induced by wildtype Q15Z91 or the various mutants tested.
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3.2.7 Enzymatic assay
3.2.7.1 RP-HPLC based end-point assay
As a convenient check for catalytic activity of the various forms of Q15Z91 studied here,
protein was incubated for a set period of time with GTP and MgCl2 and the reaction
mixtures were characterized by reverse phase high performance liquid chromatography
(RP-HPLC). Each 200 µl reaction contained 20 μM enzyme, 25 mM TRIS pH 7.5, 150 mM
NaCl, 2mM MgCl2, and 0.5 mM GTP. The GTP was prepared fresh as a 100 mM stock in
mqH2O. Reactions were incubated at room temperature for 30 min, and then quenched by
boiling for 5 min. After centrifugation at 30,000 x g for 10 min, the supernatants were
analyzed on a 150 x 3 mm Aquasil C18 column (Thermo Scientific). Buffer A was 10 mM
NaH2PO4/K2HPO4 pH 6.3, and buffer B was 30% (v/v) methanol, 70% (v/v) buffer A. The
gradient from 5% to 100% B over 28 min, then held at 100% B for 5 min, 5% buffer B for 5
min. All separations were run at 50 °C and were monitored at 254 nm.

3.2.7.2 Biomol Green microplate assay
Reactions were prepared in a volume of 500 μl and contained 10 μM enzyme, 25 mM
TRIS pH 7.5, 150 mM NaCl, 2 mM MgCl2, and 0.5 mM GTP. Reactions were initiated with the
addition of GTP. Aliquots were taken at set intervals and quenched by boiling for 5 min.
After centrifugation at 30,000 x g for 10 min, the supernatants were kept at 4 oC. The
negative control was the reaction buffer containing GTP. The amount of pyrophosphate
released was quantified by adding 0.005 U pyrophosphatase (Thermo Scientific) to each
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reaction, followed by a 1.5 h incubation room temperature. Then 50 μl of the
pyrophosphatase-treated reaction mixture were mixed with 100 μl Biomol Green reagent
and incubated at room temperature for 20 min. The absorbance of the mixtures at 620 nm
was recorded and converted to concentration of phosphate via a standard curve prepared
with 0.03125 nM-2 nM inorganic phosphate.

3.2.7.3 EnzCheck® Pyrophosphate Assay Kit (Sigma)
This assay was conducted by following the optimized procedure published by Webb12,
13.

Pyrophosphatase can catalyze pyrophosphate into 2 molecules of inorganic phosphate.

In the presence of inorganic phosphate, purine nucleoside phosphorylase (PNP) catalyzes
2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG) into ribose 1-phosphate and
2-amino-6-mercapto-7-methylpurine that absorbs maximally at 360 nm. Each 1 mL
reaction contained 1 μM enzyme with 2-amino-6-mercapto-7-methylpurine ribonucleoside
(MESG), purine nucleoside phosphorylase in the reaction buffer was incubated at 22 oC for
10 min. The reactions were initiated with the addition of GTP and the absorbance at 360
nm was monitored. The concentrations of GTP tested range from 50 μM to 1000 μM.

3.3 Results
3.3.1 Q15Z91 is an ALR-regulated diguanylate cyclase
Q15Z91 is 310 amino acids long (34.6 kDa) and consists of an N-terminal ALR domain
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fused to a diguanylate cyclase domain. Alignment of the RitR and Q15Z91 sequences shows
that the phosphorylatable aspartate residue is replaced by arginine in Q15Z91 (Figure 3-1).
The conserved C128 that has been shown to play an important role in RitR activation is
retained in Q15Z91, though the residues flanking it are different between the two proteins.
The effector domain contains the GGEEF motif characteristic of diguanylate cyclase
enzymes.

Figure 3-1: Sequence alignment of Q15Z91 with the RitR REC domain. Arginine (colored in red) substitutes
the conserved aspartate residue of the typical response regulator proteins (N53 in RitR). The conserved
Cys128 of RitR is colored in orange; the GGEEF motif of Q15Z91 is colored blue.
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3.3.2 Purification of Q15Z91
The pSUMO-Q15Z91 plasmid was transformed into BL21 Star (DE3) cells, T7 LysY/Iq
cells (New England Biolabs, Ipswich, MA), and Origami2 cells (Novagen) Single colonies
were used to inoculate large-scale expression cultures, which were grown at 37 °C to an
OD600nm of ~0.7, at which point protein expression was induced by the addition of 0.4 mM
IPTG. Three strains were attempted to express Q15Z91, but only the Origami2 cells
expressed soluble proteins and exhibited an obvious biofilm phenotype. Induction at
higher or lower OD600nm resulted in lower yields of soluble protein.
Table 3-2: Buffers from the Solubility & Stability Screen giving the highest Tm values in the
DSF assay.
Tm - Tm,averaged (oC)

Additive

8.4

Adipic acid

6.7

Ethylenediaminetetra acetic acid disodium

5.9

TCEP hydrochloride

5.9

Sodium phosphate monobasic, potassium phosphate dibasic

5.6

Ammonium sulfate

5.5

L-Argininamide dihydrochloride

5.1

Ethylenediamine dihydrochloride

5.1

Magnesium sulfate hydrate

Q15Z91 was not stable in the purification buffers. To find the optimal storage buffer
and pH, the Solubility & Stability Screen (Hampton research) and Slice pH (Hampton
research) were used in differential scanning fluorimetry assays. The results showed that
Q15Z91 is not stable, its average Tm being 33oC; this is not surprising given that P. atlantica
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is a psychrophilic bacterium. The top 10 conditions as judged by their increase in the Tm
above the average, are shown in Table 3-2 and Table 3-3. Based on these data, 25mM
TRIS/100mM citric acid pH 4.5, 150 mM NaCl was chosen as the storage buffer for Q15Z91.
Table 3-3: Buffers from the Slice pH Screen giving the highest Tm values in the DSF
assay.
Tm - Tm,averaged (oC)

Additive

5.5

Sodium citrate tribasic dihydrate pH 4.5

4.9

Citric acid pH 4.4

4.7

DL-malic acid pH 4.7

4.6

Sodium citrate tribasic dihydrate pH 4.2

4.6

DL-malic acid pH 5.0

4.3

DL-malic acid pH 5.3

4.3

Succinic acid pH 5.1

4.1

Citric acid pH 4.1

4.1

Succinic acid pH 4.8

4.1

Succinic acid pH 5.4

3.3.3 The structure of Q15Z91 with c-di-GMP and citrate bound
The structure of Q15Z91 was determined by molecular replacement using 2.0 Å
resolution data. The model contains residues 11-310, as well as two citrate molecules and
two c-di-GMP dimers. As shown in Figure 3-2A, Q15Z91 is a dimer, with citrate bound at
the active sites (A site) of the diguanylate cyclase (DGC) domains, and c-di-GMP dimers at
the inhibitory sites (I site). Chain A (light green) has no inter-domain interface, while chain
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B (light blue) has a weak interface. And there is a S-S bond between two chains. We can see
clear electron density for the disulfide bond (Figure 3-2B). This Q15Z91 dimer structure is
an inactive conformation, because the c-di-GMP bound in the I sites immobilizes the two
DGC domains in an unproductive back-to-back orientation.

Figure 3-2: The structure of Q15Z91 dimer with c-di-GMP and citrate bound (A). The two protomers are
colored light green and light blue. The ALR domain of Q15Z91 is at the top of the image, and the DGC
catalytic effector domain is at the bottom. Citrate and c-di-GMP are shown as sticks with yellow carbon
atoms. Mg2+ ions are shown as small green spheres associated with the tri-phosphate moieties of the
citrate molecules. The citrate molecules from crystallization buffer are bound in the active sites (A site)
and the c-di-GMP dimers are bound in the inhibitory sites (I site) of the DGC domain. The two
polypeptides comprising the dimer are linked by a disulfide bond formed between C142 on both chains
(B). The 2|Fo|-|Fc| electron density map contoured at 1.0σ is shown as a magenta mesh, and the 2|Fo|-|Fc|
composite omit map, also contoured at 1.0σ, is shown as a green mesh.
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The ALR domain of Q15Z91 has the same (β/α)5 topology and α4-β5-α5 dimer interface
(Figure 3-3) characteristic of typical OmpR/PhoB RRs. As shown in Figure 3-3B, the switch
residue F110 (equivalent to Y100 of RitR) is oriented inward, which is the conformation
associated with the activated forms of typical OmpR/PhoB RRs and is thought to facilitate
dimer formation. However, the other Ser/Thr switch residue is replaced by G91 in Q15Z91.
In the phosphorylation-dependent RRs, phosphorylation induces a conformational change
of the Ser/Thr switch residue that results in the reorientation of the Tyr/Phe switch
residue to facilitate dimerization. In Q15Z91, the residue that is equivalent to the Ser/Thr
switch residue in typical RRs is G91, so obviously side chain reorientation cannot be an
integral part of the activation mechanism in Q15Z91. This is similar to what was seen in
RitR, where the Ser/Thr switch equivalent, D81, had a minimal impact on dimerization. In
addition, R61 in Q15Z91 replaces the phosphorylatable aspartate residue of the typical
RRs. Comparison of the Q15Z91 and RitR ALR domains shows that the side chain of R61
takes the place of the “lid residue” K10 of RitR and that the loop between β1 and α1 shifts
away from the “phosphorylation site” comparison with that in RitR. It seems that the ALR
domain of Q15Z91 has evolved to be an obligate dimer, and that activation may be subtler
than a change from monomer to dimer as has been seen for the DNA-binding RR proteins.

Figure 3-3: ALR domains of the Q15Z91 dimer (A) and the overlay of the Q15Z91 and RitR ALR
domains (PDB ID 4LZL1) (B). Chain A of Q15Z91 ALR domain colored in light green, chain B colored
in blue. RitR ALR domain is colored cyan. The active site residues and switch residues equivalent
are shown in stick. The Cα atom of G91 (Ser/Thr switch residue equivalent) in Q15Z91 is shown in
sphere.
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The active site of each DGC domain has one molecule of citrate and a Mg2+ ion bound
(Figure 3-4). Due to the asymmetric arrangement of the domains—the lack of any interdomain interface in chain A, and the weak interface between the ALR and DGC domains in
chain B—there some differences in the way GTP binds to the two DGC domains. In chain A,
there are no contacts between the ALR domain and the citrate. Without GTP addition in the
crystallization condition, the structure of purified Q15Z91 alone has c-di-GMP bound,
which must have co-purified during the protein expression in cells. In the I site, c-di-GMP
forms a dimer through stacking their guanosine rings, interactions between phosphate
group with N11 and N21 on the Hoogsteen-edge of the guanine base of the other chain and
hydrogen bond between O61 with N7 of the other c-di-GMP (Figure 3-4).
The DGC domains found in other response regulator proteins also have a Rxx(D/E)
motif that is associated with the inhibitory site. In Q15Z91, the residues of this Rxx(D/E)
motif are R212 and D215. A shown in Figure 3-4, R212 interacts with the O6 and N7 atoms
on the Hoogsteen-edge of the guanine base of one c-di-GMP molecule with 2.9 Å and 3.0 Å,
respectively. The gunidinium group of R212 also interacts with the phosphate group of the
second c-di-GMP within the c-di-GMP dimer at a distance of 2.8 Å. The carboxyl group of
D215 forms hydrogen bonds with the N1 and N2 atoms on the Watson-Crick-edge of the
guanine base of the second c-di-GMP molecule. There are also many other residues
contributing to interacting with c-di-GMP dimer, including T232-N2 of the second c-di-GMP
(2.7 Å), R168-posphate group of the c-di-GMP (2.8 Å), E213-posphate group of the c-diGMP (2.9 Å).

129

Figure 3-4: Two molecules of c-di-GMP dimerize through stacking of their bases and bind to the
inhibitory sites on chain A (A) and chain B (B). The c-di-GMP dimers are shown as sticks with yellow
carbon atoms. R212 and D215 are the most conserved residues in the I site. The 2|Fo|-|Fc| electron density
map, contoured at 1.0σ, is shown as magenta mesh, and the 2|Fo|-|Fc| composite omit map, also contoured
at 1.0σ, is shown as green mesh.

In addition to the I site with Rxx(D/E) motif, DGC has two active sites (A site) with
GGEEF motif. In the structure of Q15Z91, two citrate molecules form the protein storage
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buffer binds in the two A site respectively (Figure 3-5). E223, D179, carbonyl group of I180
and the citrate coordinate the Mg2+ ion. The basic residues K301 and R305, as well as the
amide N atoms of F182, F183 and K184 interact with two carboxyl groups of citrate. In
chain B, where there is a small interface between the ALR and DGC domains, Q78 from the
ALR domain interacts with H192, which takes on multiple conformations. Due to the small
interaction interface, this interdomain construction is probably caused by the whole
geometry of this c-di-GMP inhibited dimer.

Figure 3-5: Citrate binds in slightly different orientations in the active sites of chain A (A) and chain B (B).
Citrate is shown as sticks with yellow carbon atoms. The residues in the A site are also shown as sticks,
with carbons colored according to the chain color. The labels of the conserved GGEEF residues are colored
in blue. The 2|Fo|-|Fc| electron density map, contoured at 1.0σ, is shown as magenta mesh, and the 2|Fo||Fc| composite omit map, also contoured at 1.0σ, is shown as green mesh.
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The structure of Q15Z91 with the substrate GTP was also determined with 1.8 Å data
(Figure 3-6). The structure of Q15Z91 with GTP and c-di-GMP is same with the structure of
Q15Z91 with citrate and c-di-GMP, except the GTP molecules bound in the A sites. The
imidazole of H192 packs on top of the 6-membered ring of the nucleotide. The carboxyl
group of D196 interacts with N2 of the guanosine. The guanidine group of R219 interacts
with O6 of GTP. K184 forms a hydrogen bonding interaction to the 3’ hydroxyl of GTP in
chain B, while it interacts with 2’-OH of GTP in chain A. E223, D179, and the phosphate
groups of GTP coordinate the Mg2+ ion; the metal, therefore, serves to anchor the triphosphate moiety of GTP to the enzyme. The basic residues K301 and R305 interact with
the terminal phosphate group. In chain B, where there is an interface between the ALR and
DGC domains, Q78 from the ALR domain interacts with H192, which takes on multiple
conformations and appears to have less of an interaction with the GTP. The relative
interactions between D196, K184, and the GTP are different from those observed in chain
A: K184 makes a hydrogen bonding interaction with the 3’ hydroxyl of GTP rather than the
2’ hydroxyl, and D196 loses the interactions with H192 due to the inter-domain interaction
between Q78 and H192.
Comparison with the structure of diguanylate cyclase PleD (PDB ID 2V0N14), the
structure of Q15Z91 with GTP and c-di-GMP is more likely an activated but productinhibited form of Q15Z91.
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Figure 3-6: The structure of Q15Z91 with c-di-GMP and GTP bound (A). Chain A is colored in light green,
while chain B is colored in light blue. Citrate and c-di-GMP are shown as sticks with yellow carbon atoms. GTP
binds in slightly different orientations in the active sites of chain A (B) and chain B (C). GTP is shown as sticks
with yellow carbon atoms. The residues involved in GTP interactions are also shown as sticks, with carbons
colored according to the chain color. The labels of the conserved GGEEF residues are colored in blue. The
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2|Fo|-|Fc| electron density map, contoured at 1.0σ, is shown as magenta mesh, and the 2|Fo|-|Fc| composite
omit map, also contoured at 1.0σ, is shown as green mesh.

It was not possible to obtain crystals of the un-inhibited (c-di-GMP-free) Q15Z91 and
the Q15Z91C142S variant discussed below. The flexible conformation of the two catalytic
domains without the product binding and disulfide bond may be one reason for the failures
in crystallization of both c-di-GMP-free Q15Z91 and Q15Z91C142S.

3.3.4 Probing the roles of conserved residues by site-directed mutagenesis
As mentioned in Chapter 2, the RitR double mutant RitRL86A/V93A exhibited activated
characteristics (extended conformation and the ability to bind DNA). So the equivalent
residues of Q15Z91, I99 and G102, were targeted for mutagenesis. C128 of RitR plays an
important role in redox control. To determine whether or not the equivalent residue of
Q15Z91, C142, has a similar role, this residue was changed to serine (C142S). Finally, R212
and D215 in the Rxx(D/E) I-site motif were mutated to Asn and Ala to determine the effect
of disrupting the I-sites required for product inhibition. As described above, Q15Z91 and its
variants only fold correctly in Origami2 E. coli cells, which have been engineered to have a
less reducing environment in the cytoplasm and thus promote formation of disulfide bonds.
After IPTG induction, biofilm formation was observed for in cultures expressing all forms of
Q15Z91 we tested (Table 3-4). The fact that all of the Q15Z91 variants promoted biofilm
formation indicates that none of them has been inactivated or catastrophically destabilized
by the mutations.
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Table 3-4: Characteristics of wild-type and mutant forms of Q15Z91.
Proteins

Biofilm formation

c-di-GMP

Q15Z91

+

+

I99A

+

+

G102A

+

+

C142S

+

-

R212N/D215A

+

-

The c-di-GMP produced during expression binds so well to the I-site that it co-purifies
with Q15Z91, even persisting through dialysis and desalting steps. To remove the product
inhibition, we used the phosphodiesterase SadR from Pseudomonas aeruginosa to linearize
c-di-GMP into pGpG, which is easily removed by gel filtration. This c-di-GMP-free protein is
called Q15Z91free. To determine whether or not the mutants had c-di-GMP bound, the
absorbance at 260 nm (due to the nucleotide) was measured for Q15Z91 and each of the
mutants. The results demonstrate that only the C142S and R212N/D215A variants do not
have c-di-GMP bound. This was expected for the double mutant, since both of those
residues are involved in key interactions with the c-di-GMP dimer in the I-site. The fact the
loss of C142S impacts product binding to the I-site as drastically it does was surprising and
likely indicates that reduction of the C142-mediated disulfide bond increases Q15Z91catalyzed DGC activity by relieving the product inhibition.
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3.3.5 The oligomeric state of Q15Z91
As shown in Figure 3-7, Q15Z91 mainly exists as a dimer with c-di-GMP bound
(retention time 5.2 min). The peak with a retention time of ~6.2 min is due to c-di-GMP,
which is verified by the higher absorption at 260 nm than at 280 nm. After treatment with
SadR and gel filtration, Q15Z91free still mainly exists as a dimer; the absence of the peak at
~6.2 min is further evidence that that peak is due to c-di-GMP. The Q15Z91free protein is
considerably less stable than Q15Z91 (with c-di-GMP bound), as evidenced by the greater
proportion of aggregated protein seen in the chromatogram. The retention time of the
Q15Z91 dimer was longer than expected based on the molecular weight standards. This
may be due to shape effects or direct interactions between the protein and column matrix.

Figure 3-7: The affects of H2O2 or DTT treatment on the oligomeric states of Q15Z91 (A) and Q15Z91free
(B) were analyzed by SEC. The traces of protein only colored in green, protein with 1 mM H2O2 treatment
colored in brown red and protein with 1 mM DTT treatment is colored in cyan.
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Figure 3-8: SEC-MALS results for Q15Z91free.

In order to get a more accurate mass estimate for the molecule responsible for the peak
at 5.2 min, Q15Z91free was analyzed by size exclusion chromatography with multi-angle
static light scattering (SEC-MALS). The chromatograms were analyzed using the ASTRA
software package (Figure 3-8). The major peak in the UV trace (retention time range 5.16.3 min) has a mass of 65-79 kDa, which is close to the mass of the Q15Z91 dimer. The
peaks that elute earlier than 5 min were verified to be high molecular weight aggregates.
To check the effects of reducing or oxidizing agents on the oligomeric state, DTT and H2O2
were added to Q15Z91 and Q15Z91free samples (1 mM each). SEC analysis (Figure 3-7)
shows that oxidizing and reducing C142 have no effect on the oligomeric state of either
form of the protein (free or product-inhibited).
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The oligomeric state of each of the Q15Z91 point mutants was also checked by size
exclusion chromatography (Figure 3-9). The mutants I99A and G102A both existed as
dimers with c-di-GMP bound. Like the wild-type protein, both mutants existed as dimers
after treatment with SadR to remove the c-di-GMP. Interestingly, in spite of being treated in
exactly the same way, SadR was apparently not able to remove all of the c-di-GMP from the
I99A mutant. Consistent with the UV/vis data, the other two mutants C142S and
R212N/D215A, existed as dimers without c-di-GMP bound. Neither of these mutants is
affected by treatment with DTT or H2O2.

Figure 3-9: The oligomeric states of Q15Z91I99A (A), c-di-GMP-free Q15Z91I99A (B), Q15Z91G102A (C), c-diGMP-free Q15Z91G102A (D), Q15Z91C142S (E), Q15Z91R212N/D215A (F) with or without H2O2 or DTT treatment
were analyzed by SEC. The traces of protein only colored in green, protein with 1 mM H2O2 treatment
colored in brown red and protein with 1 mM DTT treatment is colored in cyan.
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3.3.6 Preliminary quantitation of biofilm phenotype
In order to quantify the observed biofilm formation phenotype of Origami2 cells
expressing Q15Z91 or its mutants, the amount of biofilm material deposited on the walls of
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culture tubes was measured by the degree of staining with crystal violet as described in the
methods section. All proteins were expressed as His6-SUMO fusion proteins; the fact that
biofilm formation was observed in response to Q15Z91 expression is evidence that the
SUMO tag does not affect the catalytic activity of the protein. After dissolving the crystal
violet-stained biofilm in a mixture of ethanol and acetone, the absorbance at 540 nm was
measured. The amount of dye, and thus the absorbance, is proportional to the amount of
biofilm present. Cultures were induced at an OD600nm of ~0.7, except for the Q15Z91C142S
culture in LB with kanamycin. After growing for 7 hours at 37 °C, the OD600nm of C142S
mutant in kanamycin-containing culture was still about 0.3, so 0.4 mM IPTG was added to
induce SUMO-Q15Z91C142S expression. It is circumstantial, but this result may suggest that
the C142S variant is constitutively active, and therefore, that the reduced form of the
protein is the activated form.
In Figure 3-10A, it is clear that all of the other mutants formed biofilm and that the cells
are evenly distributed in the medium. The cells carrying the pSUMO-C142S plasmid
aggregated at the bottom of the culture tube. The A540 of the biofilm extract from the
Q15Z91C142S culture is the highest one. The double mutant R212N/D215A only formed a
small amount of biofilm, which suggests that the I-site is also important for the cyclase
activity.
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Figure 3-10: Biofilm formation after IPTG induction in Origami2 cells with Q15Z91 related plasmids. (A)
cultures photo (B) After crystal violet stain. (C) Biofilm amounts are quantified by absorbance at 540 nm. The
biofilm formed in Q15Z91C142S is significantly higher than others.

141

3.3.7 Preliminary enzymatic activity
Three different assays were attempted in order to characterize the diguanylate cyclase
activities of Q15Z91 and Q15Z91free in the presence and absence of DTT and H2O2. The first
was an end-point assay where the proteins were incubated for 30 min in the presence of
GTP and MgCl2. The reaction products were then characterized by reverse-phase HPLC.
Extensive method development work failed to identify combinations of stationary and
mobile phases whereby GTP could be separated from the product c-di-GMP. In all of the
methods tested, the analytes were not retained on the columns.
The second assay used the Biomol Green reagent to quantify the inorganic
pyrophosphate released by the DGC.

Since Biomol Green can only detect Pi,

pyrophosphotase was used to digest the PPi into two equivalents of Pi. The reactions
contained 10 µM Q15Z91 or Q15Z91free, 0.2 mM GTP, and 2 mM MgCl2, and were incubated
at RT for a total of 180 min. Aliquots were quenched at specific time points and the Pi
content was measured to build a time course of the reaction. The preliminary results for
Q15Z91 and Q15Z91free with GTP are shown in Figure 3-11. Both and Q15Z91free exhibit a
very low rate of PPi release. This is not unexpected, since Q15Z91protein purify as its
product-inhibited form and Q15Z91free may form disulfide bond and immobilize the DGC
domains. Consistent with the SEC results above, the addition of 1 mM DTT results in a
much more rapid reaction. The reaction is so rapid, in fact, that it was complete by the time
the first aliquot was taken (10 min). The effect of DTT is especially pronounced with the
Q15Z91free enzyme, likely because this reaction is not contaminated with c-di-GMP.
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Figure 3-11: Time courses for the reaction of Q15Z91 (A) and Q15Z91free (B) with 0.2 mM GTP in the
absence or presence of H2O2 or DTT. Blue line represents enzyme Q15Z91 or Q15Z91free only. Red line
represents 1 mM H2O2 treatment. Green line represents 1 mM DTT treatment. Purple line represents the
reaction conducted at 4 oC.

Due to the speed of the reaction with the DTT-treated protein, we sought a direct assay
that would allow us to monitor earlier time points. The EnzCheck assay kit (Sigma) allows
the real-time monitoring of phosphate release by coupling it to purine nucleoside
phosphorylase-catalyzed phosphorylation of the synthetic nucleotide MESG, which absorbs
light at 360 nm. The first experiments with this assay were inconclusive, since the 10 min
pre-incubation with MESG, purine nucleoside phosphorylase appeared to destabilize the
enzyme, resulting in extremely small rates.
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3.4 Discussion
Q15Z91 is a diguanylate cyclase that is regulated by an ALR domain. Key residues for
the phosphorylation-dependent activation of typical response regulator receiver domains,
particularly the acidic triad residues, have been lost in Q15Z91. The phosphorylatable
aspartate is replaced by arginine, and the other two acidic triad residues are replaced with
Met and Glu. These changes exclude the possibility of phosphorylation-dependent
activation of Q15Z91. In spite of this, the positions of the switch residues positions and the
dimer interface of Q15Z91 are similar to those of the typical, phosphorylation-dependent
OmpR/PhoB RRs. Q15Z91, like RitR, the other ALR domain-containing protein discussed
here, also has a conserved cysteine residue in the linker between the ALR and effector
domains.
Q15Z91 purifies as a product-inhibited form with c-di-GMP bound. The Q15Z91
structure, as well as the SEC results, demonstrates that Q15Z91 exsits as a dimer. After
removal of c-di-GMP, it maintains this dimer conformation. Neither H2O2 nor DTT have any
effect on the oligomeric state of Q15Z91. Preliminary activity tests show that the activities
of Q15Z91 and Q15Z91free are dramatically increased in the presence of DTT. To check the
role of the conserved cysteine residue, Cys142 was mutated into serine. The variant
Q15Z91C142S is also dimeric, providing ample evidence that Q15Z91 is not regulated by a
switch between dimer and monomer as RitR is. Interestingly, the C142S mutant is no
longer able to bind c-di-GMP, or at least only with much reduced affinity compared with the
wild-type protein. Cyclic di-GMP, as an important second messenger, regulates biofilm
formation, which is an important phenotype to check the cyclase activity in heterogeneous
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cell systems. According to the results of our biofilm assays, there is a significant increment
of biofilm formation for Q15Z91C142S mutant. In other words, the variant C142S seems to
greatly reduce product inhibition by c-di-GMP, which means the disulfide bond formation is
likely essential for c-di-GMP binding. In summary, we propose that C142 of Q15Z91 is not
essential for dimerization, but involved in facilitating c-di-GMP binding and product
feedback inhibition.
In RitR, the C128 functions as redox sensor to control the inter-domain interactions for
later dimerization and activation. Considering the dimer structure of Q15Z91, Q15Z91
appears to be constitutively active and this activity is modulated by product inhibition.
Under oxidizing conditions, where the C142 disulfide bond is formed, product inhibition is
potent and the DGC activity of Q15Z91 is low. Under reducing conditions, the C142
disulfide bond is broken, decreasing the affinity for c-di-GMP and largely removing the
product inhibition. Taken together, the cysteine located at the C-terminal end of the α5
linker helix is important for the activation mechanism of Q15Z91. This is a departure from
the well-studied phosphorylation-dependent diguanylate cyclases PleD14-16 and WspR4,
where product inhibition is modulated by changes in the oligomeric state (dimer-tetramer
equilibrium) that are influenced by additional domains. In short, Q15Z91 replaces the extra
domain of PleD and WspR with a redox-active cysteine that directly influences product
inhibition.
There are about fifty DGCs in P. atlantica T6c. These DGCs tend to be fused to PAS or
GAF sensor domains, to additional regulatory domains, or to phosphodiesterase domains.
These apparent redundancies but with different activation mechanisms DGCs/PDEs raises
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a question that how the small molecule c-di-GMP to regulate the activities of these different
diguanylate cyclase enzymes. By studying Q15Z91, we find that c-di-GMP inhibition
regulation is dependent on the C142 disulfide bond formation. So we can assume that there
are definitely other mechanisms combining with product binding to regulate specific
DGC/PDE activity upon different environmental stimulation.
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Chapter 4
An Unusual PLP-Dependent Enzyme in Enduracididine Biosynthesis

4.1 Introduction
The emergence of antibiotic-resistant pathogens is a serious and growing threat to
global health. There is an urgent need for new antibiotics to combat this threat.
Unfortunately, the pace of antibiotic development has slowed almost to a standstill (Figure
4-1).
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Figure 4-1: The numbers of new antibiotic compounds approved have been declining steadily since 1980.
Data from the FDA Center for Drug Evaluation and Research.

In response to the dismal rate of antibiotic development, among other problems,
Congress passed the Food and Drug Administration Safety and Innovation Act (FDASIA).
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Title VIII of this law, Generating Antibiotic Incentives Now (GAIN), created a fast track for
new antibiotic approvals that seems to be paying off. While there have been no new classes
of antibiotics, a number of new drugs based on old scaffolds have been introduced since the
passage of the FDASIA; in 2014-15 six new antibiotics were approved by the FDA. Happily,
it seems that interest in antibiotic development is on the rise. Consequently, any
information regarding the biosynthesis or activity of antibiotics or key building blocks of
these compounds, is potentially useful in these renewed efforts to discover new antibiotics.
In this context, the non-proteinogenic amino acid L-enduracididine (L-End, 1, Scheme
4-1) is particularly interesting. This conformationally restricted form of arginine is present
in a number of antibiotics, including some with potent activity against antibiotic-resistant
strains like methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant
enterococci (VRE). Some prominent examples are the cyclic depsipeptide antibiotics
enduracidin 3, mannopeptimycin 4 and the recently discovered teixobactin 5.
Enduracidin was first isolated from Streptomyces fungicidicus No. B 54773. It is a
seventeen amino acid lipodepsipeptide containing one residue of L-End and one of D-End
(Scheme 4-2). In spite of having different amino acids and acyl chain, the overall structure
enduracidin is similar to the cyclodepsipeptide antibiotic ramoplanin 6. Both enduracidin
and ramoplanin are active against resistant Gram-positive bacteria by binding to the
external membrane surface of the lipid II intermediate, inhibiting the transglycosylation
reaction of cell wall biosynthesis 7. Ramoplanin has entered phase III clinical trials for VRE
suppression in gastrointestinal tract infections and prevention of bloodstream infections,
but enduracidin is hampered by its low aqueous solubility 8.
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Scheme 4-1: Compounds mentioned in this chapter. 1, L-enduracididine; 2, L-β-hydroxyenduracididine;
3, D-β-hydroxyenduracididine; 4, capreomycidine; 5, L-arginine; 6, 2-oxo-4-hydroxy-5-guanidinovaleric
acid (i.e. 4-hydroxy-ketoarginine, 4HKA); 7, 2-ketoenduracididine (2KE); 8, L-3,4-dihydroxyphenylalanine
(L-DOPA); 9, dopamine.

Another cyclic End-containing nonribosomal antibiotic, mannopeptimycin, is a
glycosylated hexapeptide that also has activity against resistant Gram-positive bacteria,
including MRSA and VRE4, 9. Mannopeptimycin also inhibits peptidoglycan synthesis by
binding to lipid II9. Studies of the mechanism of action suggested that mannopeptimycin
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may first bind to the lipoteichoic acids of the Gram-positive cell wall, and then accumulates
to interact with lipid II9. The structure of mannopeptimycins α, β, γ, δ, and ε from
Streptomyces hygroscopicus LL-AC98 were characterized in 20024. They contain the nonproteinogenic

amino

acids

L-β-hydroxyenduracididine

(2,

L-βhEnd)

and

D-β-

hydroxyenduracididine (3, D-βhEnd). Methods for the total synthesis of mannopeptimycins
α and β were published recently10, but these two mannopeptimycins have relatively poor
anti-bacterial activities. Much work (a Sci-Finder search returns more than 2000 analogs)
has gone into making derivatives in the hope of finding one that has better therapeautic
properties than the mannopeptimycins11-17. However, almost all of these involve changes to
the attached glycans; very few of them alter the peptide core itself.

151

152

Scheme 4-2: Enduracididine-containing natural products. Enduracididine residues are highlighted in yellow

Mannopeptimycin and enduracidin are both antibiotics with potent activity against
antibiotic-resistant strains. To improve the physico-chemical properties and/or biological
activities for therapeutic applications, they probably require further chemical
modifications. However, the total syntheses of enduracidin and mannopeptimycin are
limited by the complexity of the structures and lmited commercial availability of some nonproteinogenic amino acid building blocks like enduracididine and its derivatives. Hence, a
supply of L-End in quantities suitable to support drug development would greatly facilitate
efforts to make derivatives of L-End-containing natural products.
Several synthetic routes to L-End or its β-hydroxy analogs have been published. Shiba
et al. began with the methyl ester of L-histidine, which underwent cleavage of the imidazole
ring to give a protected amide that was subsequently deprotected, guanidinylated, and
treated with HF to give L-End as a diasteriomeric mixture 18. The whole procedure involves
only 4 steps, but it requires HF, which is hazardous, and the yield of the proper
diasteriomer is low (22%). Dodd et al. used an aziridine-based method to synthesize 9phenylfluorenyl-protected L-End with 4 steps, but the yield is still low (33%)

19.

No

improvement in the yield was obtained after many attempts. The azide derivatives of βhydroxy-End were first synthesized by Oberthür et al.20. It takes 21 steps to synthesize 2
with ~16% overall yield, and 24 steps to synthesize compound 3 with ~10% yield. After
optimization, shorter routes were developed (e.g. 8 steps from Garner’s aldehyde), but with
no improvement in the yields (16% for 2 and 8% for 3)21. Recently, the most efficient route
to N-mannosyl-D-β-hydroxy-End was published by Cheng et al., which gave 43% yield22.
Given the difficulties of synthesizing the nitrogen-rich iminoimidazolidine ring of the L-
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End, and the presence of two chiral centers, an enzymatic or chemo-enzymatic route to LEnd may prove to be the most efficient means of producing large quantities of L-End.

4.2 Biosynthesis of enduracididine
The enduracididine biosynthetic genes were first identified by comparing the
enduracidin biosynthetic cluster in S. fungicidicus to that of the mannopeptimycins from S.
hygroscopicus 23, 24. The enduracidin and mannopeptimycin scaffolds are very different. In
fact, aside from the presence of L-End in both products, and the fact that both are nonribosomally produced depsipeptides, there are no similarities between them. Thus, the
presence of 3 pairs of genes in the two biosynthetic clusters with high pairwise sequence
identity suggested that these genes are likely responsible for L-End biosynthesis. The
products encoded by these gene pairs are MppP/EndP (85%), MppQ/EndQ (66%), and
MppR/EndR (73%) (Mpp = mannopeptimycin; End = enduracidin; Figure 4-2). Primary
sequence analysis suggested that products P and Q were pyridoxal-5’-phosphate (PLP)dependent aminotransferases, and that R was likely an acetoacetate decarboxylase.
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Figure 4-2: Comparison of the mannopeptimycin biosynthetic cluster (A) with that of enduracidin (B)
suggested that the three genes mppP/endP, mppQ/endQ and mppR/endR are involved in enduracididine
biosynthesis. These genes are enlarged and colored in blue. Comparing the sequences of MppP with EndP,
MppQ with EndQ, and MppR with EndR (C) shows a high degree of pairwise sequence identity. On the
basis of their sequences, Mpp/EndP and Mpp/EndQ are predicted to be PLP-dependent aminotransferases
and Mpp/EndR is predicted to be an acetoacetate decarboxylase.

Experiments by K. Hatano et al.25 used radio-labeled amino acids to investigate the
biosynthetic origin of L-End and found that the most radioactivity was incorporated into
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the L-End fraction of the enduracidin that was produced when cultures were fed with
labeled L-Arg. Thus, it was concluded that the biosynthesis of L-End, now presumed to be
carried out by Mpp/EndP, Mpp/EndQ, and Mpp/EndR, likely begins from L-Arg25. This, in
turn, suggests that the iminoimidazolidine ring of End is probably formed by cyclization
between the γ-carbon and one of the guanidine N atoms of arginine 25. There is precedent
for this sort of transformation in the biosynthesis of another arginine-derived nonproteinogenic amino acid, L-capreomycidine (L-Cap, 4; Scheme 4-3). Capreomycidine is
found in the antibiotic viomycin, and its biosynthesis was initially thought to provide a
possible chemical logic for L-End biosynthesis. In the viomycin biosynthetic cluster from S.
vinaceus, L-Cap (compound 4) is produced from L-Arg (compound 5) by two enzymes: VioC
and VioD. VioC is an Fe(II)/α-ketoglutarate-dependent oxygenase that hydroxylates L-Arg
at the β-carbon to give 3S-hydroxy-L-Arg 26. This product is then cyclized by VioD, a PLPdependent aminotransferase that catalyzes an intra-molecular transamination to give the
6-membered capreomycidine ring27, 28.
According to their amino acid sequences, MppP and MppQ were both predicted to be
class I/II aminotransferases, while MppR was predicted to be an acetoacetate
decarboxylase. Assuming that L-End biosynthesis likely occurs in a similar way to L-Cap
biosynthesis, that is by activation of L-Arg by hydroxylation followed by transamination, it
was not clear exactly how two aminotransferases and a decarboxylase would accomplish
this transformation. Clearly, there had to be a difference in the biosynthetic schemes of LCap and L-End.
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Scheme 4-3: L-capreomycidine biosynthesis mechanism by VioD.

The first clues came from studies of MppR

29.

In spite of its low (~20%) sequence

identity with acetoacetate decarboxylase, MppR was shown to have a nearly identical
tertiary structure. Differences in the active site of MppR, such as the loss of key residues
for the decarboxylation reaction, suggested that MppR was not a decarboxylase. This was
subsequently confirmed experimentally. The real breakthrough came when it was
demonstrated that MppR is able to cyclize the ketone derived from γ-hydroxy-L-arginine,
to give the ketone form of enduracididine (i.e. 2-keto-End, compound 7, Scheme 4-1). This
product is actually observed bound to the catalytic lysine residue of MppR in crystals
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soaked with 2-oxo-4-hydroxy-5-guanidinovaleric acid (4HKA, compound 6). In addition,
experiments with MppQ showed that it was a true aminotransferase, capable of
transaminating L-Arg and pyruvate or glyolxylate, or the reverse, 2-ketoarginine and
alanine or glycine (unpublished results). These observations suggest that MppR generates
7 from the highly oxidized arginine derivative 6, which is then transaminated by MppQ to
give the amino acid, L-End. The L-β-hydroxy-End found in mannopeptimycin is produced
from L-End by the Fe(II)-dependent oxygenase MppO, which hydroxylates the β-carbon of
L-End to give L-βhEnd (compound 2) 30. D-βhEnd is presumably generated from L-βhEnd
by epimerization

31.

All of this was plausible based on the data available at the time, but

raised the question of where the highly oxidized arginine derivative 6 comes from.
Extensive work by predecessors on the enduracididine project failed to produce any of
the S. hygroscopicus MppP in soluble form. Multiple strategies beyond the typical
optimization of expression conditions were employed, including for example, truncation of
the N- and C-termini, codon optimization, and site-directed mutagenesis. Switching to the S.
fungicidicus homolog EndP from the enduracidin pathway gave no better results. A final
BLAST search preparatory to throwing the MppP project away altogether returned a
homolog from Streptomyces wadayamensis that was significantly longer than either MppP
or EndP. Both of these are listed in GenBank at 293 amino acids, which is considerably
shorter than the ~415 residues typical of aminotransferases. The S. wadayamensis homolog
is 376 amino acids, so it would seem that a non-standard initiation codon fooled the
annotation software into thinking the MppP and EndP coding sequences began about 100
codons into the gene. This at least made it clear why the protein would not express—all of
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the expression constructs tried to date contained at most ~3/4 of the gene! The S.
wadayamensis enzyme expressed well in E. coli.
With soluble protein in hand, we were finally able to begin the work of identifying the
catalytic activity of MppP. S. wadayamensis is an endophytic strain isolated from mandarin
organge trees (Citrus reticulata), which produces, among other natural products,
mannopeptimycin 32. Since it was expected from the work with MppR and MppQ that MppP
must catalyze the first step of the pathway, the S. wadayamensis MppP (SwMppP) was
incubated with L-Arg and monitored by UV-Vis spectroscopy. The results of these first
crude experiments, which will be discussed in detail in Chapter 5, indicated that MppP
reacted with L-Arg, finally accumulating a colored (pale pink) intermediate when the
cuvette had been exhausted of dioxygen. Before delving into the experimental results we
ultimately obtained, however, it will be instructive to investigate the chemistry of PLP and
some properties of well-characterized PLP-dependent enzymes.

4.3 Pyridoxial 5’-phosphate is a versatile cofactor
PLP is a versatile cofactor catalyzing manifold reactions, including transamination,
racemization, C-C bond formation or cleavage, β- and γ-elimination/substitution, and
oxidative decarboxylation 33. Some general reaction mechanisms are shown in Scheme 4-4.
Due to its electron sink properties, PLP is inherently reactive and readily catalyzes
reactions with amino acids, for example, without the aid of any enzyme. In fact, it has been
said that, in general, PLP-dependent enzymes do not so much accelerate the PLP-catalyzed
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reaction, but rather direct the catalytic power of PLP in a single direction 34. In other words,
PLP-dependent enzymes provide modest rate accelerations and strictly control the
reaciton specificity. Toney

35

reviewed and summarized the three major factors that

determine the reaction specificity in PLP-dependent enzymes: stereoelectronic control, the
electrophilic strength of the Schiff base-pyridine ring π-electron system, and the placement
of the substrate’s side chain. Certain factors are common to most PLP-dependent enzymes,
such as the covalent complex between a catalytic lysine residue on the enzyme and the PLP
cofactor; this is the internal aldimine. When substrates bind, they react, normally by attack
on the C4’ of PLP to displace the enzyme lysine side chain and form the external aldimine.
As shown in Scheme 4-4, the external aldimine is the branch-point for many of the
reaction types, such as decaboxylation or Cα-H abstraction. Which bond is going to be
broken depends on the orientation relative to the pyridine ring. Thus, the bond aligned
parallel to the π-orbitals (perpendicular to the PLP plane) promotes π–σ-orbital overlap, is
weakened and is more easily cleaved 35. Hence, decarboxylases bind their substrates so that
the bond to the carboxyl group is located perpendicular to the PLP plane. Conversely,
enzymes that begin with Cα-H proton abstraction, such as transaminases and racemases,
orient the Cα-H bond perpendicular to the PLP ring.
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Scheme 4-4: Some examples of reactions involving PLP. Quinonoid intermediates are highlighted by green squares.

The protonation state of the pyridine nitrogen atom is another key factor influencing
the reaction specificity. In aspartate aminotransferase, for example, this nitrogen is kept in
the protonated, pyridinium form by the juxtaposition of the negatively charged carboxyl
group of a conserved aspartic acid residue 36. In enzymes like alanine racemase, where the
carbanion at Cα must be stabilized, the pyridine nitrogen is kept deprotonated via
interaction with the guanidinium group of a conserved arginine 37.
Percudani and Peracchi have created a B6 database utilizing hidden Markov models to
compare the sequences of PLP-dependent enzymes. Their analysis distributes PLPdependent enzymes into seven separate clusters based on their functions38.

The

representatives of these seven clusters are shown in Figure 4-3. Five of these clusters are
essentially identical to the traditional classification system for PLP-dependent enzymes,
which is based on 5 distinct topologies or “Fold Types”39. The Type I PLP-dependent
enzymes are also called the aspartate aminotransferase (ATase) superfamily. Enzymes in
this superfamily are typically dimeric (sometimes higher order oligomers) and have three
discontinuous domains: the N-terminal extension, the large domain, and the small domain.
The active site is located at the interface between the large and small domains, and is
composed of residues from two protomers of the oligomer. Fold Type I is the largest and
most diverse in terms of function and structure of N terminal domain, including class I, II,
III, and V aminotransferases as well as enzymes catalyzing other PLP-dependent reactions
like cystathionine γ-lyase, serine hydroxymethyltransferase39, 40. Class I ATase mainly
contains aspartate aminotransferase, tyrosine ATase, aromatic ATase, alanine ATase and laminocyclopropane-1-carboxylate synthase. Class II ATase mainly comprises glycine
acetyltransferase, 5-aminolevulinic acid synthase, histidinol-phosphate aminotransferase.
162

Class III mainly contains ornithine ATase, 4-aminobutyrate ATase, ω-amino acid-pyruvate
ATase. Class V ATase mainly contains phosphoserine ATase, serine-pyruvate ATase.
The Type II PLP-depedent enzymes are evolutionarily distinct from the Type I enzymes,
despite having similar tertiary structures33, 41. Fold type II includes the tryptophan synthase
family of enzymes that mainly catalyze replacement and elimination reactions at Cβ, while
most aspartate ATase family proteins promote reactions on the Cα atom of the substrate41.
Fold Type II also contains acetyltransferases, ammonia lyases, and some racemases. In
contrast to the Type I enzymes, the active sites of Type II enzymes are consist entirely of
residues from a single protomer (such as tryptophan synthase42). Another distinguishing
characteristic of these two enzyme families is the existence of a regulatory domain in the
Type II enzymes43, 44, whereas this is lacking in the Type I proteins.
The other fold types have fewer members than either of those discussed above. Fold
Type III, also called the alanine racemase family, contains primarily amino acid racemases
and decarboxylases. The structures of these proteins consist of an N-terminal β/α barrel
and a C-terminal mostly β sheets domain

39.

Fold Type IV contains the class IV

aminotransferases, which take mainly branched-chain amino acids and D-amino acids as
substrates. The structures of the Type IV enzymes are very similar to the Type I ATases, but
the PLP is bound in the opposite orientation compared to the Type I ATases. Fold Type V
contains just one enzyme: glycogen phosphorylase (EC 2.4.1.1), which uses the phosphate
group of PLP for catalysis54. The two new classifications obtained from the hidden markov
model analysis by Percudani and Peracchi are designated Type VI and Type VII. Type VI
includes the L- and D-lysine 5,6-aminomutases (EC 5.4.3.3 and 5.4.3.4; e.g. PDB ID: 1XRS55)
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and D-ornithine 4,5-aminomutase (EC 5.4.3.5). Type VII contains the lysine 2,3aminomutase family enzymes (e.g. PDB ID: 2A5H 56).
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Figure 4-3: Ribbon diagrams of representative structures of the seven Fold Types of PLP-dependent
enzymes. Each depicts the functional oligomeric state. The PLP and catalytic lysine, as well as substrates
when available, are shown as sticks. PDB ID 7AAT45 is the structure of mitochondrial aspartate
aminotransferase from Gallus gallus, which is the representative of fold type I and functions as a dimer (chain
A colored in green, chain B colored in cyan). PDB ID 1BKS46 is the structure of tryptophan synthase from
Salmonella typhimurium, which functions as an α2β2 complex (α subunit colored in green, β subunit colored in
cyan). The α and β subunits catalyze different reactions and indole is the channeled intermediate connecting
the two reactions (α and β)47-49. The β subunit belongs to PLP Fold Type II. PDB ID 1SFT37 is the structure of
alanine racemase from Bacillus stearothermophilus, which is the representative of fold type III and functions
as dimer (chain A colored in green, chain B colored in cyan). Each monomer contains two domains: and Nterminal eight-stranded α/β barrel and a C-terminal mostly β-strand domain. PDB ID 1DAA50 is the structure
of D-amino acid aminotransferase from Baccilus sp. YM-1, which is the representative of fold type IV and
functions as a dimer (chain A colored in green, chain B colored in cyan). Each monomer contains two domains
that are very different from the structures of the L-amino acid aminotransferases. PDB ID 1GPA51 is the
structure of glycogen phosphorylase from Oryctolagus cuniculus, which belongs to Fold Type V and functions
as dimer (chain A colored in green, chain B colored in cyan). PDB ID 1XRS52 is the structure of lysine 5,6aminomutase from Clostridium sticklandii, which is the representative of fold type VI and functions as an α2β2
tetramer (α subunits colored in green, β subunits colored in cyan). The larger α subunit consists of a PLP
binding α/β barrel surrounded with additional α helices and β strands. The smaller β subunit contains two
domains: the dimerization domain and the adenosylcobalamin (B12)-binding Rossmann domain. PDB ID
2A5H53 is the structure of lysine-2,3-aminomutase from Clostridium subterminale, which belongs to Fold Type
VII and functions as a tetramer (chain A colored in green, chain B colored in cyan, chain C colored in magenta,
and chain D colored in yellow). This enzyme is S-adenosylmethionine-, [4Fe-4S]2+-, and PLP-dependent. Sadenosylmethionine and PLP are shown as sticks; [4Fe-4S]2+ is shown in sphere.
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4.4 Aminotransferases (ATase)
The PLP-dependent aminotransferases catalyze transamination reactions in which the
α amino group of an amino acid is transferred onto the α-carbon of a 2-oxo acid, forming
the 2-oxo acid form of the amino acid and the amino acid form of the 2-oxo-acid. The
example of the thoroughly studied asparate aminotransferase-catalyzed reaction is shown
in Figure 4-4A. Aspartate aminotransferase (AATase) has a large domain, a small domain
and an N-terminal extension (Figure 4-4B). It functions as a dimer with the active site
residues contributed by both domains and by both chains of the dimer, as discussed above.
In L-amino acid aminotransferases, the catalytic lysine residue is located on the si face of
C4’ of the cofactor and the re face is accessible by solvent or substrate.
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Figure 4-4: The reaction catalyzed by aspartate aminotransferase (A). Ribbon representation of the aspartate
aminotransferase dimer (PDB ID: 1ARS57). Chain A is colored grey, chain B is colored light green. The active
site of AATase shows the binding mode of PLP in this and similar enzymes (C). The catalytic K258 and PLP are
shown as sticks with yellow carbon atoms. The asterisk on atom labels denotes that the residue is contributed
by the other chain of the dimer.

4.4.1 The AATase active site
As shown in Figure 4-4C, the catalytic K258 of the E. coli AATase is covalently bound to
the PLP as the internal aldimine. The negatively charged D222 stabilizes the pyridine N
atom of PLP as the pyridinium, which allows the ring to accept electrons from the substrate
stabilizing the carbanion that forms during catalysis. The C3’ hydroxyl group of PLP makes
a hydrogen bonding interaction with N194 and Y225, both highly conserved among the
Type I AATases. The phosphate group of the cofactor interacts with R266, T109, S257, Y70*
(from the other protomer of the dimer); S296* interacts with the phosphate group through
an intervening water molecule. The pyridine ring of PLP is clamped between W140 above
and A224 below. W140 is important for retaining PLP in the active site. Mutating W140 to
His in the E. coli AATase resulted in a 50-fold increase in the dissociation rate constant for
PLP58. Also, the angled, unstacked imidazole ring of this W140H variant facilitated water
access to the re face of the substrate Cα, resulting in a faster rate of racemization and
decreased aminotransferase activity58.
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4.4.2 Conformational changes associated with catalysis
Because the substrates of AATase are aspartate and α-ketoglutarate, the elimination
and replacement reactions cannot happen. In the structure of the E. coli AATase with the
inhibitor 2-methyl-L-aspartate (PDB ID: 1ART59), R386 coordinates the α-carboxylate
group of the inhibitor and holds in in the plane of the PLP ring, which discourages
decarboxylation. After the deprotonation of Cα, the resulting quinonoid intermediate is
capable of undergoing either transamination or racemization. Kochhar and Christen found
that human mitochondrial AATase that had been truncated by limited proteolysis with
trypsin (residues 27/32-410) had the same racemization activity as the intact protein, but
much lower transamination activity60. In addition, increasing organic solvent (methanol)
proportion in the reaction resulted in decreased racemization but the same transamination
activity of AATase60. Thus, it appears that AATases have evolved a strategy to discourage
the racemization reaction by limiting the access of water to the catalytic center. This
strategy involves closing the active site with N-terminal extension. This excludes water
from the active site, preventing water molecules from pronating the re side of the
quinonoid intermediate.
The small domains of many Type I aminotransferases also shift towards the large
domains upon substrate binding, forming a “closed” conformation57, 61, 62. In E. coli AATase,
this movement of the small domain creates a repulsive interaction between G38 and Y225,
which may reduce the pKa of the aldimine and, thus, enhance catalysis61. The lower imine
pKa of the internal aldimine is mainly due to the 90 ° torsion angle of the C4-C4’ bond (C3-
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C4-C4’-Nζ) and the repulsive interaction between G38 and Y225 that destabilizes the
unprotonated aldimine in the Michaelis complex 61, 63.

4.4.3 Dual substrate recognition
As mentioned above, the aminotransferase reaction involves two different substrates
being transformed, in succession, into two products. In many cases, these two substrates
have very different side chains, such as different charges (e.g. alanine vs α-ketoglutarate),
inverse absosolute configuration (e.g. D-p-hydroxyphenylglycine and L-glutamate), and/or
different size side chains (e.g. aspartate and α-ketoglutarate). Aminotransferases have
evolved several ways to solve the problem of having such different substrates binding in
the same active site in the same orientation relative to the same PLP cofactor. These
include the “glutamate switch,” the “arginine switch,” and remodeling of hydrogen bonding
networks33, 64.
The “glutamine switch” works as shown in Figure 4-5. When the substrate, lysine, forms
the external aldimine with PLP (PDB ID: 2CJD65) in the lysine ε-aminotransferase from
Mycobacterium tuberculosis, the carboxylate group of E243 neutralizes the guanidinium
group of R422. This prevents repulsion due to the juxtaposition of like charges. However, in
the structure of the lysine ε-aminotransferase with α-ketoglutarate bound (PDB ID:
2CJH65), E243 rotates out of the active site, which allows the interaction between R422 and
the α-carboxylate group of α-ketoglutarate. The “arginine switch” works in a similar way,
as it is also based on the flexibility of active site residues as demonstrated in the active site
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of GABA aminotransferase. Comparing the structures of GABA aminotransferase in
complexes with either an inactivator CPP-115 with one carboxylate group (similar to
GABA) (PDB ID: 4ZSY 66) or the metabolite of CPP-115 with two carboxylate groups that is
similar to glutamate (PDB ID: 4ZSW 66), R445 that interacts with the one carboxylate group
of the CCP-115 metabolite, switches out and interacts with E270 in the CPP-115 bound
structure 66, 67.
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Figure 4-5: Dual substrate recognition in lysine ε-aminotransferase from Mycobacterium tuberculosis. When
lysine is bound in the active site of lysine ε-aminotransferase as the external aldimine (A), E243 forms a salt
bridge with R422. When α-ketoglutarate is bound in the active site (B), E243 rotates away from R422, which
allows R422 to interact with the α-carboxylate group of α-ketoglutarate.
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4.5 L-3,4-dihydroxyphenylalanine (L-DOPA) decarboxylase
4.5.1 Mechanisms of decarboxylation and oxidative deamination
Some PLP dependent enzymes were found to react with O2, such as 3,4dihydroxyphenylalanine (DOPA) decarboxylase/L-aromatic amino acid decarboxylase

68,

and so-called “paracatalytic” reactions 69 with O2 have been described. DOPA decarboxylase
catalyzes the conversion of L-DOPA (compound 8) and L-5-hydroxy tryptophan into two
important neurotransmitters, dopamine (compound 9) and serotonin. The mechanism is
shown in Scheme 4-5A. Upon substrate binding, the internal aldimine is converted into
external aldimine. Due to the orientation of the substrate carboxyl group perpendicular to
the PLP ring, decarboxylation happens. The subsequent quinonoid intermediate is
protonated at Cα position, giving the corresponding amine product (9). Mutagenesis
studies of Y332 demonstrated that this residue is probably the proton donor in the step of
quinonoid protonation70. Notably, the mutant Y332F has a decarboxylation-dependent
oxidative deaminase activity, rather than decarboxylase70. In other words, Y332F reacts
with L-amino acids and dioxygen to generate the corresponding aromatic aldehydes, CO2
and ammonia.
DOPA decarboxylase also catalyzes the oxidative deamination of serotonin and
dopamine71, 72. The proposed oxidative mechanism of 9 is shown in Scheme 4-5B. The
internal aldimine is converted into the external aldimine with dopamine, and after
deprotonating on Cα, the quinonoid intermediate forms. Based on its close proximity to the
substrate Cα and mutagenesis studies, T246 is thought to function as a nucleophile to
abstract the α-proton 73. In the presence of O2, the quinonoid intermediate reacts with O2
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and forms a superoxide anion and semiquinone, followed by a hydroperoxy-PLP
intermediate. After several steps, the final aldehyde product, H2O2, and ammonia form. In
the absence of O2, the quinonoid intermediate would equilibrate with a ketimine73.

Scheme 4-5: Decarboxylation (A) and oxidation deamination (B) by DOPA decarboxylase.
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4.5.2 Structure of human DOPA decarboxylase
DOPA decarboxylase belongs to group II of Fold Type I, which contains the L-amino acid
decarboxylases. The group II of L-amino acid decarboxylases include aromatic amino acid
decarboxylase, histidine decarboxylase, and glutamate decarboxylase

74.

They share a

similar active site conformation and many conserved features. Binding of PLP into the
apoenzyme is thought to be the essential regulator of activity 75. Upon PLP binding, DOPA
decarboxylase undergoes a large conformational change into a more compact and less
solvent accessible conformation 1.
As shown in Figure 4-7, human DOPA decarboxylase is a homodimer with three
domains: a N-terminal domain composed of three α-helices that contact with the other
protomer, a large domain with a central seven-stranded β-sheet surrounded by α helices,
and a C-terminal domain with a 4-stranded β-sheet covered by α helices on one side. The
apoenzyme adopts an open conformation (PDB ID: 3RBL 1); while after PLP binds in the
two active sites, it forms a closed conformation (PDB ID: 1JS62). In the apoenzyme
structure, Y274 interacts with H302. After PLP binding, this movement (from open to
closed conformation) makes the aromatic stacking interactions among W304, F80 and
Y274 (Figure 4-7B). In the active site, the catalytic K303 covalently binds to PLP as the
internal aldimine. H192 and A273 are stacked above and below the PLP ring. H192 is also
involved in the catalysis of oxidative deamination. In the substrate analog-bound structure
(PDB ID: 1JS32), the iminic nitrogen of H192 is 4.8 Å away from the OH group of T246,
which facilitates the deprotonation of T246 76. As mentioned above, the deprotonated T246
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Figure 4-7: (A) The structure of DOPA decarboxylase in an open (PDB ID: 3RBL 1) and closed
(PDB ID: 1JS62) conformation. The domain organization of chain A is highlighted with different
colors (N-terminal domain colored in purple, large domain colored in blue, and C-terminal
domain colored in orange). Chain B colored in grey. (B) Conserved residues in human DOPA
decarboxylase are shown in stick.
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would abstract the Cα hydrogen and trigger the formation of the quinonoid intermediate
(Scheme 4-5B). D271 makes a salt bridge interaction with the protonated pyridine nitrogen
of PLP. Several residues, including S194, S149, H302, F309, are involved in interacting with
phosphate group of PLP. I101* and F103* (from the other chain), Y79, F80, T82 are
involved in substrate binding.
The sequence of SwMppP suggests that it belongs to the class I/II ATase group of the
Fold Type I PLP-dependent enzymes. The sequence identity between SwMppP and a Fold
Type I ATase (PDB ID 1ARS57) or DOPA decarboxylase (PDB ID 3RBL1) is quite low (20%
and 17%, respectively). In addition, many of the key active site residues of both the ATases
and DOPA decarboxylase are different in SwMppP, suggesting that SwMppP probably has a
different function. Two other genes in the L-End biosynthesis gene cluster, MppR and
MppQ, are involved in the cyclization of 6 into 7 and the transamination of 7 into L-End (1),
respectively (Figure 4-2). Hence, we speculate that SwMppP can only be a novel PLPdependent hydroxylase/deaminase to catalyze the oxidation of L-Arg (5) into its γhydroxy, 2-oxo derivative 6. To find out the relationship between the function and
structure, we used biophysical methods, as well as enzyme kinetics, to characterize
SwMppP. Our findings are detailed in Chapter 5.
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Chapter 5
Streptomyces wadayamensis MppP is a PLP–Dependent L-Arginine Oxidase in the LEnduracididine Biosynthetic Pathway

5.1 Background
A UV-visible spectrum of SwMppP with L-Arg (Figure 5-1A) has the peak at 415-420 nm
associated

with

the

internal

aldimine

form

of

Fold

Type

I

PLP-dependent

aminotransferases. In buffers with pH < 7.0, like MES pH 6.7, the spectrum of SwMppP was
unchanged over a full hour at room temperature. Thus, 10 mM MES pH 6.7 was chosen as
the storage buffer for the enzyme. In high pH buffers, like NaPO4 pH 8.4 or BIS-TRIS
propane pH 9.0, the enzyme exhibits much higher activity, even though the enzyme loses
both its color and the peak at 415 nm (t1/2 ≈ 30 min). So we use high pH buffers for later
kinetics study.
Since enduracididine biosynthesis is thought to begin from L-Arg, and the other two
enzymes in the pathway, MppR and MppQ, are thought, based on our own results, to be
involved in later steps, we tested SwMppP for activity with L-Arg. Upon addition of 1 mM LArg to a solution of 30.0 μM SwMppP in 50 mM Bis-TRIS propane, pH 9.0, the peak at 415420 nm shifted ~10 nm to the right (425-430 nm), indicative of formation of the external
aldimine 1, 2 (Figure 5-1A). After approximately 70 seconds, two new species absorbing at
510 and 560 nm began to accumulate. The former reached a maximum and plateaued,
while the latter only accumulated for a short time and then quickly decayed (Figure 5-1A,
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inset). Agitating the cuvette resulted in the disappearance of the 510 nm peak. After a short
time, the 510 nm peak would accumulate again. This observation suggested that SwMppP
reacts with molecular oxygen as well as L-Arg. To confirm this putative reaction with O , we
2

performed the same experiments in a Clark electrode to monitor the consumption of dioxygen
directly. As is evident in Figure 5-1B, dioxygen is consumed upon addition of the enzyme, and
the rate of O consumption increases with the concentration of L-Arg.
2

Figure 5-1: SwMppP reacts with L-Arg. Absorbance spectra recorded on a Hewlett-Packard 8453
diode array spectrophotometer for the reaction of 30 μM SwMppP with 2 mM L-Arg and ambient
(∼250 μM) O2 (A). Spectra were recorded every 0.5 s, but only the traces every 10 s are shown here
for clarity. The purple line represents the enzyme alone in 50 mM BIS-TRIS propane pH 9.0. The
blue gradient traces represent the absorbance changes over 300 s (10 s interval data from lighter to
darker blue as time goes). The inset shows the absorbance changes at 510 (green), and 560 nm
(orange). The consumption of dioxygen was confirmed by monitoring the reaction in a Hansatech
Oxygraph Clark electrode (B). Reactions were initiated by adding SwMppP into solutions containing
different concentrations of L-Arg (black arrow).
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Having established that SwMppP reacts specifically with L-Arg and molecular oxygen,
we set about identifying the product(s) of the reaction. Proton NMR analysis of SwMppP
reaction mixtures and an L-Arg standard (Figure 5-2), showed that SwMppP converted LArg into at least one new product. Preliminary data from 1H COSY, 1H-13C HSQC, and 1H-13C
HMBC spectra (Appendix 5-1) showed that the SwMppP-catalyzed reaction between L-Arg
and molecular oxygen yields two products: 2-oxo-4(R)-hydroxy-5-guanidinovaleric acid
(i.e. 4-hydroxy-2-ketoarginine, compound 2 in Figure 5-3) and 2-oxo-5-guanidinovaleric
acid (i.e. 2-ketoarginine, compound 3 in Figure 5-3).

Figure 5-2: Proton NMR results of L-Arg (2.0 mM, bottom) and the reaction of 10 μM SwMppP with 2.0 mM LArg (top), both in 20 mM sodium phosphate pH 8.4 buffer.
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Figure 5-3: Compounds encountered in our studies of SwMppP. 1 is L-arginine. 2 and 3 are the two products
of the reaction of SwMppP with L-Arg, 2-oxo-4(R)-hydroxy-5-guanidinovaleric acid (2) and 2-oxo-5guanidinovaleric acid (3), respectively. 4 and 5 are the H2O2-catalyzed decarboxylation products of 2 and 3
that were observed by mass spectrometry in the absence of catalase, 4-guanidino-(S)-3-hydroxybutyric acid
and 4-guanidinobutyric acid, respectively. Compounds 6 -10 are analogs of L-Arg used to explore the
substrate specificity of SwMppP: 6 is L-ornithine; 7 is L-citrulline; 8 is L-canavanine; 9 is NG-methyl-Larginine; 10 is D-arginine.
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5.2 Methods
5.2.1 Cloning, expression, and purification of S. wadayamensis and Streptomyces
globisporus MppP
The coding sequences of SwMppP (GenBank accession code KDR62041) and Streptomyces
globisporus MppP (SgMppP; GenBank accession code IH67_RS0105915) were optimized for
expression in E. coli and synthesized by GenScript Inc. (Piscataway, NJ). The synthetic
genes were subcloned into the pE-SUMOkan expression vector (LifeSensors Inc., Malvern,
PA) using primers containing BsaI and XbaI restriction sites (Table 5-1). The integrity of
the SwMppP coding sequence was confirmed by Sanger sequencing (GeneWiz, Inc). The
H29S and F191Y mutants of SwMppP were constructed by the QuickChange mutagenesis
method with primers pSUMO-SwPH29A_F/R or pSUMO-SwPF191Y_F/R, respectively, and
the pSUMO-SwMppP plasmid as the template. The H29A, F115Y, S190A, D218S, E15A and
E15Q mutants of SwMppP were generated with the Q5 site-directed mutagenesis kit (New
England Biolabs).
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Table 5-1: Primers used for mutagenesis
Names

Primers sequences

pSUMO-SwMppP_F

5′-GGTCTCAAGGTATGACGACGCAACCGC-3

pSUMO-SwMppP_R

5′-GCTCTAGATCATTAGCGGGTTTCCAGGAC-3′

pSUMO-SgMppP_F

5′-GCGGTCTCAAGGTATGAACCGCATTCTGCCGAAAGTC-3′

pSUMO-SgMppP_R

5′-GCTCTAGATTAGCCTTGACGTTCAGCGGTATC-3′

pSUMO-SwPH29A_F

5’-CGCAGACGGCGCCGCCCGTCAGG-3’

pSUMO-SwPH29A_R

5’-ATGTTCAGTTCGGAGTTCAGTGC-3’

pSUMO-SwPH29A_F

5’-GAACATCGCAGACGGCAGCGCCCGTCAGGCAC-3’

pSUMO-SwPH29A_R

5’-GTGCCTGACGGGCGCTGCCGTCTGCGATGTTC-3’

pSUMO-SwPF115Y_F

5’-TCATCCGACGTATGATAACATCGCTG-3’

pSUMO-SwPF115Y_R

5’-ACCAGTGCCACGCGATCG-3’

pSUMO-SwPF191Y_F

5’-CACTGGATACGAGTTATCGTGGTTTCGATG-3’

pSUMO-SwPF191Y_R

5’-CATCGAAACCACGATAACTCGTATCCAGTG-3’

pSUMO-SwPS190A_F

5’-ACTGGATACGGCTTTTCGTGGTTTCGATGCG-3’

pSUMO-SwPS190A_R

5’-GCCAGAACGGTGCCATGT-3’

pSUMO-SwPD218S_F

5’-GGTTATTGAATCTACCGGTAAACTGTGGCCGACGC-3’

pSUMO-SwPD218S_R

5’-ACCCAGCGACAGCCAGCT-3’

pSUMO-SwPT12A_F

5’-CTGAAAGAAAACCTGGCGCAATGGG-3’

pSUMO-SwPT12A_R

5’-CCCATTGCGCCAGGTTTTCTTTCAG-3’

pSUMO-SwPE15A_F

5’-GACGCAATGGGCATACCTGGCAC-3’

pSUMO-SwPE15A_R

5’-AGGTTTTCTTTCAGTTGCGGTTG-3’

pSUMO-SwPE15Q_F

5’-GACGCAATGGCAATACCTGGCAC-3’

pSUMO-SwPΔ1-22_F

5’- TAGGTCTCTAGGTCTGAACATCGCAGACGGC-3’
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The His6-SUMO-SwMppP fusion proteins were expressed from E. coli BL21 Star (DE3)
cells (Invitrogen Inc., Carlsbad, CA) carrying the pE-SUMO-SwMppP plasmid. Cultures were
grown in Luria-Bertani medium with 50 μg/mL kanamycin at 37 °C. When the cultures
reached an OD600nm of ∼1.0, protein expression was induced with 0.4 mM isopropyl β-D-1thiogalactopyranoside (IPTG). The temperature was reduced to 25°C, and the cultures were
grown overnight while being shaken at 250 rpm. Cells were harvested by centrifugation,
resuspended in 5 mL/g of buffer A (25 mM TRIS pH 8.0, 300 mM NaCl, 10 mM imidazole,
and 100 μM PLP) supplemented with 0.1 mg/mL DNase I (Worthington Biochemical Corp.,
Lakewood, NJ). The cells were lysed using a Branson Sonifier S-450 cell disruptor (Branson
Ultrasonics Corp., Danbury, CT) for a total of 10 min at 60% amplitude with 30 s pulses
separated by 50 s rest periods. The temperature was maintained at or below 4 °C by
suspending the steel beaker in an ice bath directly over a spinning stir bar. The lysate was
clarified by centrifugation at 39000 x g for 45 min and then applied to a 5 mL HisTrap
column (GE Lifesciences, Piscataway, NJ) at a flow rate of 5 mL/min to isolate the His6SUMO-SwMppP fusion protein. The protein was eluted by a four-step gradient of buffer B
(25 mM TRIS (pH 8.0), 300 mM NaCl, and 250 mM imidazole; 5, 15, 50, and 100%). The
His6-SUMO-SwMppP fusion protein eluted in the third and fourth steps and was ∼90%
pure, as judged by Coomassie-stained sodium dodecyl sulfate−polyacrylamide gel
electrophoresis (SDS-PAGE). Peak fractions were pooled and dialyzed overnight against 4 L
of 25 mM TRIS pH 8.0, 150 mM NaCl, 100 μM PLP, and ∼3 μM SUMO protease (LifeSensors
Inc.). The dialysate was passed through the HisTrap column a second time to remove the
cleaved His6-SUMO tag as well as the protease. The resulting SwMppP preparation was
>95% pure. The protein was desalted using a HiTrap desalting column (GE Lifesciences)
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into 10.0 mM MES pH 6.7 and 20 μM PLP and stored at −80°C. All SwMppP mutants were
purified by the same protocol as the wild type enzyme. Selenomethionine-labeled SgMppP
was expressed from T7 Express Crystal cells (New England Biolabs, Ipswich, MA) carrying
the pE-SUMO-SgMppP plasmid. Cells were grown in Selenomethionine Medium Complete
(Molecular Dimensions, Newmarket, Suffolk, U.K.) with 50 μg/mL kanamycin. SgMppP was
expressed and purified using the same protocols described for SwMppP, except that
SgMppP was desalted into three different buffers based on the results of differential
scanning fluorimetry experiments with the Slice pH screen (10 mM ADA pH 7.0, 20 μM PLP;
10 mM DL-Malic acid pH 6.0, 20 μM PLP; 10 mM Succinic acid pH 6.0, 20 μM PLP).

5.2.2 UV/Vis spectroscopy of SwMppP and its mutants reacting with L-Arginine and
dioxygen
Hewlett-Packard 8453 diode array spectrophotometer was used for scanning the 700 μL
reaction of ~30 μM enzyme (SwMppP or its mutants) with 2 mM L-Arg and ambient (∼250
μM) O2 in 50 mM BisTris propane pH 9.0 buffer. The scan was taken every 0.5 s from 200
nm and 700 nm.

5.2.3 Characterization of MppP reaction products by NMR
Reactions (4.8 mL) were conducted in 50 mL conical tubes with gentle agitation to
prevent depletion of dioxygen. All enzymes were stored in 10 mM MES pH 6.7, 20 μM PLP
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buffer. To avoid side reactions due to free PLP, the concentration of free PLP was limited by
concentrating the proteins to ~600 μM, thus limiting the volume of enzyme (with free PLP)
required for the reaction. For wild type SwMppP, ~10 μM SwMppP was added to a solution
of 2 mM L-Arg in 20mM sodium phosphate pH 8.4. Due to the reduced catalytic efficiency of
the mutants, more enzyme (~65 μM) was used in these reactions. The SwMppPF115Y variant
was desalted into 20 mM sodium phosphate pH 8.4, 10 μM PLP buffer, since it was not
stable in the absence of free PLP. Control reactions contained 2 mM L-Arg in 20 mM sodium
phosphate pH 8.4, with the same volume of enzyme storage buffer (i.e. no enzyme). All
reactions were shaken at 25oC, 200 rpm for 2.5 h and protected from light. At the end of the
reaction time, samples were evaporated to dryness using a Centrifan PE Rotary Evaporator
(KD Scientific, Holliston, MA) at 40oC for 6 h. The resulting residue was taken up in 600 μL
D2O and centrifuged at 13,000 x g for 10 min to remove any remaining particulates. The
supernatants (500 μL) were loaded into NMR tubes for 1H NMR, 13C NMR, and 2D NMR (1H1H

COSY, HSQC, and HMBC) to determine the structures of the reaction products.

5.2.4 Characterization of MppP reaction products by mass spectrometry
Reactions (1.0 mL) contained 2 mM L-Arg in MilliQ H2O, 10 μM SwMppP in MilliQ H2O,
with or without 53 U of catalase from bovine liver (Sigma-Aldrich, St. Louis, MO). The two
negative controls were 2 mM L-Arg in MilliQ H2O and 2mM L-Arg in water with 53 U
catalase. Reactions were run in the dark at 25 °C for 2.5 h with shaking at 200 rpm. All
samples were boiled for 10 min and centrifuged at 30,000 x g for 10 min. The supernatants
were diluted 10-fold with MilliQ H2O and then directly injected into a Shimadzu LCMS192

2020.

5.2.5 Ammonium detection by NADH based GDH assay3
To detect ammonium formation in the reaction of SwMppP with L-Arg and O2, I referred to
the well-known method summarized in Scheme 5-1. L-glutamate dehydrogenase (GDH) is
an NAD(P)H-dependent enzyme that catalyzes the conversion of α-ketoglutarate, NH4+ and
NADH into glutamate, NAD+, and H2O. NADH absorbs UV light at 340 nm, but NAD+ does
not. So upon addition of GDH, the absorbance at 340 nm decreases in the presence of NH4+.

Scheme 5-1: Ammonia assay reaction. The assay detects the absorbance decrease at 340 nm, due to the
NADH oxidation.

The 1000 μl reactions were conducted in 50 mM HEPES pH 7.5 buffer and included 20
μM SwMppP, 20 μM or 50 μM L-Arg, 140 μM NADH and 3.5 mM α-ketoglutarate. The
reaction components were mixed and incubated for 10 min at room temperature. This was
used to blank the spectrophotometer and the absorbance at 340 nm was monitored to
ensure a flat baseline. The reaction was initiated by the addition of 10-2 units of GDH
(Sigma) and the absorbance at 340 nm was recorded for ~15 min, until the absorbance
reached a plateau.
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5.2.6 Defining the relationship between O2 usage and H2O2 formation
To determine how many O2 were used to generate H2O2, the regeneration of O2 by
catalase was measured in a Hansatech dioxygen electrode. The reaction mixtures contained
25 μM, 50 μM, or 100 μM L-Arg in 50 mM BIS-TRIS propane pH 9.0. When the O2
concentration was stable, 10 μM SwMppP was added into the solution and O2 consumption
was monitored. When the reaction reached equilibrium (plateau in the dioxygen
concentration), 10 μl of 0.5 mg/mL catalase was added to the 1 mL reaction to
disproportionate two equivalents of H2O2 into one equivalent of O2 and two equivalents of
water.

5.2.7 Reactions with 18O2, H218O
Reactions in the presence of

18O

2

were conducted in a tonometer, a closed, airtight

reaction vessel. The body of the tonometer contained 10 μM SwMppP in 100 mM
ammonium bicarbonate pH 9.0 with 50 ng/mL catalase. One short arm of the tonometer
contained 20 μL of 500 mM L-Arg, and the other was connected to a 500 mL bottle of 18O2
with an air-tight valve. The tonometer was connected to a Schlenk line, which was used to
purge the tonometer of oxygen by 45 cycles of vacuum (~5 s) and flushing with argon (45
s). Prior to removing the tonometer from the Schlenk line, the atmosphere was removed
with the vacuum pump to enable the labelled dioxygen to fill the tonometer. The tonometer
was closed and removed from the Schlenk line. The reaction was started by mixing the
enzyme solution in the tonometer body with the L-Arg in the side arm. Without O2, the
194

quinonoid I intermediate accumulated, which has a pale pink to orange color. Then the 18O2
was allowed to fill the tonometer. The reaction was carried out at room temperature for 2
h. After the reaction, the tonometer was opened and samples were analyzed by ESI-MS.
The 200 μl reaction of SwMppP and L-Arg in H218O was conducted in 1.7 mL eppendorf
tubes at room temperature overnight. The reaction contained 10 μM SwMppP, 2 mM L-Arg
and ~95.4% H218O. The products of the reaction were identified by ESI-MS.

5.2.8 Crystallization of wild-type and mutant forms of SwMppP, as well as SgMppP
Initial crystallization conditions were identified by screening 15 mg/mL SwMppP and
its mutants against the Index HT screen (Hampton Research). After optimization,
diffraction-quality SwMppP crystals were obtained by the hanging drop vapor diffusion
method from 30% polyethylene glycol monomethyl ether 550 (PEG MME 550), 50 mM
MgCl2, and 0.1 M HEPES pH 8.0. Drops contained 2 μL of protein solution at 15 mg/mL and
1 μL of crystallization solution. Crystals formed as plates or rods after 3−4 days and grew
to maximum dimensions of ∼200 μm × ~50 μm × ~5 μm. Initial crystallization conditions
for the homologous enzyme SgMppP (S. globisporus) were identified in the same way by
screening 15 mg/mL SgMppP against the Index HT screen. Crystals of SeMet-substituted
SgMppP in 10 mM ADA pH 7.0, 20 μM PLP were grown from 10% PEG MME 5000, 5%
Tacsimate pH 7.0, and 0.1 M HEPES pH 7.5. SgMppP crystallized as small rods (∼100 μm ×
~10 μm × ~10 μm). Both types of crystals were cryo-protected by sequential soaks in
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holding solutions containing 5, 10, or 20% glycerol and flash cooled by plunging into liquid
nitrogen.
The structure of SwMppP with D-Arg bound was obtained by transferring crystals into
30 μL drops of the crystallization solution supplemented with 35 mM D-Arg. After being
soaked for 5 min at RT, crystals were treated with paratone N and flash-cooled. The
structure of SwMppP with L-Arg bound was obtained by transferring crystals into 30 μL
drops of the crystallization solution supplemented with 10 mM L-Arg and 20% glycerol.
After being soaked for 5 h at RT, crystals were plunged into liquid N2. The structure of
SwMppP with 2 bound was obtained by transferring crystals into 30 μL drops of the
crystallization solution supplemented with 10 mM 2-keto-Arg (contaminated with ~10%
L-Arg) with 20% glycerol. After being soaked for 2 h at RT, crystals were plunged into
liquid N2.
SwMppPH29A and SwMppPH29A crystalized under the same conditions as the wild-type
protein. SwMppPH29A and SwMppPH29A at 12 mg/ml in 10 mM MES pH 6.7, 20 μM PLP were
mixed 2:1 with 30% (w/v) PEG MME 550, 0.1 M HEPES pH 7.5, 0.1 M MgCl2. The volume of
the resulting drops was 3 µl. Crystals of SwMppPF115Y were grown by mixing 1 µl of enzyme
at 12 mg/ml in 10 mM MES pH 6.7, 20 µM PLP with 1 µl of 17.5% PEG 3350, 0.04 M citric
acid, 0.06 M BIS-TRIS propane, pH 6.4. Crystals of SwMppPD218S were grown by mixing 2 µl
of enzyme at 12 mg/ml in 10 mM MES pH 6.7, 20 μM PLP with 1 µl of 20% (w/v) PEG
3350, 0.1 M magnesium formate. The well solution contained microseeds derived from
poor crystals grown during screening. The structures of Ala and Ser mutants of H29
(SwMppP(H29A/S)) with L-Arg bound were obtained by transferring crystals into 30 μL
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drops of the crystallization solution supplemented with 10 mM L-Arg and 20% glycerol.
After being soaked for 5 h at RT, crystals were plunged into liquid N2.
X-ray diffraction data for SeMet SgMppP and native SwMppP were collected at beamline
21-ID-D of the Life Science Collaborative Access Team (LS-CAT) at the Advanced Photon
Source (APS). The SwMppP·D-Arg data set was collected at LS-CAT beamline 21-ID-G. All
data were processed with HKL20004.
The structure of SgMppP was determined by the single wavelength anomalous
diffraction (SAD) method using 3.5 Å resolution data collected from a crystal of SeMetsubstituted SgMppP at 0.97889 Å, 61.0 eV below the tabulated K-edge wavelength for Se
(0.97950 Å). AutoSHARP5 was used to determine the Se substructure, which contained 14
of the 16 Se atoms in the asymmetric unit, and calculate density-modified electron density
maps. An initial model comprising ∼90% of the asymmetric unit content was built using
BUCCANEER6.
Chain A of this partially refined model (with B factors set to 20.0 Å2) was used as the
search model for molecular replacement in PHASER7 to phase the unliganded SwMppP
data set. The molecular replacement solution was subjected to iterative cycles of manual
model building in COOT8 and maximum likelihood-based refinement using the PHENIX
package (phenix.refine9). Ordered solvent molecules were added automatically in
phenix.refine and culled manually in COOT. Hydrogen atoms were added to the model
using phenix.reduce10 and were included in the later stages of refinement to improve the
stereochemistry of the model. Positions of H atoms were refined using the riding model
with a global B factor. Regions of the model for translation-libration-screw (TLS)
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refinement were identified using phenix.find_tls_groups (P. V. Afonine, unpublished work),
and the TLS parameters were refined in phenix.refine. Once the refinement converged (R =
0.136, and Rfree = 0.162), the model was validated using the tools implemented in COOT
and PHENIX9, 11. Sections of the backbone with missing or uninterpretable electron density
were not included in the final model. Side chains with poor or missing electron density
were modeled in favored rotameric conformations, and the B factors were allowed to refine
without additional restraints. This was done to alert end users, who are more likely to
display a model colored by B factors than to pay attention to atom occupancy values or
download electron density maps, that these residues are not well defined in the electron
density.
The final, refined model of SwMppP, stripped of water molecules and H atoms, and with
all B factors set to 20.0 Å2, was used to determine the structure of the enzyme with L–Arg
bound, 2, 3 and D-Arg bound by difference Fourier. The model was also used to determine
the mutants’ structures. Restraints for the L-Arg-PLP, 2, 3 and D-Arg-PLP external aldimine
were generated with phenix.elbow12. Data collection and model refinement statistics are
listed in Appendix C. Coordinates and structure factors for both SwMppP and SwMppP·DArg models have been deposited in the Protein Data Bank (www.rcsb.org) with accession
codes 5DJ1 and 5DJ3.
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5.2.9 Preparation of 2-keto-arginine (3)
The 2-oxo acids used in this study were prepared by a modification of the procedure
first described by Meister13. For example, compound 3 was prepared by dissolving 2 g of LArg in 50 mL of water and the pH was adjusted to 7.2 with concentrated HCl. Next, 100 mg
of Crotalus atrox L -amino acid oxidase (LAAO) and 1.5 mg of catalase were dissolved in 10
mL of water and added to the amino acid solution. The volume was adjusted to 100 mL
with water, and the reaction mixture was incubated in the dark at room temperature while
being vigorously stirred. After 18 h, the 100 mL reaction mixture was concentrated to 7 mL
at 50 °C under vacuum. The 2-oxo acid crystallized from the concentrated reaction mixture
at 4 °C after approximately 1 week. The crystalline material was harvested, dried, and
stored at − 20 °C. The compound was characterized by nuclear magnetic resonance (NMR)
and ESI-MS and found to be predominantly the desired product.

5.2.10 Steady State Enzyme Kinetics
All 1.0 mL kinetic assays were conducted in triplicate at 25 °C in 50 mM BIS-TRIS
propane, pH 9.0. The initial velocity of SwMppP-catalyzed hydroxylation of L-Arg was
measured directly by monitoring the decrease in the dioxygen concentration using a
dioxygen electrode (Hansatech Instruments, Norfolk, U.K.). The concentration of L-Arg was
varied from 10 to 10,000 μM. The kcat and KM values were determined from the initial
velocity data using the equation v0 = Vm[A]/(KM + [A]), where [A] is the concentration of LArg, v0 is the initial velocity, Vm is the maximal velocity, and KM is the Michaelis constant.
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5.2.11 The stoichiometry of L-Arg and O2 in the reaction
The stoichiometry of the reaction was determined by measuring the quantity of O2
consumed in reactions with a constant enzyme concentration (10 μM SwMppP or its
mutants) and different L-Arg concentrations. Reactions were monitored using the
Hansatech dioxygen electrode. The concentration of dioxygen remaining when the reaction
reached equilibrium was subtracted from the starting concentration to obtain the
concentration of dioxygen consumed. The stoichiometry was computed using the following
formula:

AB. EF G2 HEIJKL/M N/O /B. EF !OP QMM/M =

[G2]UIU&UQV − [G2]O/LQUIUIP
[W − !OP]

5.2.12 SwMppP substrate specificity
Reactions containing 686 μl of 30 µM SwMppP in 50 mM BIS-TRIS propane pH 9.0 were
initiated by adding different L-Arg analogs (compounds 6, 7, 8, 9 and 10) to a final
concentration of 2 mM. The reactions were monitored by recording spectra from 200-700
nm (0.5 s between scans) for 300 s in a Hewlett-Packard 8453 diode array
spectrophotometer. The products of these reactions were identified by NMR and ESI-MS as
discussed previously.
The inhibition constant of D-Arg was determined using the O2 consumption assay
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described above for the steady state kinetics. D-Arg concentrations ranging of 0, 250, 500,
1,000, 2,500, 5,000, and 10,000 µM were added to different L-Arg solutions (5, 10, 25, 50,
100, 250, 500, 1000, 2500 and 5000 µM) in 50 mM BIS-TRIS propane pH 9.0. Reactions
were initiated by the addition of SwMppP to a final concentration of 10 µM and initial
velocities were recorded. The inhibition constant was determined using the following
equation:
XE =

∆[Y2 ]
4

Equation 1

Each data set of rate vs L-Arg concentrations was fitted with Michaelis-Menten equation
(Equation 2).
X = (Xmax ∗ [L-Arg])/(dM + [L-Arg])

Equation 2

Reciprocal plot of resulting vmax and L-Arg concentration gives a series of linear plot at
different D-Arg concentrations. The slope is KM/vmax(1+[D-Arg]/Ki), and the intercept is
1/Vmax. Reploting the slope vs [D-Arg], and the data were fitted linearly, which gives Ki (-x
intercept).
Fluorescence titration experiments were conducted to measure the binding constant of
D-Arg. SwMppP (10 µM after mixing) was mixed with different concentrations of D-Arg (40
μM, 80 μM, 160 μM, 320 μM, 640 μM and 1280 μM) and the total fluorescence was
measured with excitation at 415 nm. The results are shown in Figure 5-25. By fitting the
fluorescence data into the following single exponential equation:
y = A1^exp(−kobs ∗ x) + C
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Equation 3

In this equation, A1 is the amplitudes associates with the phase rate constants kobs. The C is
the constant of fluorescence intensity at the end of the reaction. The dependence of the
observed rate constants kobs was fitted into the following hyperbola equation to give the
Kd,app:
kobs= kmax*[D-Arg]/(Kd,app+[D-Arg])

Equation 4

5.2.13 Testing for communication between the two binding sites of SwMppPD188A
5.2.13.1 Isothermal Titration Calorimetry (ITC)
The D188A mutant was used for the determination of binding constants, since this
mutant is catalytically dead. About 3 mL of ~300 µM SwMppPD188A was prepared for ITC
analysis by dialysis against 2 L of 15 mM MES pH 6.7 overnight at 4 oC. The dialysis buffer
was used to dilute the protein to 90 μM, and was also used to prepare a solution of 80 mM
L-Arg. All solutions were degassed at 4oC for 30 min before loading into the Nano ITC
instrument (TA Instruments, New Castle, DE). The protein solution was placed in the
reaction chamber, and the 80 mM L-Arg solution in the syringe. Injections of 2.5 μl were
made every 300 s for a total of 20 injections. The titration experiments were done in
triplicate at 4, 10, 12, 18 and 20 °C in order to find the optimal temperature (maximal
signal-to-noise and best baseline).

5.2.13.2 Determination of binding constants by fluorescence titration
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Binding constants for the D188A mutant of SwMppP were also determined by
fluorescence titration. Reactions were prepared by mixing 1.5 mL of 14 μM SwMppPD188A in
100 mM BIS-TRIS propane pH 9.0 with 1.5 mL of solutions with concentrations of L-Arg
ranging from 5 to 2560 µM in the same buffer. The reactions were mixed by pipetting and
incubated at room temperature for 8 min. Fluorescence data were collected on a RF-6000
spectrofluorophotometer (Shimadzu, Japan). Samples were excited at 415 nm (5 nm
bandwidth) and the emission was measured from 436-700 nm (15 nm bandwidth).
The delta fluorescence data at 480 nm on each L-Arg concentration was obtained by
subtract the fluorescence intensity with 0 µM L-Arg in 100 mM BIS-TRIS propane pH 9.0
buffer. Then the fraction of sites occupied and the concentration of D188AL-Arg complex
were calculated. The plot of calculated [D188AL-Arg] complex versus [L-Arg] at 480 nm
was fitted to hyperbolic equation:
[EL] 480 = ([EL]480, max * [L-Arg])/(Kd,app + [L-Arg])

Equation 5

5.2.14 Pre-steady state enzyme kinetics
Pre-steady state kinetics data were collected on a model SF-61 DX2 double-mixing
stopped flow spectrophotometer. Since the reaction of SwMppP with L-Arg consumes
oxygen, the substrate binding and related changes at the PLP center could be monitored by
watching the total fluorescence signal when exciting the internal aldimine at 415 nm in
samples of anaerobic enzyme and L-Arg. Likewise, the rate of formation of the first
quinonoid intermediate (Q1) could be measured by monitoring the absorbance at 510 nm
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under anaerobic conditions. The instrument was prepared for anaerobic work by overnight
incubation with a solution of 1 mM dextrose, 10 U/mL glucose oxidase, which had been
flushed through the entire system. Solutions for anaerobic stopped flow experiments were
prepared in a tonometer. Briefly, 7 ml of 20 μM SwMppP in 10 mM MES pH 6.7, 20 μM PLP
and 100 μM glucose (with or without 5 ng/mL catalase) were placed in the main body of
the tonometer and 25 μl (1 U/µl) glucose oxidase were placed in the side arm. The
tonometer was attached to a Schlenk line and dioxygen was removed from the solution
using 45 cycles of vacuum (~5 s) and flushing with argon (~30 s). Because the SwMppP
protein is light-sensitive and somewhat unstable at room temperature, this procedure was
conducted on ice and the tonometer was covered with foil to protect it from light. Different
concentrations of L-Arg in 100 mM BIS-TRIS propane pH 9.0 with 200 μM glucose were
placed in glass syringes and sparged with argon gas for 5 min to remove dioxygen. Before
removing the argon nozzle and mounting the syringe on the stopped flow instrument, 10 μl
of glucose oxidase were injected through the luer tip. Single mixing experiments were
conducted at 25 °C with 10 µM SwMppP and 10 to 1280 µM L-Arg (all concentrations are
after mixing 1:1)
To measure the rates of the O2-dependent steps, double mixing experiments were
performed where anaerobic enzyme was mixed 1:1 with a saturating amount of anaerobic
L-Arg. This was then mixed 1:1 with buffer containing various concentrations of dioxygen.
As above, the instrument was made anaerobic overnight with the glucose/glucose oxidase
treatment described above. The first tonometer contained 40 μM enzyme, 10 ng/mL
catalase in 10 mM MES pH 6.7, 20 μM PLP under anaerobic conditions. The second
tonometer, made anaerobic as described above, contained 2,560 μM L-Arg in 100 mM BIS204

TRIS propane pH 9.0. The third tonometer contained 100 mM BIS-TRIS propane pH 9.0
with different concentrations of dioxygen (20, 40, 78, 158, 296, 465 μM). Defined dioxygen
concentrations were obtained using a Maxtec Maxblend gas blender to mix high purity O2
gas with gaseous N2. The concentrations of dioxygen produced at different settings of the
mixing valve were determined using the Clark-type electrode. Samples of oxygenated
buffer were prepared by sparging the 100 mM BIS-TRIS propane pH 9.0 buffer with set
concentrations of dioxygen for 5 min. After the first mixing step, the reactions were aged
for 20 s prior to the second mixing step in order to convert all of the enzyme to the Q1
intermediate. The second step mixed the anaerobic reaction mixture with buffer containing
different concentrations of dissolved O2. The reactions were monitored at 510 nm and 560
nm for 100 s for each data set.

5.3 Results
5.3.1 The products of SwMppP with L-Arg and O2
The products of SwMppP with L-Arg was also confirmed by mass spectrometry with
electrospray ionization (ESI-MS), which detected peaks in the positive mode spectrum at
m/z=146 and m/z=162. These masses correspond to the five-carbon products derived
from 2 and 3, 4-guanidino-3(S)-hydroxybutyric acid (4) and 4-guanidinobutyric acid (5).
The result was also verified by

13C-NMR

(Figure 5-4). These products are the result of

oxidative decarboxylation of 2 and 3, like catalyzed by H2O2 as has been observed for other
α-keto acids 14, 15. This observation was the first suggestion that H2O2 might be a product of
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SwMppP-catalyzed oxidation of L-Arg. Therefore, the experiment was repeated, this time
with catalase in the reaction mixture. The masses for both products are 174 and 190,
corresponding to 3 and 2. The fully oxidized product 2 is produced at a ratio of ~1.7:1
compared to the partially oxidized product 3. Thus, once in every two to three turnover
cycles, the enzyme loses its substrate to hydrolysis before it can be fully oxidized. This
observation likely has important implications for the mechanism of this novel enzyme.
Note that 2 is the same compound that MppR was able to cyclize to give the
iminoimidazolidine ring of L-End observed in a crystal structure of MppR in the presence of
2. MppP is therefore the first enzyme in L-End biosynthesis, reacting directly with L-Arg to
create the substrate for MppR.

Figure 5-4:

13C-NMR

spectrum of the reaction of 10 μM SwMppP with 2.0 mM L-Arg in 20 mM sodium

phosphate pH 8.4 buffer.
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5.3.2 Ammonia is also a product of SwMppP with L-Arg and O2
The 4-electron oxidation of L-Arg suggested by the results detailed above would require
ammonia to also be a product of the reaction, since the PLP cofactor needs to be converted
from the pyridoxamine form to the aldehyde (PLP) at the end of the reaction cycle. A
glutamate dehydrogenase (GDH)-coupled assay was employed to determine whether or
not the reaction of SwMppP with L-Arg produces ammonia. The assay takes advantage of
the fact that GDH can be run in reverse, where α-ketoglutarate is reduced by ammonia and
NADH to give glutamate, water, NAD+, and a proton. By constructing a standard curve of
the rate of loss of absorbance from NADH at 340 nm vs the concentration of ammonia, it is
possible to estimate the concentration of ammonia in, for example, SwMppP reaction
mixtures. The results of these experiments are shown in Figure 5-5. The correlation
coefficient (R2) of the standard curve is 0.9992, so the response of the GDH initial velocity
to the ammonia concentration is linear. In the reaction of 20 μM SwMppP and different
concentrations of L-Arg, after the GDH addition, the absorbance at 340 nm decreased and
the rate of this decrease is proportional to the centration of L-Arg. In 15 min,
approximately 80% of the L-Arg was consumed and an equal amount of ammonia was
released.
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Figure 5-5: (A) The standard curve of NADH based GDH assay. (B) The ammonium formation is proportional
to the L-Arg concentration according to the GDH assay.

5.3.3 SwMppP is an oxidase and not an oxygenase
Reactions of SwMppP with 3 concentrations of L-Arg were monitored using an oxygen
electrode (Figure 5-6). When the reactions reached equilibrium, catalase was added. The
addition of catalase resulted in the regeneration of dioxygen amounting to half of that
originally consumed by SwMppP in each reaction. This result indicates that H2O2 is another
formal product of the SwMppP reaction, and that each molecule of O2 consumed by
SwMppP is reduced to H2O2 during the catalytic cycle.
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Figure 5-6: O2 regeneration after adding catalase into equilibrated SwMppP with varied [L-Arg] solutions.
The concentration of dioxygen was monitored in a Hansatech dioxygen electrode. The reactions were
initiated by add 10 μM SwMppP into solutions containing 25 μM (n, top), 50 μM ( , middle), and 100 μM ( ,
bottom) L-Arg in 50 mM BisTris Propane pH 9.0 buffer. When the reaction was equilibrated, 50 ng/mL
catalase were added into the solution. As the table shown, the regenerated O2 is around half of the O2
consumed by SwMppP, which suggests that all O2 was consumed to form H2O2.
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The observation that each molecule of dioxygen consumed is reduced to hydrogen
peroxide logically dictates that none of the oxygen atoms incorporated into the products (2
or 3) can come from dioxygen. SwMppP is therefore an oxidase, and not an oxygenase. To
confirm that the oxygen atoms incorporated into the products do indeed derive from water
and not dioxygen, reactions of SwMppP with L-Arg were conducted with either

18O

2

or

H218O. Catalase was included in the reactions to prevent the H2O2-mediated
decarboxylation of the products that would complicate the interpretation of the results.
The products of these reactions were analyzed by ESI-MS. This analysis showed that in the
presence of

18O

2,

the products were detected at m/z=174 and m/z=190, indicating that

neither product contained

18O.

When the reactions were run in H218O, the products were

detected at m/z=176 and m/z=194. This is consistent with the incorporation of two atoms
of 18O into the fully oxidized 2, and a single atom of 18O into 3 (Figure 5-7).

Figure 5-7: Mass spectrometric analysis results. A) Spectrum of SwMppP with L-Arg in the presence of 18O2.
The mass of both products did not change. B) Spectrum of SwMppP with L-Arg in H218O. The hydroxy oxygen
atom of 2 product originated from H218O. And the keto oxygen atom of both products also came from the
H218O by hydrolysis.
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While other PLP-dependent enzymes are known to react with molecular oxygen, such
as DOPA decarboxylase/aromatic L-amino acid decarboxylase
“paracatalytic” reactions with O2 have been described

18,

16, 17,

and so-called

SwMppP is the first PLP-

dependent enzyme to produce a hydroxylated product. Given the sequence similarity
between SwMppP and more typical PLP-dependent aminotransferases, it would be
particularly interesting to know how the structure of SwMppP differs, and why these
differences result in the enzyme acting as an L-Arg γ-hydroxylase rather than a
decarboxylase or aminotransferase.

5.3.4 The structures of SwMppP
The experiments described thus far show that SwMppP is an L-Arg oxidase. However,
analysis of the primary sequence suggests that SwMppP likely has a very similar structure
to the Fold Type I aminotransferases. So what structural features of SwMppP allow it to
catalyze a very difficult reaction (oxidation of an unactivated carbon center) using a
scaffold normally associated with simple aminotransfer chemistry?

To explore the

relationship between the structure and function of SwMppP, we set out to determine its
structure by X-ray diffraction. SwMppP crystallized by the hanging drop vapor diffusion
method from 2 μL of protein solution at 15 mg/mL in 10 mM MES pH 6.7, 20 μM PLP and 1
μL of crystallization solution (30% polyethylene glycol monomethyl ether 550 (PEG MME
550), 50 mM MgCl2, and 0.1 M HEPES (pH 8.0)). These crystals diffracted to 2.1 Å
resolution.

A

number

of

aminotransferases,

including

the

human

kynurenine

aminotransferase II (PDB ID 5EUN 19) had ~30% sequence identity to SwMppP, so we first
211

sought to obtain initial phases for the structure by molecular replacement. Numerous
search models were tested, including those based on different aminotransferase structures,
with separated domains (in case the domains had a different orientation in MppP), and
ensemble structures built from superpositions of several models. None of these resulted in
suitable phase estimates. We then attempted SAD phasing, but were stymied by the
unusually low number of methionine residues (3 methionines of 376 AA) in the S.
wadayamensis enzyme. Rather than attempt to soak in compounds with anomalously
scattering atoms, we decided to target a highly similar homolog of MppP that had more
methionine residues.
The MppP from S. globisporus (SgMppP) was identified through BLAST searches of the
SwMppP sequence and is XX% identical to SwMppP. This enzyme crystallized from XXX,
but the crystals were not well ordered and only diffracted to ~3.5 Å resolution. However,
this was sufficient to build a nearly complete model of the protein that was then used as the
search model for successful molecular replacement phasing of the SwMppP data set.
SwMppP crystallized in space group P212121 with the following unit cell dimensions: a =
85.7 Å, b = 108.3 Å, and c = 195.4 Å. The asymmetric unit contained four molecules that
formed two independent homodimers (Figure 5-8). The overall structure of SwMppP, as
expected from the sequence analysis, is very similar to typical Type I aminotransferases
like aspartate aminotransferase. As in AATase, there are also two domains in SwMppP: a
large domain (A33-G272), a small domain (L23 – Q32 and G273 – R376) and an N-terminal
extension (M1-E22). The large domain contains a seven-stranded mixed β–sheet flanked
by ten α–helices (α-β-α sandwich), while small domain has a mixed α-β topology.
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Figure 5-8: (A) SwMppP dimer with one chain shown as a blue ribbon representation and the other shown as
a wheat surface representation. The K221-PLP internal aldimine in the active sites is shown in yellow stick.
The N terminus (1-22 aa) is disordered in the crystal. (B) E. coli aspartate aminotransferase (PDB ID: 1ARS20)
with one chain shown as a light green ribbon representation and the other shown as a wheat surface
representation. The K258-PLP internal aldimine in the active sites is shown in yellow stick. The N terminus
(1-30 aa) ordered and interacts with the large domain of the other chain.

Three of the four chains in the asymmetric unit are missing 22 residues from the Nterminus, while the fourth (chain D) is missing only 10 residues. The extra 12 residues in
chain D form a loop and α helix that points outward, away from the enzyme and interacts
with a symmetry-related molecule (25 Å from the active site). There is nothing in these
interactions to suggest that they are physiologically relevant. All four chains are missing
one to three residues from the C-terminus.
As alluded to above, and as shown in Figure 5-8, the tertiary structure of SwMppP is
213

similar to the type I aminotransferases (ATases)21. The E. coli aspartate ATase (PDB entry
1ARS20) superimposes well onto the structure of the SwMppP dimer. The root-meansquare deviation (rmsd) value obtained using secondary structure matching (SSM)22 of 3.4
Å for 567 of the 704 Cα atoms in SwMppP underscores the similarity of these two enzymes.
For reference, different structures of the same protein can have rmsd values of more than
0.5 Å. The most obvious difference between the tertiary structures of SwMppP and AATase
is that the N-terminal extension is disordered or points outward in SwMppP, which leaves
the active sites open to the solvent, whereas this part of the AATase structure closes over
the active site, covering the cofactor almost completely.
As in the ATases, the active site is located at the interface between the large and small
domains of each protomer. Unlike the ATases, however, there is minimal contribution from
the other chain in the dimer. The position of the cofactor is also similar to that seen in all
known Fold Type I aminotransferases, in a cleft formed by the central β-sheet and the Ntermini of helices α4 and α5 (Figure 5-8). In the absence of bound ligands, PLP is covalently
attached to K221 by an aldimine linkage. The C5’ phosphate of PLP is held by fewer direct
interactions than in other PLP-dependent enzymes. In SwMppP, the only direct interactions
between the enzyme and the C5’ phosphate are an electrostatic interaction with K229 and
a hydrogen-bonding interaction with S91. There may also be a weak hydrogen bond to
H29. The remaining interactions constituting the C5’ phosphate-binding site are watermediated hydrogen bonding interactions with D218 as well as Y88* and the main chain
amide of L252* from the other protomer of the dimer (Figure 5-9). As in all fold type I
aminotransferases, there is a negatively-charged residue, D188, placed near the pyridine N
atom of the cofactor to stabilize the positive charge that forms during the catalytic cycle 23214

25.

The C3’ hydroxyl of PLP is involved in a hydrogen-bonding interaction with N160, which

also makes a hydrogen-bonding interaction with R352, an absolutely conserved residue in
the Type I aminotransferases. In the E. coli aspartate aminotransferase (EcAAT), for
example, the equivalent Arg residue (R386) interacts with the α-carboxylate group of the
substrate. Finally, the pyridine ring of PLP is clamped between F115 above and S190
below. Aminotransferases typically have an aromatic side chain packed against the “top”
surface of the PLP ring, though the residue below the ring is more typically an Ala.
While there are a number of similarities between the active sites of SwMppP and
EcAAT, there are a number of interesting differences that likely play a role in the divergent
activity of SwMppP. As mentioned above, the phosphate-binding site is anchored by Lys
instead of Arg, and whereas most ATases have 2-3 Ser/Thr residues binding the phosphate
group, and SwMppP has only one. One of the positions typically occupied by a Ser/Thr is
taken by D218 in SwMppP. The carboxylate group of D218 is within hydrogen bonding
distance of S190; this interaction is not observed in most other PLP-dependent enyzmes,
most of which have Ala in the position occupied by S190. In many ATases, such as EcAAT,
there is a Tyr residue that makes a hydrogen bond to the C3’ hydroxyl of PLP and affects
the electron distribution in the cofactor

26.

This residue is a Phe in SwMppP. The last

unusual feature of the SwMppP active site is H29. This position is not conserved in other
PLP-dependent enzymes, but is absolutely conserved among MppP homologs27. H29 is
adjacent to the catalytic K221 and makes hydrogen bonding interactions with D27 and,
perhaps, with the phosphate moiety of the cofactor. In two of the four molecules in the
asymmetric unit, H29 takes on at least two conformations.
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Figure 5-9: The active site of SwMppP. The stereoview of the SwMppP active site (A) shows the PLP
covalently bound to enzyme, forming internal aldimine. The 2|Fo| - |Fc| electron density map contoured at
1.0σ, is shown as magenta mesh, and the 2|Fo| - |Fc| composite omit map also contoured at 1.0σ, is shown as
green mesh. The schematic view of the active site (B) shows potential hydrogen bonding interactions as
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green, dashed lines. Water molecules are shown as blue spheres. The chloride ion is shown as a green sphere.
Panel A was generated using POVSCRIPT and POV-Ray. Panel B was created using a combination of
MarvinSketch (https://www.chemaxon.com) and Adobe Illustrator CS6.

5.3.5 The structure of the SwMppP•L-Arg complex
The structure of SwMppP•L-Arg was obtained by soaking SwMppP crystals in a solution
containing 10 mM L-Arg. Unlike the unliganded structure, where the N-terminus is
disordered and leaves the active site exposed to the solvent, in the structure with L-Arg
bound, the N-terminal extension orders and covers the active site (Figure 5-10).
Superimposition of the unliganded SwMppP and SwMppP•L-Arg structures gives a rootmean-square deviation of 0.356 for Cα atoms in the SwMppP dimer, indicating that, except
for the N-termini, there are no significant structural alterations as a result of ligand
binding. So unlike many ATases, there is no closing movement of the small domain.
Once the substrate binds in the active site, the α-amino group attacks C4’ of internal
aldimine to form the external aldimine, displacing K221. Compared with the unliganded
SwMppP, there are no significant changes in the active site, only a few subtle side chain
movements, as shown in Figure 5-11. The Cl- ion bound to R352 is replaced by the αcarboxylate of L-Arg. T12 and E15 in the N-terminal helix form hydrogen bonds with
guanidine group and carboxyl group of L-Arg, respectively. The guanidine group also forms
hydrogen bonds with N117, S91, and the carbonyl groups of S248 and D249 from the other
protomer. The side chains of H29, D27 and R31 are shifted towards the external aldimine.
The ring of F115 rotates away from the PLP ring and is closer to L-Arg.
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Figure 5-10: Ribbon representation of SwMppP (A) and SwMppPL-Arg (B) dimers. (A) Chain A is colored in
grey, chain B is colored in light green. The N termini of both chains are disordered. The L23 Ca atoms in both
chains are shown as blue spheres. (B) Chain A colored dark blue, chain B colored light green and the Nterminal helices colored purple. The PLP cofactors in the active sites are shown in stick. The N-terminal helix
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ordered and covers the active site. The K8 Ca atoms in two chains are shown as blue dots. (C) Overlaying the
active site of SwMppP and SwMppPL-Arg. The major change is the E15 and T12 interactions with L-Arg.
Also, the rings of F115 and F191Y shift.

Figure 5-11: The external aldimine structure in active site of SwMppPL-Arg. (A) SwMppPL-Arg active site
showing the L-Arg covalently bound to the PLP as the external aldimine. The 2|Fo| - |Fc| electron density map
contoured at 1.0σ, shown as magenta mesh, and the 2|Fo| - |Fc| composite omit map also contoured at 1.0σ, is
shown as green mesh. (B), Schematic view of the active site showing potential hydrogen bonding interactions
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as green, dashed lines. Water molecules are shown as blue spheres. Panel A was generated using POVSCRIPT
and POV-Ray. Panel B was created using a combination of MarvinSketch (https://www.chemaxon.com) and
Adobe Illustrator CS6.

5.3.6 Structures of SwMppP•product complexes
The structures of the SwMppP•2 complex (Figure 5-12) and the SwMppP•3 complex
(Figure 5-13) have no big difference on the guanidine is bound from SwMppP•L-Arg
structure, but the fact that the products are not external aldimine is a big difference. Also
there are several residues side chain movements (overlay results are shown in Appendix F
and Appendix G). S190 side chain shifted to hydrogen bond with D218. In the structure of
SwMppP•2, 4HKA hydroxyl group made hydrogen-bonding interactions with the
phosphate group and H29.
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Figure 5-12: The active site of SwMppP•2. (A) SwMppP•2 active site showing the PLP covalently bound to
the enzyme as the internal aldimine. E15 and T12 interact with 2 carboxylate group and guanidine group,
respectively. His29 bonds to hydroxyl group of 2. The 2|Fo|-|Fc| electron density map contoured at 1.0σ,
shown as magenta mesh, and the 2|Fo|-|Fc| composite omit map also contoured at 1.0σ, is shown as green
mesh. (B) Schematic view of the active site showing potential hydrogen bonding interactions as green, dashed
lines. Water molecules are shown as blue spheres. Panel A was generated using POVSCRIPT and POV-Ray.
Panel B was created using a combination of MarvinSketch (https://www.chemaxon.com) and Adobe
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Illustrator CS6.

Figure 5-13: The active site of SwMppP•3. (A) SwMppP•3 active site showing the PLP covalently bound to
the enzyme as the internal aldimine. E15 and T12 interact with 3 carboxylate group and guanidine group,
respectively. The 2|Fo|-|Fc| electron density map contoured at 1.0σ, shown as magenta mesh, and the 2|Fo||Fc| composite omit map also contoured at 1.0σ, is shown as green mesh. (B) Schematic view of the active site
showing potential hydrogen bonding interactions as green, dashed lines. Water molecules are shown as blue
spheres. Panel A was generated using POVSCRIPT and POV-Ray. Panel B was created using a combination of
MarvinSketch (https://www.chemaxon.com) and Adobe Illustrator CS6.
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5.3.7 Characterization of N-terminus and active site residues
The tertiary structure of SwMppP is very similar with type I aminotransferase, there are
several residues differences in the active site, which probably results in the hydroxylasedeaminase activity rather than aminotransferase. Bioinformatic analysis27 showed that
H29, F115, F191, and D218 are conserved in all of the MppP homologs but not in the Type I
aminotransferases. To explore the specific roles of these different residues, site-directed
mutagenesis was used to make point mutants that were characterized both structurally
and kinetically.

Figure 5-14: Different residues (colored in orange) in the active site of SwMppP•L-Arg. The 2|Fo| - |Fc|
electron density map contoured at 1.0σ, shown as magenta mesh, and the 2|Fo| - |Fc| composite omit map also
contoured at 1.0σ, is shown as green mesh.
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5.3.8 Characterization of SwMppP and mutants
5.3.8.1 Stability of SwMppP and mutants by differential scanning fluorimetry
The Tm value for each mutant is listed in Table 5-2. Except SwMppPF191Y, other mutants’
stability are same with that of wild-type SwMppP. The Tm value of SwMppPF191Y is so low
that only flat curve was got.
Table 5-2: Tm values of SwMppP and mutants

Proteins

Tm (oC)

SwMppP

53.3 ± 0.1

SwMppPE15A

55.75 ± 0.1

SwMppPE15Q

53.3 ± 0.1

SwMppPH29A

47.5 ± 0.1

SwMppPH29A

46.6 ± 0.1

SwMppPF115Y

51.4 ± 0.2

SwMppPF191Y

Not applicable

SwMppPD218S

50.0 ± 0.1

SwMppPΔ1-22

50.2 ± 0.1

5.3.8.2 Determination of the reaction products of the mutants
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To determine what reaction these mutants catalyzed, the 4.8 mL reaction contains ~65
μM mutants protein and 2 mM L-Arg in 20 mM sodium phosphate pH 8.4 buffer were
shaked at 25oC, 200 rpm overnight. Then the solutions were concentrated for 8 fold and
analyzed by proton NMR. The results are summarized in Table 5-3.
Table 5-3: The products of SwMppP and its mutants with L-Arg and O2
Products

[2]/[3]

SwMppP

2 and 3

1.7:1

SwMppPT12A

3

0:1

SwMppPE15A

3

0:1

SwMppPE15Q

2 and 3

1:2.4

SwMppPT12A/E15A

3

0:1

SwMppPH29A

3

0:1

SwMppPH29A

3

0:1

SwMppPF115Y

3

0:1

SwMppPF191Y

2 and 3

1.6:1

SwMppPD218S

Trace 3

-

SwMppPΔ1-22

Trace 3

-

SwMppP catalyzes the oxidation of L-Arg and O2 into 2 and 3 in the ratio of 1.7 : 1.
Except SwMppPF191Y and SwMppPE15Q, all mutants lost the hydroxylase activity. They only
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produce the side product 3. The products ratio of variant F191Y is 1.6 :1, which is same
with that of wild-type SwMppP. However, because the Tm of F191Y is low, the amounts of
substrate F191Y catalyzed are much less. Another mutant E15Q still have the hydroxylase
activity, although it does make less hydroxylated products (with the [2] : [3] at the ratio of
1 : 2.4). The substitution of same residue E15 into alanine lost the hydroxylase activity. To
figure out why the E15A variant lost the hydroxylase activity, I crystallized the E15A
proteins and soaked the crystals with 10 mM L-Arg to get the E15AL-Arg structure
(shown in Figure 5-15). In the structure of E15AL-Arg structure, L-Arg covalently bonds to
PLP, forming external aldimine. The N terminus still covers the active site when substrate
binds. And T12 residue interacts with the guanidine group of L-Arg. The main chain of A15
is same with that of E15 in wild type protein. But the shorter side chain of A15 probably
creates a void where water can be retained, and which could hydrolyze the quinonoid
intermediate prematurely.
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Figure 5-15: The active site of E15AL-Arg. The N terminus colored in purple. Chain A colored in blue, chain
B colored in light green. PLP-L-Arg is shown in golden stick. The 2|Fo| - |Fc| electron density map contoured at
1.0σ, shown as magenta mesh, and the 2|Fo| - |Fc| composite omit map also contoured at 1.0σ, is shown as
green mesh.

5.3.8.3 The steady state parameters monitored by O2 consumption
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SwMppP reacts with L-Arg and O2 forming 2 and 3. The catalytic parameters (KM, kcat)
of O2 usage were determined and are listed in Table 5-4.
Table 5-4: Steady state parameters monitored by O2 consumption
Proteins

KM,L-Arg (µM)

kcat (s-1)

kcat/KM (M-1 s-1)

SwMppP

26.5 ± 4.2

0.20 ± 0.006

7641.5 ± 1232.8

T12A

105.8 ± 12.1

0.05 ± 0.0016

483.2 ± 57.4

E15A

28.0 ± 4.0

0.24 ± 0.006

8424.4 ± 1212.7

E15Q

19.0 ± 3.5

0.24 ± 0.007

12538.3 ± 2340.2

T12A/E15A

74.5 ± 7.7

0.035 ± 0.002

465.2 ± 54.3

Δ1-22

234.8 ± 33.4

0.072 ± 0.002

306.0 ± 44.6

H29A

25.4 ± 5.6

0.11 ± 0.004

4472.9 ± 1003.2

H29S

16.9 ± 3.6

0.07 ± 0.003

4327.6 ± 931.3

F115Y

66.5 ± 4.8

0.20 ± 0.003

2940.3 ± 217.7

F191Y*

8.9 ± 2.4

0.05 ± 0.003

4983.2 ± 1349.4

D218S

353.2 ± 53.5

0.07 ± 0.003

183.5 ± 28.7

* means inaccurate data due to the instability of protein F191Y.

The KM of the T12A and T12A/E15A mutants were 3- to 5-fold higher than that of wild
type. The turnover numbers (kcat) of the two mutants were also lower than the wild type,
which makes the catalytic efficiency (kcat/KM) ~15-fold less than the wild type. In Figure 5228

16, the spectra of both the T12A and T12A/E15A variants exhibit a shift from the external
aldimine peak (435nm) back to the internal aldimine peak (415 nm) as the reaction goes.
The truncation mutant, however, showed an approximately 10-fold increase in KM and a 3fold decrease in kcat, which reduced the pseudo-second order rate constant by almost 25fold. The truncation mutant also produced only 2-ketoarginine. According to the spectrum
of SwMppPΔ1-22 with L-Arg and O2 (Figure 5-16), the external aldimine also shifts into
internal aldimine as the reaction goes. The mutants E15A and E15Q have no effect on KM,
kcat or catalytic efficiency. Interestingly, although the steady state kinetics (as measured by
dioxygen consumption) is indistinguishable for the E15A and E15Q variants, the E15A
variant does not produce 2, only the abortive product 3 based on the NMR results (Table 54).
Alteration of the N-terminus altered the ratios of products produced, but had no, or
only a modest effect on the steady state kinetics as monitored by dioxygen consumption.
However, as the spectra shown in Figure 5-16 demonstrate, the external aldimine peak
(435 nm) gradually shifted to internal aldimine peak (415 nm) as reaction went,
demonstrating that the N-terminal helix, especially T12, plays a key role in stabilizing the
external aldimine and Quinonoid intermediate.
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Figure 5-16: The spectrum (300 nm-600 nm) of SwMppP and its N terminus mutants with L-Arg. The insets
are the changes at 510 nm and 560 nm for each mutant. There are 3 major peaks (430 nm, 510 nm, 560 nm)
for wt SwMppP with L-Arg. The blue lines from lighter to darker represents the data collect from 1.4 s to 300
s. The insets also describe the trends of these mutants reactions in a timer order in comparison with wt
SwMppP. For the truncated N-terminal helix mutant SwMppPΔ1-22, the only peak (430 nm) shifted to 420 nm
as the reactions goes. For SwMppPE15A, there are only 2 peaks (430 nm, 510 nm). But for the mutant
SwMppPE15Q, there are three peaks (430 nm, 510 nm and small 560 nm).

230

In unliganded protein structure, H29 is close to the catalytic K221 and make hydrogen
bonding with D27. In the product 2 bound structure, H29 hydrogen bonds to the hydroxyl
group. To study the role of this special histidine residue, it was substituted into aliphatic
alanine and polar serine. The steady state parameters on O2 consumption are very similar
to wild type SwMppP (Table 5-4). The structures of H29A and H29S are both obtained. The
structures and spectra of both mutants are identical, so only the spectrum of H29A is
shown in Figure 5-17. Only the external aldimine and quinonoid I peak formed. No
absorbance at 560 nm was observed. In the first 20 s, the Quinonoid I intermediate
accumulated are more than wild type SwMppP (the inset in Figure 5-17A). However, the
Quinonoid I intermediate accumulation rate and final amounts of H29A/S are less than
those of wild type SwMppP. Overlaying the H29A structure with wild type SwMppP,
(Figure 5-17B), there is no difference on the active site residues. However, in the H29A
mutant active site, there are more water molecules around the PLP, which suggests that
H29, together with F115 and F191, may be involved in the water exclusion in the active
site. Given that H29 coordinates the hydroxyl group of 2 and the H29A/S mutants lose the
hydroxylase activity, H29 may also be involved in positioning a water molecule for
hydroxylation.
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Figure 5-17: (A) The spectrum of H29A with L-Arg. The 700μl solution containing 30 μM H29A proteins with
1.4 mM L-Arg were scanned on diode array spectrophotometer every second over 300 s. The blue color gets
darker as time goes. The inset is the 510nm 560 nm change comparison between SwMppP and H29A. (B)
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Superposition of the active sites of SwMppP (colored in grey) with H29A (dark blue). Water molecules all
from H29A are shown in blue sphere. Cl- ion in SwMppP is shown as cyan sphere. In the active site, the H29A
has more water molecules.

The structure of H29A with L-Arg was obtained by soaking 5 mM L-Arg. The
asymmetric unit contained four molecules that form two independent homodimers. Three
of the four chains have L-Arg bound forming external aldimine with PLP, while there is
nothing bound in the active site of chain D and PLP covalently bound to catalytic K221 that
forms internal aldimine. As mentioned above, there are more water molecules in the active
site of H29A mutant. When the substrate L-Arg bound into the active site, L-Arg covalently
bonds to PLP and excludes the water molecules. The water molecules in Figure 5-18A are
from H29A internal aldimine structure. The ring of F151 moves close to L-Arg and packed
with the Cα of L-Arg. The ring of F191 rotates about 90 degree and packed to the oxygen
atom of carboxylate group. Except these two residues, other residues in the active site are
same with apo enzyme SwMppP. Overlaying theH29AL-Arg structure with SwMppPLArg, the active site residues are exactly same (Figure 5-18B). However, the short side chain
of A29 cannot exclude the water molecules from the active site, so there are two water
molecules close to A29 that are not found in the structure of wild-type SwMppP with L-Arg
bound.
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Figure 5-18: (A) Overlaying the active site of H29A (chain A colored in blue) and H29AL-Arg (chain A
colored in grey). Both chain B colored in light green. Upon the substrate bound, N terminus cover the active
site. E15 and T12 interact with the carboxylate group and guanidinium group of L-Arg, respectively. The ring
of F115 and F191 moves closer to the L-Arg. (B) Overlaying the active site of SwMppPL-Arg (chain A colored
in blue) and H29AL-Arg (chain A colored in grey) demonstrates that there is no difference between them
except two more molecules in the active site due to the short side chain of A29. Both chain B colored in light
green.

F115 is another conserved residue in MppP homologs. To study the specific role of
F115 play in the mechanism, it was mutated into tyrosine. The KM of F115Y mutant were 3
folds higher than that of wild type SwMppP. The turnover numbers (kcat) of F115Y is same
with that of swMppP, which makes the catalytic specificity (kcat/KM) were ~3 fold less than
the wild type SwMppP protein. As time goes, the external aldimine peak shifted back to
internal aldimine peak (Figure 5-19A). The quinonoid I intermediate peak firstly
accumulated, then decayed gradually. These features suggest that mutated Y115 probably
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Figure 5-19: (A) The spectrum of F115Y with L-Arg. The 700μl solution containing 30 μM F115Y proteins
with 1.4 mM L-Arg were scanned on diode array spectrophotometer every second over 300 s. The blue color
gets darker as time goes. The inset is the 510nm 560 nm change comparison between SwMppP and F115Y.
(B) Superposition of the active sites of SwMppP (colored in grey) with F115Y (dark blue). Water molecules all
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from F115Y are shown in blue sphere. Cl- ion in SwMppP is shown as cyan sphere. In the active site, the
F115Y has more water molecules.

disrupts the stability of Quinonoid I and external aldimine, thus the equilibrium shifted into
internal aldimine. The quinonoid II intermediate did not accumulate. Overlaying the F115Y
structure with wild type SwMppP (Figure 5-19B), there are no differences in the active site
residues with the exception of H29. In the structure of SwMppPF115Y, H29 only adopts one
conformation. Water molecules align differently between the active site of chain A and
chain B. In chain B, one water molecule mediates the interaction between OH of mutated
Y115 side chain and NE2 of H29.
S190 and F191 are two adjacent conserved residues in MppP homologs. To study the
specific role of S190 and F191, they were mutated into alanine and tyrosine, respectively.
The purification of S190A failed because this mutant does not fold correctly and forms
inclusion bodies. The mutant F191Y is also not stable due to the low Tm value mentioned
above. The turnover numbers (kcat) of F115Y is much slower than that of SwMppP. The KM
of F191Y mutant were 3 folds lower than that of wild type SwMppP. which makes the
catalytic specificity (kcat/KM) were ~2 fold less than the wild type SwMppP protein. These
parameters are based on the enzyme concentration, but the accurate concentration of
active F191Y enzyme in the solution is unknown due to the instability property. The F191Y
mutant is not stable, so I did not get the protein crystallized. As shown in Figure 5-20, there
are four small peaks (358 nm, 430 nm, 510 nm, 560 nm) formed in the reaction of F191Y
with L-Arg. The Quinonoid I intermediates accumulate much less than that in SwMppP,
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while the Quinonoid II intermediates accumulates much more than that in SwMppP (Figure
5-20 inset). The peak with maximum absorbance at ~358 nm probably corresponds to
ketimine intermediate that forms in aminotransferase (Figure 4-5). This peak first
accumulated and then decreased as time goes. The position of F191 is usually tyrosine in
aminotransferase (Figure 4-7C). These facts suggest that F191 is probably involved in
exclusion of water close to C5. Substitution of F191 into tyrosine, the water may exist close
to C5 and results in the ketimine intermediates formation.

Figure 5-20: The spectrum of F191Y with L-Arg. F191Y enzyme (30 μM) was mixed with 1.4 mM L-Arg and
recorded every second in 300s. There are 4 small peaks (358 nm, 430 nm, 510 nm, 560 nm) formed. Based on
the thermo-Fluor assay results, F191Y mutant is not stable, which probably resulted in the small peaks.
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Figure 5-21: The spectrum of D218S with L-Arg. D218S enzyme (30 μM) was mixed with 1.4 mM L-Arg
and recorded every second in 300s. There are 3 peaks (344 nm, 430 nm, 510 nm). The inset is the 510 nm
and 560 nm comparison with wild type SwMppP.

In the PLP bound internal aldimine structure of SwMppP, D218 hydrogen bonding to
the OH of S190, C5 of PLP and the main chain amine of T219 and G220. In the substrate
bound external aldimine structure, D218 also interacts with the free K221. The SwMppP
protein is yellow with PLP bound. However, the color of mutant D218S is less yellow even
they are stored in the same buffer. The structure of D218S with poor electron density map
showed that there is no PLP in the active site. The crystallization condition needs to be
optimized for better diffraction. The spectrum of D218S demonstrates that there are three
peaks (maximum absorbance at 340 nm, 430 nm and 510 nm) formed. As shown in the
238

inset in Figure 5-21, the external aldimine and Quinonoid I peaks decrease as time goes,
while the peak with maximum absorbance at 340 nm keeps increase. This peak range from
310 nm to 370 nm may be pyridoxamine phosphate (PMP) or ketimine. Given that no PLP
bound in the D218S active site and little products formed by NMR, the peak probably
represents PMP (or both by hydrolyzing ketamine into PMP). If PMP cannot be hydrolyzed
into PLP and form internal aldimine with K221, the PMP may dissociate out of the active
site. So the D218 probably participates in PMP hydrolysis or internal aldimine formation.

5.3.9 Full oxidation of L-Arg requires two equivalents of O2
The stoichiometry of O2 consumed and L-Arg added was explored by O2 electrode
(Table 5-5). For wild type SwMppP producing 2 and 3 in the ratio of 1.7:1, the ratio of [O2]
consumed to [L-Arg added] is 1.4:1. The variant E15A, which only produces one product 3,
only needs 1 equivalent of O2. But for E15D that producing both products, the ratio of [O2]
consumed to [L-Arg added] is >1, suggesting that the 2 branch requires more than one
(probably two) equivalent of O2 and the 3 branch only needs one. The ratios for mutants
T12A, T12A/E15A and SwMppPΔ1-22 were lower than 1:1, which was probably due to the
lower catalytic efficiency as shown in Table 5-4.
For wt SwMppP, E15Q and F191Y, producing both products, the ratio is > 1:1. And for
those mutants only forming keto-Arg as the product, the ratio is ≤ 1:1. Because both 3 and
2 are the products of SwMppP with L-Arg and O2, we assumed that 3 pathway only
consumed one equivalent of O2 and 2 pathway consumed two equivalents of O2.
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Table 5-5: The ratio of [O2 consumption]/[L-Arg added] of SwMppP and its mutants reactions

[L-Arg]/μM

SwMppP T12A

E15A

E15Q

T12A/E15A H29A

25

1.40:1

0.64:1

1.05:1

1.44:1 0.76:1

50

1.43:1

0.54:1

0.95:1

1.28:1 0.65:1

H29S

F115Y F191Y D218S

SwMppPΔ1-22

0.70:1 0.84:1

0.85:1

1.54:1

0.61:1

0.77:1 0.82:1

0.77:1

1.38:1

little
0.45:1
activity
100

1.38:1

0.59:1

0.95:1

1.29:1 0.72:1

0.81:1 0.80:1
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0.80:1

1.37:1

0.47:1

5.3.10 Substrate specificity
Reacting with L-Arg and O2 showed the Cγ-hydroxylation activity of SwMppP27. To
check if the L-Arginine precursors L-ornithine and L-citrulline are the possible substrates,
the hydroxylation reaction was determined by spectrometric scan of the intermediates and
MS analysis of the products. No intermediate peak formed by spectroscopy (Figure 5-22),
even the external aldimine peak. As shown in Figure 6A, when SwMppP reacted with Lornithine, the broad internal aldimine peak became smaller and a new peak at ~320 nm
showed up. When SwMppP reacts with L-citrulline, the broad internal aldimine peak got
smaller and red shifted (~425 nm to ~410 nm) as shown in Figure 5-22B. To detect the
substrate specificity in more detail, the reactions of SwMppP with L-Arg derivatives Lcanavanine, methyl-L-arginine and D-arginine were also determined (Figure 5-22). Upon
D-Arg addition, the external aldimine formed and gradually shifted back holoenzyme
(internal aldimine). There is no intermediate and product formed by NMR and MS (data not
shown). The inhibitory constant (Ki) of D-arginine is 325 μM by monitoring the
fluorescence signal at 415 nm on stop-flow. But for the L-canavanine reaction, the
intermediate quinonoid I, which has maximum absorbance at 510 nm, accumulated when
O2 was used up in the cuvette. And there is one species formed at ~370 nm and decayed
when another species formed which have broad absorbance around 330 nm. After several
hours, the quinonoid I intermediate peak disappeared and two broad peaks at ~330 nm
and ~425 nm still exist. For the reaction of SwMppP with methyl-L-arginine, quinonoid I
peak quickly accumulated and gradually decreased. The NMR results showed that only
keto-methyl-L-arginine formed. SwMppP did not catalyze the hydroxylation of methyl-Larginine. Apparently, SwMppP exhibits very strong substrate specificity for hydroxylation.
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Figure 5-22: The spectrum of SwMppP with L-arginine (A), L-ornithine (B), L-citrulline (C), L-canavanine (D),
methyl-L-arginine (E) and D-arginine (F). The spectrum of enzyme only was shown as dash line. After
compounds addtion, the spectrum was recorded (from light grey to black).
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5.3.11 The structure of SwMppP with D-Arg
As shown in Figure 5-22F, D-Arg is not the substrate of SwMppP, but it can bind to PLP
forming external aldimine (peak shiftment from internal aldimine to external aldimine).
Based on this, SwMppP crystals were soaked in 35 mM D-Arg to obtain the SwMppPD-Arg
external aldimine structure (Figure 5-23). The active site explains why D-Arg is not a
substrate: the α-proton points toward the bulk solvent and away from any suitable general
base catalyst (probably K221). Except the aldimine covalent bond, the carboxyl group of DArg forms salt bridges with R352 (Figure 5-23B). The guanidine group interacts with D27
and D227 and located in the position of N-terminal helix lid, which disrupts the N terminus
covering the active site. Hence, unlike the L-Arg binding, N terminus disorders in the
structure of SwMppP•D-Arg. Comparison of the SwMppP•L-Arg (Figure 5-11) and
SwMppP•D-Arg (Figure 5-23), there are less interactions from the other chain in
SwMppP•D-Arg. Because the side chain of L-Arg well aligned in the active site, the S248*
and D249* from the other chain interacts with the guanidinium group of L-Arg. And the S91
also interacts with the guanidinium group. However, the side chain of D-Arg points away
from the active site, so it loses these interactions.
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Figure 5-23: The active site of SwMppP•D-Arg. (A) SwMppP•D-Arg active site showing the PLP covalently
bound to the enzyme as the internal aldimine. The 2|Fo| - |Fc| electron density map contoured at 1.0σ, shown
as magenta mesh, and the 2|Fo| - |Fc| composite omit map also contoured at 1.0σ, is shown as green mesh. (B)
Schematic view of the active site showing potential hydrogen bonding interactions as green, dashed lines.
Water molecules are shown as blue spheres. Panel A was generated using POVSCRIPT and POV-Ray. Panel B
was created using a combination of MarvinSketch (https://www.chemaxon.com) and Adobe Illustrator CS6.
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D-Arg, as a competitive inhibitor, forms external aldimine with PLP in SwMppP active
site. The dissociation constant of D-Arg (Ki) is determined by both O2 probe assay and
fluorescence change at 415 nm on stop flow. For O2 probe assay, 10 μM SwMppP firstly
incubated with 0 μM, 250 μM, 500 μM, 1 mM, 2.5 mM, 5 mM and 10 mM D-Arg in 50 mM
BisTris propane pH 9.0 buffer for 5 min. For each data set (e.g 10 μM SwMppP with 250 μM
D-Arg), a series of L-Arg were added and the O2 consumption rate was determined. The
result is shown in Figure 5-24. Each data set of rate vs L-Arg concentrations was fitted into
Equation 2. Reciprocal plot of resulting vmax and L-Arg concentration gives a series of linear
plot at different D-Arg concentrations. The slope is KM/vmax(1+[D-Arg]/Ki), and the
intercept is 1/vmax. Linearly fitting the slope vs [D-Arg] data gives Ki of 253.4 μM.
.

Figure 5-24: The D-Arg dissociation constant (Ki) determination. (A) The reciprocal plot of Vmax and L-Arg
concentration gives a series of linear plot at different D-Arg concentrations. represents 0 μM D-Arg.
represents 250 μM D-Arg.
Arg.

represents 500 μM D-Arg.

represents 5000 μM D-Arg,

represents 1000 μM D-Arg. represents 2500 μM D-

represents 10000 μM D-Arg. (B) The slope from (A) was plotted versus

D-Arg concentration and the data is fitted linearly. The absolute x-intercept is the Ki (253.4 μM).
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Fluorescence titration experiments were conducted to measure the kinetics of external
aldimine formation step with D-Arg. SwMppP (10 µM after mixing) was mixed with
different concentrations of D-Arg (40 μM, 80 μM, 160 μM, 320 μM, 640 μM and 1280 μM)
and the total fluorescence was measured with excitation at 415 nm. The results are shown
in Figure 5-25. The fluorescence data of SwMppP with different concentrations of D-Arg
only have one phase and were fitted into Equation 3. The dependence of kobs were fitted
into Equation 4 and gave Kd,app of 329.3 μM.
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Figure 5-25: Dissociation constant (Ki) determination of D-Arg into SwMppP by fluorescence determination
excited at 415 nm. (A) Fluorescence signal fitting by first exponential. . represents 40 μM D-Arg. represents
80 μM D-Arg.

represents 160 μM D-Arg.

represents 320 μM D-Arg.

represents 640 μM D-Arg.

represents 1280 μM D-Arg. (B) The plot of kobs from data (A) versus D-Arg concentration gives the Kd,app value
of 329.3 μM.
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5.3.12 Proposed mechanism of SwMppP
Based on all structural and kinetics studies shown above, we proposed the mechanism
of SwMppP with L-Arg and O2 (Scheme 5-2). Upon L-Arg binding, it attacks the internal
aldimine, forming external aldimine. The free Lys221 on the enzyme would abstract the α
proton, resulting in the formation of the Q1 intermediate, which has maximum absorption
at 510 nm. Residues that differentiate the MppP active site from those of
aminotransferases, like D218 and H29, likely play roles in stabilizing the electron-rich
intermediate Q1. In the presence of O2, one of the β protons is attacked by superoxide
anion. After rearrangement, quinonoid 2 likely forms and it is at this point that Q2 can
break down to release H2O2 and 3, or Q2 could react with dioxygen to give 2 and a second
molecule of hydrogen peroxide. The PLP is regenerated by hydrolysis of PMP with the
release of ammonia. It is also a possibility that the product is released as the imine,
recycling PLP directly. Subsequent non-enzymatic hydrolysis of the imine would yield 2
and ammonia.
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Scheme 5-2: Proposed mechanism of SwMppP.

5.3.13 Presteady state kinetics of SwMppP
Changes at the PLP center upon binding of L-Arg were monitored using stopped flow
spectroscopy under anaerobic conditions, and exciting the internal aldimine at 415 nm.
When the enzyme (10 µM after mixing) is mixed with various concentrations of L-Arg in
the absence of dioxygen, there is a biphasic decay of fluorescence (Figure 5-26A), indicating
that there are at least two steps occuring. The external aldimine absorbs UV light at 425430 nm, rather than 415 nm, so the first phase likely corresponds to rapid binding of L-Arg
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and conversion to the external aldimine. Since there is no dioxygen in the reaction, the
second phase, must be due to the conversion of the external aldimine to the fist quinonoid
intermediate (Q1). Put another way, the internal aldimine, which has its absorbance
maximum at 415 nm, fluoresces strongly, as would the non-covalent enzyme-arginine
complex. The first phase in the observed loss of fluorescence is due to the conversion of the
internal aldimine to the external aldimine, which has a slightly longer wavelength
absorbance and therefore gives rise to a lower fluorescence signal when excited at 415 nm.
The second phase is due to conversion from the external aldimine to a quinonoid
intermediate, which absorbs at 510 nm and would therefore not fluoresce when excited at
415 nm.
This identification of the second phase in the fluorescence data is confirmed by
monitoring the increase in absorbance at 510 nm (Figure 5-26B). In this experiment, the
increase in absorbance is due to the accumulation of the first quinonoid intermediate (Q1)
in the absence of dioxygen. This proves two things: first that the electron-rich quinonoid
species is the form of the enzyme that reacts with dioxygen. Second, that the enzyme
stabilizes the quinonoid intermediate to an unusual degree. Quinonoids are not unusual in
PLP-dependent enzymes, but one that persists for the length of time observed with
SwMppP is unprecedented. Comparing the timing of the second decay phase in the
fluorescence data (Figure 5-26A) with the appearance of Q1 at 510 nm (Figure 5-26B), it is
clear that these two signals represent the same event, that is, the appearance of the first
quinonoid intermediate. The lag phase in the beginning of the experiment in Figure 5-26B
corresponds to the substrate binging step and conversion to the external aldimine.
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Figure 5-26: Global fitting of pre-steady state kinetics data in KinTek Explorer. (A) The change in
fluorescence upon mixing 20 µM anaerobic SwMppP with various concentrations of anaerobic L-Arg (20
[red], 40 [green], 80 [blue], 160 [yellow], 320 [cyan], and 640 µM [purple]). (B) The same reaction conditions
as in A, but monitoring absorbance at 510 nm. (C) Double mixing experiments where anaerobic SwMppP (40
µM) was mixed with 1280 µM anaerobic L-Arg and aged for 10 s before mixing with buffer containing various
concentrations of dioxygen (81 [red], 160 [green], 250 [blue], 375 [yellow], and 519 µM [cyan]). The loss of
absorbance at 510 nm due to the first quinonoid intermediate was monitored. (D) Double mixing
experiments where anaerobic SwMppP (40 µM) was mixed with 1280 µM anaerobic L-Arg and aged for 10 s
before mixing with buffer containing various concentrations of dioxygen (20 [red], 42.5 [green], 78 [blue],
158 [yellow], 296 [cyan] and 465 µM [purple]). The absorbance at 560 nm was monitored. In all panels, the
black lines show the results of the fitting by simulation based in the model in Figure 5-27. The grey shading
beneath the fits show the fit through the entire ranges of all parameters derived from the fitting.
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In order to examine the later, oxygen-dependent steps in the reaction, we employed
double mixing stopped flow experiments where anaerobic SwMppP was mixed with
anaerobic L-Arg and aged for 10 s to allow the first quinonoid intermediate to accumulate.
The second mixing step introduced buffer with varying concentrations of oxygen to the
pre-formed Q1 intermediate. The data in Figure 5-26C show that there is a monophasic
decrease in the absorbance at 510 nm as Q1 reacts with dioxygen. The rate of the reaction
with dioxygen does not appear to saturate, but increases with the concentration of
dioxygen. The lack of saturation indicates that there is no defined binding site for dioxygen
and the rate is governed by the frequency with which dioxygen encounters the quinonoid
intermediate.
A peak was observed at 560 nm in earlier UV-vis spectroscopy experiments. This peak
is likely due to a second quinonoid intermediate, Q2, having more extended conjugation
(i.e. an additional double bond compared with Q1). The rates of formation and decay of this
intermediate were probed using the same double mixing experiment described above
(with slightly different dioxygen concentrations) and monitored at 560 nm (Figure 5-26D).
That this second quinonoid evolves from Q1 is established by the fact that Q2 only
accumulates after Q1 decays, as can be seen by comparing the times in Figures 5-26C and
D. The dependence on the accumulation of Q2 on the concentration of dioxygen is
counterintuitive; it accumulates most in the reactions with the least dioxygen.

This

behavior is most likely due to the “2-ketoarginine branch.” Including this uncoupled
product in the model for global fitting by simulation was the only way to reproduce this
pattern in the simulated data.
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Figure 5-27: The model used for global fitting by simulation in KinTek Explorer. The rate constants for each
step are given as the boundaries identified by the FitSpace routine in KinTek Explorer. The green rate
constant estimates are well constrained by the data. Those in orange range somewhat widely, and those in
red have only an upper or lower limitdefined and were fixed at those limits. Steps with unidirectional arrows
had the corresponding reverse rates fixed at zero in the simulation.

Owing largely to the pseudo-first order conditions used in these experiments, much of
these data, particularly those monitoring Q2 (Figure 5-26D) were difficult, if not
impossible, to fit well by traditional non-linear least squares fitting. The multiple up and
down phases in Figure 5-26D make it impossible to know the amplitudes of each phase
with certainty. On top of this, the complicated mechanism (e.g. Figure 5-27), makes it
difficult to assign the various kmax or Keq terms that would be obtained from secondary plots
of kobs vs concentration to specific steps in the mechanism. For these reasons, all of the data
were fit simultaneously in KinTek Explorer35-37. In this program, one defines a model for
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the reaction, and the software derives all of the differential equations required to calculate
the concentrations of all reactants, products, and intermediates over the timecourses of the
experiments. The FitSpace routine within KinTek explorer is used to validate the resulting
models by calculating “confidence contours” for each parameter estimated from the fitting.
This analysis defines the range of values for each parameter that would result in essentially
the same fit. Thus, the tighter the FitSpace boundaries, the better determined the
parameter. KinTek Explorer was used to build a model of the SwMppP reaction (Figure 527). The experiments described above adequately defined rate constants for most of the
steps in this very complicated model. Key points of the mechanism that were only clarified
by the global fitting analysis include the suggestion that the “2-ketoarginine branch” occurs
at the second quinonoid intermediate and that the intersystem crossing step presumed in
the proposed mechanism (Scheme 5-2) is fast enough that it appears to be a single step in
the modelling. Changing either point in the model—placing the branch at E4/5 or breaking
E4/5 into two separate steps (e.g. E4 = E5) resulted in a significant degradation of the
fitting results. The other interesting conclusion that resulted from the fitting is the
possibility of a slow isomerization step (e.g. Ei = E). Inclusion of this pre-equilibration was
the only parameterization of the model that reproduced the slow up-phase in the
accumulation of Q1 (Figure 5-26B). This is a plausible addition to the model, since the
enzyme is essentially inactive in the storage buffer (10 mM MES pH 6.7) and active, but
minimally stable in the reaction buffer (100 mM BIS-TRIS pH 9.0). It is conceivable that the
activation may not be instantaneous upon the shift to pH 9.0.
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Figure 5-28: Accumulation of the fully oxidized 4-hydroxy-2-ketoarginine (red) and the uncoupled 2ketoarginine (green) products based on the global fitting by simulation. The grey swathes represent the
range of values consistent with the model. The ~2:1 ratio predicted by the proposed mechanism and
associated model is not far from the ~1.7:1 ratio observed experimentally. Note that in the simulation, the
dioxygen concentration was not replenished, as it was by stirring in the actual experiments.

5.3.14 Preliminary pre-steady state kinetics analysis of SwMppPH29A
As shown in Figure 5-29, the kinetics of the H29A mutant of SwMppP are significantly
altered from the wild-type enzyme (compare Figure 5-29A (wild-type) and B (H29A)).
Qualitatively speaking, the first phase observed in the fluorescence experiments (exciting
the internal aldimine) do not appear to be changed much from the wild-type. This suggests
that H29 does not have a central role in substrate binding and/or attack on the internal
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aldimine to form the external aldimine. Both the second phase of the fluorescence change
and the increase in absorbance at 510 nm due to formation of the first quinonoid
intermediate have much lower amplitudes than observed in the wild-type. This indicates a
likely role for H29 in promoting the conversion of the external aldimine to Q1.

Figure 5-29: Comparison of fluorescence (λex=415 nm) and absorbance (510 nm) of wild-type SwMppP
(A) and the H29A mutant (B) reacting with L-Arg (10, 25, 50, 125, 250, 500, 1000 μM for WT or 25, 50,
100, 150, 200, 400, 600, 800, 1200 μM for H29A). The fluorescence traces in both panels are shown in a
gradient from pink (low [Arg] to purple [high [Arg]. Likewise, the absorbance data are shown as a
gradient from light blue (low [Arg]) to dark blue (high [Arg]).
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5.3.15 Preliminary pre-steady state kinetics analysis of SwMppPΔ1-22
The changes in total fluorescence (λex = 415 nm) upon mixing SwMppPΔ1-22 (10 μM
after mixing) with concentrations of L-Arg ranging from 25 to 1200 μM are shown in Figure
5-30. The amplitudes of the transients observed are smaller than those seen with either the
wild-type or H29A mutant. These data did not fit well to simple exponential equations, and
were instead fit globally in KinTek Explorer using the first 3 steps of the new model
mentioned above as the model. However, the data was still fitted well. So we need to do
more studies to optimize the experiments in the future.

Figure 5-30: Fluorescence excited at 415 nm of SwMppPΔ1-22 with L-Arg substrate under anaerobic condition.
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The fluorescence data (dots) of SwMppPΔ1-22 (10 μM) versus different L-Arg concentrations ( 25, 50, 75,
100, 150, 200, 400, 600, 800 and 1200 μM) was fitted globally (lines with different colors) to the
same model mentioned above.

5.3.16 Independent binding between two binding sites of SwMppP
The structures of SwMppP or mutant H29A/S with L-Arg shows two different states in
the two binding sites within one dimer. For example, in the two active sites of SwMppPLArg, chain A has the L-Arg bound to PLP while chain B has the product 2 bound. Some
structures have 3 bound and internal aldimine state in chain A and chain B, respectively. In
the structure of H29AL-Arg, chain A has L-Arg bound but chain B has PLP covalently
bound to catalytic lysine. So to check if the two binding sites within one dimer are
independent or not, ITC and fluorescence experiment that monitoring the internal aldimine
decay was determined. SwMppP would form Quinonoid I eventually under anaerobic
condition, which make the data harder to analyze. D188 hydrogen bonds to the NH of PLP
ring, which is important for Quinonoid I formation. After mutated D188 into alanine, the
variant D188A reacts with L-Arg to form external aldimine. So this mutant was used to
study the dependence binding of two binding sites.
ITC is a physical technique that works by determining the heat released or absorbed
during a binding event. Before the experiment, the system is chemically calibrated. The
sample cell containing 300 μl of 90 μM dialyzed, degassed SwMppPD188A protein in 15 mM
MES pH 6.7 buffer was incremental titrated with 2.5 μl of 800 μM L-Arg in the same buffer
each titration. After load both sample cell and the burret with L-Arg, the system would keep
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equilibrate the system with stirrer on, which usually takes 1.5 h to get acceptable heat
change deviation. And the later titration experiment takes about 1 hour. The titration heat
rate curve has a shifted baseline due to the instability of D188A protein. After continuous
agitating for 2.5 h, the protein D188A precipitated and the baseline shifted upwards. I tried
to decrease the temperature to 4 oC, the baseline is almost flat but periodic noise peak
show up at this low temperature. Then I tried 10 oC, 12 oC and 18 oC, they all have shifted
baseline. After many attempts, the ITC results are not satisfactory. So fluorescence
experiments with short time and gentle treatment was used to monitor the internal
aldimine decay and determine the binding relationship. The reaction containing 1.5 mL of
SwMppPD188A (14 μM) and equal volume of different concentrations of L-Arg (0 - 2560 μM)
in 100 mM BisTris propane buffer was incubated for 8 min before excitation at 415 nm. As
shown in Figure 5-31A, there are two species changing during the experiment. As substrate
concentration increases, the peak with maximum absorbance at 480 nm decreased, while
the peak with maximum absorbance at 542 nm increased. Hence, the species that
emissions maximally at 480 nm corresponds to internal aldimine, and the species that
emissions maximally at 542 nm corresponds to external aldimine. According to the data,
SwMppPD188A is almost saturated with 1280 μM L-Arg. Both 480 nm and 542 nm delta
fluorescence data are not fitted into Hill equation, which suggested independence binding
between two binding sites. The plot of calculated [D188AL-Arg] complex versus [L-Arg] at
480 nm was fitted to Equation 4 and the Kd for internal aldimine decay is 92.8 μM (Figure
5-31B).
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Figure 5-31: (A) Fluorescence change of SwMppPD188A with different concetrations of L-Arg (0, 5, 10, 20, 40,
80, 160, 320, 640, 1280 and 2560 μM). There are two major peaks changing as the substrate concentration
increases. The peak with maximum absorbance at ~480 nm decreased as [L-Arg] increases, which suggests
this species is internal aldimine. The other peak with maximum absorbance at ~542 nm corresponds to
external aldimine increases as substrate increases. (B) The fitting data of enzyme and L-Arg complex versus
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[L-Arg] at 480 nm was fitted hyperbolically, rather than Hill plot. The inset is the zoomed initial data points
and fitting. The data fits hyperbola pretty well, rather than a sigmoid curve.

5.4 Discussion
The nonproteinogenic amino acid L-enduracididine is a critical component of the
mannopeptimycins, a family of cyclic glycopeptide antibiotics with potent activities against
drug-resistant pathogens like MRSA. Creating derivatives of mannopeptimycin and other LEnd-containing natural products is hampered by the limited availability of L-End. We are
investigating the L-End biosynthetic pathway in order to develop an efficient enzymatic or
chemo-enzymatic route to produce this unusual amino acid. Recently, we found that MppP
is a PLP-dependent L-Arg oxidase in L-End biosynthesis in S. wadayamensis, and not an
aminotranferase as the sequence suggested. The quaternary structure of SwMppP is very
similar to the Fold Type I aminotransferases. The major difference is the N-terminus. For
type I aminotransferases, the N-terminal helix interacts with the small domain of the other
chain, and the small domain shifts towards the large domain forming a “closed”
conformation when the substrate binds20,

28, 29.

However, SwMppP mainly exists as

homodimer with the active site exposed to the solvent in the unliganded state; the Nterminus is disordered. The fluorescence data of SwMppP

D188A

with L-Arg demonstrated

that the two active sites within the SwMppP dimer are independent; there is no evidence of
half-sites reactivity or cooperativity. Upon substrate binding, the N-terminus orders to
form an α-helix that covers the active site and interacts with L-Arg. In addition, there is no
movement of the small domain, as is often, though no always, observed in
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aminotransferases. The PLP-dependent cystathionase MalY from E. coli (PDB entry:
1D2F30) and a number of aminotransferases (e.g. PDB entry 4DQ6 and 3DZZ) have a high
degree of structural similarity with SwMppP. Overlaying the SwMppP structure with these
demonstrates that the small domain of SwMppP is closer to the large domain, and that the
small domain and large domain arrangement of unliganded SwMppP is more like the
“closed” conformation of the aminotransferases.
In E. coli aspartate aminotransferase, the inward movements of the small domain create
steric clashes between G38 and Y225, which results in a lower pKa of the aldimine and
enhanced catalysis28. The lower imine pKa of the internal aldimine is mainly due to the 90°
torsion angle of the C3-C4-C4’-Nζ bond and the repulsive interactions between G38 and
Y22528, 31. However, the corresponding torsion angle of SwMppP is ~9°. And SwMppP has a
higher catalysic activity at higher pH27, which suggests a pronated internal aldimine form in
SwMppP.
SwMppP reacts with L-Arg and dioxygen to yield two products, 2 and 3 in a ratio of
~1.7:1. Compound 2 is the products that can be cyclized by MppR (Figure 4-4B).
Compound 3 is the result of uncoupled turnover. L-Arg is an important amino acid, which is
involved in many pathways and serves as a carbon and nitrogen source32. MppQ has been
shown to catalyze the transamination of 3 back to L-Arg (unpublished data), which brings
the deadend product 3 back into the metabolite pool of the cell.
Two N-terminal residues, T12 and E15, interact with L-Arg in the active site. To
understand what roles these two residues and the N terminus play, we made mutations of
these two residues as well as truncation on the N terminus (Δ1-22 aa). The N-terminal
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variants T12A, E15A, T12A/E15A and SwMppPΔ1-22 only produce 3, which indicates that
the N-terminal helix is essential for hydroxylation. In addition, T12A, T12A/E15A and
SwMppPΔ1-22 have lower catalytic efficiency. As the spectra shown in Figure 5-16 indicate,
the external aldimine peak (435 nm) gradually shifts back to the internal aldimine peak
(415 nm) during the reaction, suggesting that the N-terminal helix, especially T12, plays a
key role in stabilizing external aldimine. The mutant E15A has similar KM and kcat values
with wild type SwMppP but is deficient in the hydroxylase activity. In the structure of
E15A•L-Arg, the N terminus also orders and covers the active site. T12 in N terminus still
interacts with the guanidine group of L-Arg. But the short side chain of Ala15 creates a
void that is filled by water, which probably disrupts the hydroxylation pathway. E15Q
variant still produced the mixture of 2 and 3, although it does make less of the
hydroxylated product. Hence, the N terminus interaction is crucial for the stability of
external aldimine and later hydroxylation activity.
The reaction of SwMppP with L-Arg and O2 forms two quinonoid intermediates (Q1 at
510 nm and Q2 at 560 nm). Under anaerobic conditions, the accumulated Quinonoid I is
very stable, which suggests this carbanion is stabilized by SwMppP to some extent. When
the O2 is present, Quinonoid I quickly reacts with O2, which is similar to the PLP-dependent
DOPA/aromatic L-amino acid decarboxylases33. When the substrate covalently bonds to
PLP, the free catalytic K221 forms a hydrogen bonding interaction or salt bridge with D218,
which is similar in DOPA/aromatic L-amino acid decarboxylases (PDB ID 1JS334). To study
the role of this residue, D218 was substituted with Ser. There is a peak at ~430 nm in the
reaction of the D218S mutant withL-Arg that is most likely due to either PMP or a ketamine
intermediate that results from deprotonation of the quinonoid by K221. In addition, there
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is no PLP in the structure of the D218S mutant. These results suggest that D218 either
participates in the PMP hydrolysis or helps to stabilize the quinonoid intermediate by
preventing K221 from readily deprotonating the Q1 intermediate. In the structures of
H29A, F115Y and H29A•L-Arg, there are more water molecules in the active sitethat are
not seen in the wild-type structure. In the reaction of F191Y with L-Arg, there is a ketimine
intermediate formed. The ketimine formation needs a water or K221 to provide H to the
imine. In conclusion, the water molecule is an important factor to regulate the product
pathway. In addition, E15, H29, F115 and F191 are all involved in water exclusion. In
SwMppP with L-Arg spectrum, Q2 first accumulates and then quickly decays. But according
to the spectrum of F191Y with L-Arg, Q2 persists, which suggests that F191 is also involved
in the reaction of Q2 with O2.
According to the spectra of all proteins mentioned above, Q2 only accumulates in the
enzymes producing both products. For those mutants producing 3 only, no Q2 intermediate
peak was observed. These facts suggest that Q2 formation belongs to the hydroxylation
pathway. Pre-steady state data of Quinonoid I decay and Quinonoid 2 formation shows that
Quinonoid 2 only forms after Quinonoid I decay.
The portion of O2 consumed to form H2O2 was determined by adding catalase after the
reaction attained equilibration. Catalase catalyzes 2 moles of H2O2 into 1 mole of O2, and
the ratio of O2 consumed over O2 regenerated is 2:1, which indicated that each equivalent
of O2 consumed is converted to 1 equivalent of H2O2. In addition, the products mass of
SwMppP with L-Arg and O2 conducted in H218O demonstrates that the hydroxyl O atom of 2
comes from water. So SwMppP is an oxidase.
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The mutant E15A, producing 3 only, has similar catalytic efficiency with wild type. The
ratio of [O2 consumed] over [L-Arg added] for variant SwMppP E15A that produces 3 only is
1:1, which suggested that 3 formation only requires one equivalent of O2. For the other
mutants (T12A, T12A/E15A, SwMppPΔ1-22, H29A/S and F115Y) that producing 3 only, the
ratios of [O2 consumed] over [L-Arg added] are smaller than 1. The ratio is based on the
amounts of L-Arg added, not L-Arg consumed, so the mutants with lower catalytic
efficiency would give a smaller ratio. The ratios of [O2 consumed] over [L-Arg added] of
wild type SwMppP, E15Q and F191Y, producing both 3 and 2, is 1.4:1, which suggested that
2 formation requires 2 equivalents of O2.
The structural and kinetic characterization of the wild-type and several variants of
SwMppP allowed us to propose a model where the oxygen atom incorporated in the 2
product is derived from water rather than from dioxygen. And 2 formation requires 2
equivalents of O2, while the abortive product, 3, requires only 1 equivalent.
As described above, SwMppP catalyzes the Cγ-hydroxylation of a non-activated
methylene moiety on L-Arg with very high stereospecificity. The stereochemistry of the Cα
atom is crucial for the reaction. The α proton of D-arginine is located opposite to the
general base catalyst for the Q1 intermediate formation27, and the external aldimine
conformation is not stabilized by the interactions in the active site. Hence, the external
aldimine gradually shifted into internal aldimine by the K221 attack. In addition, the
position of the guanidinium group is essential for the hydroxylation activity. The
guanidinium group of L-Arg is hydrogen bonding with the PLP phosphate group, T12, S91
and the carbonyl groups of S248 and D249 from the other chain. The L-Arg homologs, L-
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citrulline, L-canavanine and methyl-L-arginine, disrupt the coordinations and resulted in
the loss of hydroxylation. The side chain of D-Arg pointed away from the PLP cofactor and
disrupted the N-terminus interaction, which also leads to the inactivity. The length of the
substrate is also important for SwMppP activities. Shorter L-Arg analog, L-Orn cannot be
deaminated or hydroxylated.

5.5 Reference
[1] Goldberg, J. M., and Kirsch, J. F. (1996) The Reaction Catalyzed by Escherichia coli
Aspartate Aminotransferase Has Multiple Partially Rate-Determining Steps, While
That Catalyzed by the Y225F Mutant Is Dominated by Ketimine Hydrolysis,
Biochemistry 35, 5280-5291.
[2] Lu, Z., Nagata, S., McPhie, P., and Miles, E. W. (1993) Lysine 87 in the beta subunit of
tryptophan synthase that forms an internal aldimine with pyridoxal phosphate
serves critical roles in transimination, catalysis, and product release, The Journal of
biological chemistry 268, 8727-8734.
[3] Han, L., Schwabacher, A. W., Moran, G. R., and Silvaggi, N. R. (2015) Streptomyces
wadayamensis MppP Is a Pyridoxal 5'-Phosphate-Dependent L-Arginine alphaDeaminase, gamma-Hydroxylase in the Enduracididine Biosynthetic Pathway,
Biochemistry 54, 7029-7040.
[4] Pacheco, A. A., McGarry, J., Kostera, J., and Corona, A. (2011) Techniques for
investigating hydroxylamine disproportionation by hydroxylamine oxidoreductases,
Methods in enzymology 486, 447-463.
[5] Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data collected in
oscillation mode, Methods in enzymology 276, 307-326.
[6] Vonrhein, C., Blanc, E., Roversi, P., and Bricogne, G. (2007) Automated structure solution
with autoSHARP, Methods in molecular biology (Clifton, N.J.) 364, 215-230.
[7] Cowtan, K. (2006) The Buccaneer software for automated model building. 1. Tracing
protein chains, Acta crystallographica. Section D, Biological crystallography 62, 10021011.
[8] McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., and Read,
R. J. (2007) Phaser crystallographic software, Journal of applied crystallography 40,
658-674.
[9] Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and development
of Coot, Acta crystallographica. Section D, Biological crystallography 66, 486-501.
[10] Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J.,
Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., McCoy, A. J., Moriarty, N. W.,
265

Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S., Terwilliger, T. C., and
Zwart, P. H. (2010) PHENIX: a comprehensive Python-based system for
macromolecular structure solution, Acta Crystallographica Section D: Biological
Crystallography 66, 213-221.
[11] Word, J. M., Lovell, S. C., Richardson, J. S., and Richardson, D. C. (1999) Asparagine and
glutamine: using hydrogen atom contacts in the choice of side-chain amide
orientation11Edited by J. Thornton, Journal of molecular biology 285, 1735-1747.
[12] Urzhumtseva, L., Afonine Pv Fau - Adams, P. D., Adams Pd Fau - Urzhumtsev, A., and
Urzhumtsev, A. Crystallographic model quality at a glance.
[13] Terwilliger, T. C., Adams, P. D., Read, R. J., McCoy, A. J., Moriarty, N. W., GrosseKunstleve, R. W., Afonine, P. V., Zwart, P. H., and Hung, L.-W. (2009) Decision-making
in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol
wizard, Acta Crystallographica Section D 65, 582-601.
[14] Meister, A. (1952) Enzymatic preparation of alpha-keto acids, The Journal of biological
chemistry 197, 309-317.
[15] Vlessis, A. A., Bartos, D., and Trunkey, D. (1990) Importance of spontaneous alphaketoacid decarboxylation in experiments involving peroxide, Biochemical and
biophysical research communications 170, 1281-1287.
[16] Li, C., and Lu, C.-D. (2009) Arginine racemization by coupled catabolic and anabolic
dehydrogenases, Proceedings of the National Academy of Sciences 106, 906-911.
[17] Bertoldi, M., and Borri Voltattorni, C. (2000) Reaction of dopa decarboxylase with Laromatic amino acids under aerobic and anaerobic conditions, The Biochemical
journal 352 Pt 2, 533-538.
[18] Bertoldi, M., and Borri Voltattorni, C. (2003) Reaction and substrate specificity of
recombinant pig kidney Dopa decarboxylase under aerobic and anaerobic
conditions, Biochim Biophys Acta 1647, 42-47.
[19] Bunik, V. I., Schloss, J. V., Pinto, J. T., Dudareva, N., and Cooper, A. J. (2011) A survey of
oxidative paracatalytic reactions catalyzed by enzymes that generate carbanionic
intermediates: implications for ROS production, cancer etiology, and
neurodegenerative diseases, Advances in enzymology and related areas of molecular
biology 77, 307-360.
[20] Nematollahi, A., Sun, G., Harrop, S. J., Hanrahan, J. R., and Church, W. B. (2016)
Structure of the PLP-Form of the Human Kynurenine Aminotransferase II in a Novel
Spacegroup at 1.83 A Resolution, International journal of molecular sciences 17, 446.
[21] Okamoto, A., Higuchi, T., Hirotsu, K., Kuramitsu, S., and Kagamiyama, H. (1994) X-ray
crystallographic study of pyridoxal 5'-phosphate-type aspartate aminotransferases
from Escherichia coli in open and closed form, Journal of biochemistry 116, 95-107.
[22] Eliot, A. C., and Kirsch, J. F. (2004) Pyridoxal phosphate enzymes: mechanistic,
structural, and evolutionary considerations, Annual review of biochemistry 73, 383415.
[23] Krissinel, E., and Henrick, K. (2004) Secondary-structure matching (SSM), a new tool
for fast protein structure alignment in three dimensions, Acta crystallographica.
Section D, Biological crystallography 60, 2256-2268.
[24] Kirsch, J. F., Eichele, G., Ford, G. C., Vincent, M. G., Jansonius, J. N., Gehring, H., and
Christen, P. (1984) Mechanism of action of aspartate aminotransferase proposed on
the basis of its spatial structure, Journal of molecular biology 174, 497-525.
266

[25] Mehta, P. K., Hale, T. I., and Christen, P. (1993) Aminotransferases: demonstration of
homology and division into evolutionary subgroups, European Journal of
Biochemistry 214, 549-561.
[26] Yano, T., Kuramitsu, S., Tanase, S., Morino, Y., and Kagamiyama, H. (1992) Role of
Asp222 in the catalytic mechanism of Escherichia coli aspartate aminotransferase:
the amino acid residue which enhances the function of the enzyme-bound coenzyme
pyridoxal 5'-phosphate, Biochemistry 31, 5878-5887.
[27] Yano, T., Mizuno, T., and Kagamiyama, H. (1993) A hydrogen-bonding network
modulating enzyme function: asparagine-194 and tyrosine-225 of Escherichia coli
aspartate aminotransferase, Biochemistry 32, 1810-1815.
[28] Hayashi, H., Mizuguchi, H., Miyahara, I., Nakajima, Y., Hirotsu, K., and Kagamiyama, H.
(2003) Conformational change in aspartate aminotransferase on substrate binding
induces strain in the catalytic group and enhances catalysis, The Journal of biological
chemistry 278, 9481-9488.
[29] McPhalen, C. A., Vincent, M. G., Picot, D., Jansonius, J. N., Lesk, A. M., and Chothia, C.
(1992) Domain closure in mitochondrial aspartate aminotransferase, Journal of
molecular biology 227, 197-213.
[30] Clausen, T., Schlegel, A., Peist, R., Schneider, E., Steegborn, C., Chang, Y. S., Haase, A.,
Bourenkov, G. P., Bartunik, H. D., and Boos, W. (2000) X-ray structure of MalY from
Escherichia coli: a pyridoxal 5'-phosphate-dependent enzyme acting as a modulator
in mal gene expression, The EMBO journal 19, 831-842.
[31] Islam, M. M., Hayashi, H., Mizuguchi, H., and Kagamiyama, H. (2000) The substrate
activation process in the catalytic reaction of Escherichia coli aromatic amino acid
aminotransferase, Biochemistry 39, 15418-15428.
[32] Cunin, R., Glansdorff, N., Piérard, A., and Stalon, V. (1986) Biosynthesis and metabolism
of arginine in bacteria, Microbiological Reviews 50, 314-352.
[33] Bertoldi, M., Cellini, B., Montioli, R., and Borri Voltattorni, C. (2008) Insights into the
mechanism of oxidative deamination catalyzed by DOPA decarboxylase,
Biochemistry 47, 7187-7195.
[34] Burkhard, P., Dominici, P., Borri-Voltattorni, C., Jansonius, J. N., and Malashkevich, V. N.
(2001) Structural insight into Parkinson's disease treatment from drug-inhibited
DOPA decarboxylase, Nature structural biology 8, 963-967.
[35] Johnson, K. A. (2009) Chapter 23 Fitting Enzyme Kinetic Data with KinTek Global
Kinetic Explorer, In Methods in enzymology, pp 601-626, Academic Press.
[36] Johnson, K. A., Simpson, Z. B., and Blom, T. (2009) FitSpace Explorer: An algorithm to
evaluate multidimensional parameter space in fitting kinetic data, Analytical
Biochemistry 387, 30-41.
[37] Johnson, K. A., Simpson, Z. B., and Blom, T. (2009) Global Kinetic Explorer: A new
computer program for dynamic simulation and fitting of kinetic data, Analytical
Biochemistry 387, 20-29.

267

Appendices
Appendix A: Crystallographic data collection and refinement statistics.
RitR(C128
S)
(5U8K)
Space group

RitRox
(5U8M)

RitR(C128
D)

rdlv

rd2lv

(5VFA)

C121

P212121

C121

C121

P21212

141.1, 60.1,

74.3, 74.8,

142.8, 59.7,

93.9, 50.0,

40.2, 115.3,

53.3

102.8

52.5

63.0

125.4

90.0, 96.0,

90.0, 90.0,

90.0, 96.3,

90.0, 121.4,

90.0, 90.0,

90.0

90.0

90.0

90.0

90.0

Resolution (Å)

40.33-1.69

50.00-2.10

50.00-1.45

50.00-1.83

50.00-2.60

(last shell)a

(1.75-1.69)

(2.14-2.10)

(1.48-1.45)

(1.86-1.83)

(2.64-2.60)

0.97872

0.97872

0.97857

0.97857

0.97872

276131(24

206898(88

396912(14

81689(326

263987(100

543)

42)

482)

6)

59)
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33913(166

76689(338

21809(103
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4)
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99.9 (99.6)

99.0 (89.1)

99.1(97.0)
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0.071

0.046
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(0.340)

(0.586)

(0.498)

(0.436)

(0.890)
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5.6 (5.1)

6.1 (5.3)

5.2 (4.3)

3.7 (3.2)

14.2 (10.9)

<I/σ(I)>a

16.6 (8.1)

25.2 (2.5)

28.6 (2.9)

13.3 (2.6)

16.9 (3.3)

23890

17730

Cell dimensions
a, b, c (Å)
α, β, γ (°)

Wavelength (Å)
No. of reflections
Observed
Unique
Completeness (%)a
Rmerge (%)a,b

18645(919)
100.0
(100.0)

Model Refinement Statistics
Reflections in work
set

91682

64031

268

76664

Reflections in test

3718

3805

2000

1204

1770

0.1435

0.1881

0.1641

0.2357

0.1976

(0.1685)

(0.2309)

(0.1854)

(0.2767)

(0.2886)
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458
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733
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49
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17
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1
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Protein atoms

12.9

46.3

25.9

24.1

43.3

Solvent

27.4

40.7

36.4

30.5

38.0

Bond lengths (Å)

0.010

0.011

0.008

0.012

0.015

Bond angles (°)

1.021

1.053

0.976

1.311

1.474

0.11

0.26

0.14

0.22

0.40
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95.7/3.0/1.
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3
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(Å2) c

RMS deviations

Coordinate error
(Å)
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Appendix B: Crystallographic data collection and refinement statistics.

Space group
Cell dimensions
a, b, c (Å)
α, β, γ (°)
Resolution (Å)
(last shell)a
Wavelength (Å)
No. of reflections
Observed
Unique
Completeness (%)a
Rmerge (%)a,b
Multiplicity
<I/σ(I)>a
Model Refinement Statistics
Reflections in work set
Reflections in test set
Rcryst (Rfree)
No. of residues
No. of solvent atoms
Number of TLS groups
Average B-factor (Å2) c
Protein atoms
Ligandd
Solvent
RMS deviations
Bond lengths (Å)
Bond angles (°)
Coordinate error (Å)
Ramachandran statistics
(favored/allowed/outliers)
a

Q15Z91
P212121

Q15Z91·GTP
P212121

82.1, 116.0, 167.6
90.0, 90.0, 90.0
50.00-1.85
(1.88-1.85)
0.97872

82.9, 116.5, 167.3
90.0, 90.0, 90.0
50.00-1.95
(1.98-1.95)
0.97857

797511(33484)
135739 (6671)
100.0 (99.8)
0.090 (0.613)
5.9 (5.0)
17.9 (2.7)

720622(28138)
117445(5618)
98.8(95.6)
0.103 (0.540)
6.1 (5.0)
13.5 (2.7)

135607
2000
0.1662 (0.1833)
1192
931
8

117218
1996
0.2616 (0.3161)
1073
427
9

38.2
25.4
41.8

56.8
41.5
45.1

0.011
1.259
0.17

0.013
1.667
0.27

96.8/2.5/0.7

90.1/6.2/3.8

Values in parentheses apply to the high-resolution shell indicated in the resolution row.

R = Σ(||Fobs|-scale*|Fcalc||) / Σ |Fobs|.
Isotropic equivalent B factors, including contribution from TLS refinement.
d In the structure of Q15Z91, “ligands” refers to c-di-GMP and citrate. In the structure of Q15Z91·GTP,
“ligands” refers to c-di-GMP and GTP.
b
c
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Appendix C: Crystallographic data collection and refinement statistics.
SwMppP
P212121

SwMppP·D-Arg
P212121

SwMppP·L-Arg
P212121

SwMppP·2KA
P212121

SwMppP·4HKA
P212121

a, b, c (Å)

85.7, 108.3, 195.4

86.8, 109.1, 194.8

85.8, 108.4, 196.2

85.9, 108.8, 195.5

86.0, 108.4, 196.5

α, β, γ (°)

90.0, 90.0, 90.0

90.0, 90.0, 90.0

90.0, 90.0, 90.0

90.0, 90.0, 90.0

90.0, 90.0, 90.0

Resolution (Å)

41.45-2.10
(2.14-2.10)

44.53-2.25
(2.29-2.25)

50.00-2.20
(2.24-2.20)

44.59-1.83
(1.87-1.83)

50.00-1.93
(1.96-1.93)

0.97852 (D)

0.97856 (G)

0.97872

0.97849

0.97856

Observed

1532933(60186)

256371 (12494)

408941 (15090)

1055413 (53434)

650654 (25173)

Unique

106188 (5236)

79816 (3984)

85820 (3839)

160466 (7902)

135654 (6682)

100.0 (100.0)

90.2 (91.2)

91.6 (84.1)

99.9 (100.0)

98.4 (98.3)

0.106 (0.734)

0.106 (0.726)

0.057 (0.193)

0.074 (0.567)

0.066 (0.488)

14.4 (11.5)

3.2 (3.1)

4.8 (3.9)

6.6 (6.8)

4.8 (3.8)

30.7 (5.2)

10.0 (1.9)

24.7 (6.1)

14.4 (3.3)

21.8 (2.3)

100876
5256
0.148 (0.177)
1417
903
29

76747
3015
0.162 (0.197)
1404
693
33

85724
1999
0.145 (0.195)
1458
745
30

160326
2000
0.151 (0.175)
1434
1032
31

135549
2000
0.156 (0.178)
1454
930
20

Protein atoms

32.0

34.1

28.8

31.2

32.4

Ligands

30.9

43.9

31.6

37.6

41.9d

Solvent

35.6

36.6

33.0

37.3

36.9

Space group
Cell dimensions

(last shell)

a

Wavelength (Å)
No. of reflections

Completeness (%)
Rmerge (%)

a

a,b

Multiplicity
a

<I/σ(I)>
Model Refinement Statistics
Reflections in work set
Reflections in test set
Rcryst (Rfree)
No. of residues
No. of solvent atoms
Number of TLS groups
Average B-factor (Å2) c

d
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d

RMS deviations
Bond lengths (Å)

0.013

0.015

0.010

0.010

0.011

Bond angles (°)

1.395

1.565

1.141

1.140

1.155

Coordinate error (Å)

0.17

0.22

0.17

0.19

0.19

98.3 / 1.7 /0.0

98.4 / 1.6 / 0.0

97.2 / 2.5 / 0.3

97.6/ 2.0 / 0.4

98.2/ 1.8 / 0

Ramachandran

statistics

(favored/allowed/outliers)
a

Values in parentheses apply to the high-resolution shell indicated in the resolution row.

b

R = Σ(||Fobs|-scale*|Fcalc||) / Σ |Fobs|.
Isotropic equivalent B factors, including contribution from TLS refinement.
d
In L-Arg complex structure, “ligands” refers to the L-Arg-PLP unit; in the 2KA complex structure,
it refers to the 2KA and L-Arg-PLP molecules; and in the 4HKA complex structure, it refers to the
4HKA molecules. In the protein only, “ligands” refer to Cl- ion.
c
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E15A·L-Arg
P1 21 1

H29A
P212121

H29S
P212121

H29A·L-Arg
P212121

H29S·L-Arg
P212121

F115Y
I121

a, b, c (Å)

64.4, 200.5,
139.9

85.9, 108.3,
195.7

85.8, 108.0,
195.7

85.5, 107.7,
195.5

111.62, 63.25,
243.10

α, β, γ (°)

90.0, 103.3, 90.0

90.0, 90.0, 90.0

85.8, 108.0,
195.6
90.0, 90.0,
90.0

90.0, 90.0, 90.0

90.0, 90.0, 90.0

90.0, 90.29, 90.0

Resolution (Å)

50.00-2.20
(2.28-2.24)

50.00-1.90
(1.93-1.90)

50.00-1.95
(1.98-1.95)

50.00-2.30
(2.34-2.30)

50.00-2.10
(2.14-2.10)

60.77-1.92
(1.96-1.92)

Space group
Cell dimensions

(last shell)a

0.97872

Wavelength (Å)
No. of reflections
Observed

977686(170041)

837303(143854)

252515(12536)

494009(79839)

726298 (27943)

433940 (18551)

Unique

36991(8030)

35984 (7049)

131339(6470)

17981(3685)

104882 (5113)

128901 (6294)

Completeness (%)a

97.0 (92.2)

99.4 (99.1)

99.8 (99.3)

97.8 (92.3)

99.8(98.9)

99.7 (98.7)

Rmerge (%)a,b

0.110 (0.588)

0.076 (0.555)

0.083 (0.551)

0.078 (0.369)

0.088 (0.460)

1.162 (3.647)

Multiplicity

5.7 (4.6)

5.8 (5.1)

7.1 (6.8)

6.2 (4.9)

6.9 (5.5)

3.4 (2.9)

<I/σ(I)>a
Model Refinement Statistics
Reflections in work set
Reflections in test set
Rcryst (Rfree)
No. of residues
No. of solvent atoms

14.9 (2.1)

21.7 (2.8)

22.9 (3.1)

20.5 (3.7)

22.6 (3.4)

1.9 (0.3)

156239
2001
0.2054(0.2656)
2839
1432
72

143740
2000
0.1503(0.1818)
1421
1072
30

131221
1999
0.1508(0.1838)
1421
943
25

79748
1999
0.1607(0.2183)
1456
472
26

104781
2000
0.1562(0.1989)
1455
688
30

120037
1827
0.2620(0.3453)
1441
468
18

Protein atoms

46.5

29.1

30.4

41.4

37.8

23.1

Ligands

38.0d

25.1d

28.1d

38.8d

35.4d

-

Solvent

39.0

37.5

36.9

39.2

40.1

23.1

0.012

0.009

0.010

0.011

0.011

0.014

Number of TLS groups
Average B-factor (Å2) c

RMS deviations
Bond lengths (Å)
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Bond angles (°)

1.255

1.055

1.108

1.181

1.173

1.411

Coordinate error (Å)

0.29

0.17

0.15

0.22

0.17

0.38

97.2 / 2.5 / 0.3

98.1 / 1.6 / 0.4

98.2 / 1.5 / 0.4

97.1/ 2.6 / 0.3

97.2/ 2.4 / 0.4

90.6 / 7.4 / 2.0

Ramachandran statistics
(favored/allowed/outliers)
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Appendix D: Proton NMR spectra for the products of SwMppP and its N-terminal
mutants with L-Arg.
(A) Pure L-Arg (2.0 mM,

); (B) a reaction mixture containing 10.0 μM SwMppP and 2.0 mM L-Arg ( ),; (C) a

reaction mixture containing 50.0 μM SwMppPΔ1-22 and 2.0 mM L-Arg ( ); (D) a reaction mixture containing
50.0 μM SwMppPT12A and 2.0 mM L-Arg ( ); (E) a reaction mixture containing 50.0 μM SwMppPE15A and
2.0 mM L-Arg ( ); (F) a reaction mixture containing 50.0 μM SwMppPE15Q and 2.0 mM L-Arg ( ); (G) a
reaction mixture containing 50.0 μM SwMppPT12A/E15A and 2.0 mM L-Arg ( ). All in 20 mM sodium
phosphate buffer (pH 8.4).
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Appendix E: Proton NMR spectra for SwMppP active site mutants with L-Arg.
(A) L-Arg (2.0 mM) with MES (2.0 mM); (B) a reaction mixture containing 10.0 μM SwMppPH29A in MES pH 6.7
(2 mM, final concentration) buffer and 2.0 mM L-Arg; (C) a reaction mixture containing 10.0 μM SwMppPH29A
in MES pH 6.7 (2 mM, final concentration) buffer and 2.0 mM L-Arg; (D) a reaction mixture containing 10.0
μM SwMppPF115Y in MES pH 6.7 (2 mM, final concentration) buffer and 2.0 mM L-Arg; (E) a reaction mixture
containing 10.0 μM SwMppPF191Y in MES pH 6.7 (2 mM, final concentration) buffer and 2.0 mM L-Arg; (F) a
reaction mixture containing 10.0 μM SwMppPD218S in MES pH 6.7 (2 mM, final concentration) buffer and 2.0
mM L-Arg.
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Appendix F: Overlay the structure (A) and active site (B) of SwMppPL-Arg with
SwMppP2

Appendix G: Overlay the structure (A) and active site (B) of SwMppPL-Arg with
SwMppP3
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